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ABSTRACT 
Neurospora crassa is a model organism for circadian rhythm research. The FRQ-
WCC feedback loop is the main mechanism driving rhythms in Neurospora. Recent 
evidence revealed a second oscillator in the absence of the FRQ-WCC loop, the FRQ-less 
oscillator (FLO). The purpose of this study was to identify the components and 
mechanism of the FLO. One mutation, UV90, disrupts the rhythmic conidiation of the 
FLO, and locating this gene will lead to better understanding of the FLO mechanism. 
Mapping of the UV90 gene location was performed using Cleaved Amplified 
Polymorphic Sequence (CAPS) markers and gene knockout screens. DNA sequencing 
and complementation tests were performed to characterize the nature of the mutation and 
confirm the restoration of the UV90 phenotype. 
Sequencing and complementation tests failed to reveal the exact nature of the 
mutation; however mapping and gene knockout studies confirmed the UV90 gene is 
represented by locus NCU05950 on Linkage Group VI. 
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CHAPTERl 
INTRODUCTION 
1.1 Circadian rhythms 
Circadian rhythms control many physiological processes and are found in nearly 
all organisms including mammals, fungi, bacteria, and plants (Liu and Bell-Pedersen, 
2006; Harmer, 2009; Brunner and Schafmeier, 2006). Circadian clocks affect 
physiological processes such as the sleep-wake cycle in humans, plant flowering, and 
even behavioural activities such as hibernation in mammals and migration patterns in 
butterflies and birds (Harmer, 2009). In order for a rhythm to be classified as circadian, it 
needs to exhibit 3 criteria: it has a period length of approximately 24 hours under 
constant conditions (free-running period), it is entrained by environmental factors (i.e. 
light and temperature), and it can compensate for fluctuations in temperature with little 
effect on the period length (Liu and Bell-Pedersen, 2006; Harmer, 2009; Brunner and 
Schafmeier, 2006; Johnson et al., 2008; O'Neill and Reddy, 2011; Lakin-Thomas, 
2006a). Daily rhythms in organisms are generally thought to arise from internal 
biological (genetic) clocks that are entrained by environmental factors such as light and 
temperature (Ellman et al., 1984; Harmer, 2009; Nagel and Kay, 2012). It is believed 
circadian rhythms can allow an organism to anticipate environmental changes and adjust 
physiological processes accordingly (Harmer, 2009; Mohawk et al., 2012). Free-running 
rhythms are seen in the absence of cycles of light and temperature, yet often do not fall 
into 24-hour periods (Ellman et al., 1984; Harmer, 2009). It is thought that external, 
1 
environmental factors adjust these internal cellular and genetic rhythms to a 24-hour 
cycle (Ellman et al., 1984; Harmer, 2009; Nagel and Kay, 2012). Rhythms have been 
seen in gene transcription in individual cells with no coupling of clocks between 
neighbouring cells (Harmer, 2009). However, rhythms have also been seen in 
cyanobacteria proteins in vitro, and even in red blood cells which do not contain DNA, 
indicating that gene transcription is not the sole component that can produce a rhythm 
(Harmer, 2009; Johnson et al., 2008; Mohawk et al., 2012; O'Neill and Reddy, 2011; 
Lakin-Thomas, 2006a; Lakin-Thomas, 2006b; Nakajima et al., 2005). 
In the past, some argued that environmental factors were the only force driving 
rhythms in organisms, using cues from the Earth's daily rotation on its axis (Ellman et al., 
1984). A clear endogenous rhythm was seen in Neurospora crassa cultures that were 
sent to outer space and kept in the dark, proving that a rhythm can still be seen without 
the effect of environmental factors (Ellman et al., 1984). The amplitude of this 
endogenous rhythm in outer space was reduced, thus indicating that the environment does 
play an important role, yet again, it is not the only factor that controls circadian rhythms 
(Ellman et al., 1984). 
There is some debate as to whether or not there is one main oscillator controlling 
circadian rhythms in organisms. Evidence of multiple oscillators has been observed in 
several organisms (Swann and Turek, 1985; Harmer, 2009; Johnson et al., 2008; Mohawk 
et al., 2012; Zhang and Kay, 2010). In constant exposure to light, rodents can experience 
a splitting of the locomotor activity into two circadian rhythms occurring 12 hours apart, 
2 
as opposed to every 24 hours (Swann and Turek, 1985; Pickard et al., 1984; Pickard and 
Turek, 1982). The 12 hour circadian rhythms initially have different free-running 
periods, but then become synchronized with each other, indicating that there are multiple 
oscillators involved (Swann and Turek, 1985; Pickard et al., 1984; Pickard and Turek, 
1982). Different free-running periods are often a strong indicator of multiple oscillators 
(Harmer, 2009; Pickard et al., 1984; Pickard and Turek, 1982). It is also common for 
individual components of the clock to have multiple functions. For example, 
glucocorticoid release from the adrenal cortex in mammals is regulated by the 
suprachiasmatic nucleus (SCN) in the brain, as well as rhythmic levels of corticotropin 
releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) (Mohawk et al., 
2012). Multiple interactions between clock components make circadian systems more 
complex to study (Harmer, 2009; Mohawk et al., 2012). Given the wide range of 
organisms in which circadian rhythms are found, the important physiological processes 
they control, and the high conservation between organisms, it is important to understand 
how these circadian systems function (Liu and Bell-Pedersen, 2006; Hardin, 2009). 
1.2 Circadian rhythms in Drosophila 
The fruit fly, Drosophila melanogaster has long been used in genetic studies and 
has a well-studied circadian rhythm system (Hardin, 2009). Drosophila produced the 
first genetic model of circadian rhythms: the transcription-translation feedback loop 
(TTFL) (Hardin, 2009). Gene transcription results in the translation of a protein product, 
which in turn will feedback once its levels are high enough and represses its own gene 
3 
transcription (usually by repressing other proteins). After the protein levels drop, the 
repression is lifted and gene transcription and translation begins again. This rhythm 
occurs in many organisms on a 24 hour cycle, with protein levels peaking at specific 
times each day (Hardin, 2009). Molecular studies using Drosophila have increased the 
knowledge of TTFLs not only in insects but other organisms as well. 
In Drosophila, the central pacemaker cells are found in the lateral neurons in the 
brain (Cashmore et al., 1999). Pigment-dispersing factor-expressing neurons in the brain 
control the locomotor rhythms in Drosophila (Lim and Allada, 2013; Plautz et al., 1997). 
The Drosophila circadian system is shown in Figure 1 (Hardin, 2009). Phosphorylated 
CLOCK (CLK) protein forms a heterodimer with CYCLE (CYC) to activate gene 
transcription of period (per), timeless (tim ), and vrille ( vri), and clockwork orange ( cwo) 
(Fig. 1) (Hardin, 2009; Ceriani et al., 1999; Van Gelder et al., 2003). CLK-CYC will 
bind to the E-box (CACGTG sequence) on the per, tim, vri and cwo gene promoters 
(Hardin, 2009; Ceriani et al., 1999; Avivi et al., 2001). The mRNA and protein levels of 
per and tim cycle approximately every 24 hours (Ceriani et al., 1999; Plautz et al., 1997; 
Leloup et al., 1999). A complex with PER and DOUBLETIME (DBT) kinase (and 
sometimes TIM) will in turn feedback and repress transcription by CLK-CYC (Hardin, 
2009; Avivi et al., 2001; Van Gelder et al., 2003). VRI has also been seen to repress 
activation of elk and tim (Zhang and Kay, 2010; Van Gelder et al., 2003). TIM may also 
be involved in repressing transcription by the CLK-CYC complex (Hardin, 2009). 
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Increased phosphorylation of CLK causes the release of CLK-CYC from the per and tim 
genes (Hardin, 2009). 
PER and TIM are phosphorylated by casein kinase 2 (CK2) and Shaggy (SGG), 
respectively, and dephosphorylated by protein phosphatases 1 and 2a (PPl, PP2a) 
(Hardin, 2009; Zhang and Kay, 2010; Van Gelder et al., 2003). PER-DBT-TIM complex 
will bind to CLK in the nucleus and increase phosphorylation, causing CLK-CYC 
complex to release from the gene promoters, forming a negative feedback loop to repress 
their own transcription (Hardin, 2009; Ceriani et al., 1999; Leloup et al., 1999). 
Phosphorylation of PER causes its degradation, and allows CLK-CYC to positively 
regulate and activate transcription once PER and TIM levels drop (Hardin, 2009). The 
vri gene, which is also activated by CLK-CYC, feeds back and negatively regulates by 
repressing Clk transcription (Hardin, 2009; Van Gelder et al., 2003). It is unknown how 
the CWO protein affects the circadian rhythm, yet is it believed to be important in the 
clock system, since cwo knockouts have reduced CLK-CYC activated transcription 
(Hardin, 2009). 
Another protein, CRYPTOCHROME (CRY) acts as a photoreceptor and has been 
shown to repress function of PER-TIM complex in response to light (Fig. 1) (Ceriani et 
al., 1999; Cashmore et al., 1999). Light also regulates TIM protein levels, and CRY 
protein has been shown to interact with TIM to stop the PER-TIM complex from 
repressing transcription (Ceriani et al., 1999; Leloup et al., 1999; Cashmore et al., 1999). 
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per is expressed in cells in the head, thorax and abdominal tissues in Drosophila, 
indicating that individual cells are capable of running rhythms autonomously (Plautz et 
al., 1997; Levine et al., 2002). It is possible that individual cells are photoreceptive and 
capable of running their own rhythms, and receive their cues and entrainment from light 
in the environment as opposed to the main oscillator in the brain (Plautz et al., 1997). 
The circadian rhythms of locomotor activity in Drosophila that were housed together in 
total darkness for 2 weeks were more synchronized than flies that were isolated (Levine 
et al., 2002). This was also observed in honey bees, where the circadian system 
developed faster in bees that were housed together as opposed to isolated (Eban-
Rothschild et al., 2012). This is further evidence that circadian rhythms take cues from 
the environment, and possibly even from other organisms (Levine et al., 2002; Eban-
Rothschild et al., 2012). 
It was recently found that another protein, ATAXIN-2 (ATX2), activated PER 
translation (Lim and Allada, 2013). ATX2 interacts with TWENTY-FOUR (TYF), 
which activates translation of PER (Lim and Allada, 2013). ATX2 in humans has been 
implicated in diseases such as amyotrophic lateral sclerosis and Parkinson's disease (Lim 
and Allada, 2013). This indicates that there are many other important components of the 
Drosophila system that have not yet been discovered that can also be related to diseases 
in other organisms (Lim and Allada, 2013). 
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1.3 Circadian rhythms in plants 
Circadian rhythms in plants control many processes such as leaf movement, 
timing of flowering, plant growth, photosynthesis, and scent release (Harmer, 2009; 
Nagel and Kay, 2012). Not as much is known about the circadian system in plants as 
compared to other organisms such as Drosophila and Neurospora (Salome and McClung, 
2004; Green and Tobin, 1999). One of the most studied plants in circadian rhythm 
research is Arabidopsis thaliana (Salome and McClung, 2004). The current model of the 
circadian system in Arabidopsis is shown in Figure 2. 
In Arabidopsis, red light photoreceptors cause the transcription of the LHCB gene, 
which shows a circadian rhythm of gene expression (Harmer, 2009; Salome and 
McClung, 2004). CIRCADIAN CLOCK ASSOCIATED 1 (CCAl) protein was found to 
bind to the light response element on the LHCB promoter. A similar protein called LATE 
ELONGATED HYPOCOTYL (LHY) was also discovered (Salome and McClung, 2004). 
Overexpression of CCAl and LHY cause similar disruptions in plant rhythms: 
arrhythmic leaf movement and LHCB gene expression, long hypocotyls and late 
flowering (Salome and McClung, 2004; Nagel and Kay, 2012). ccal or lhy null mutants 
produce a shorter period in leaf movement and LHCB expression, yet double mutants are 
arrhythmic (Salome and McClung, 2004; Green and Tobin, 1999). Either ccal or lhy 
null mutants do not produce completely arrhythmic oscillations, suggesting that they may 
be able to compensate for each other (Salome and McClung, 2004; Green and Tobin, 
1999). 
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CCAl and LHY bind to and repress expression of the TIMING OF CAB 
EXPRESSION 1 (TOCJ) gene promoter when their levels are higher (Fig. 2, Loop A) 
(Salome and McClung, 2004; Harmer, 2009; Nagel and Kay, 2012). CCAJ and LHY 
expression is also induced by light (Harmer, 2009; Green and Tobin, 1999). CCAl also 
represses expression of the LHY gene (Green and Tobin, 1999). TOCl in turn will 
positively regulate expression of CCAJ and LHY genes when their protein levels are low 
(Fig. 2, Loop A) (Salome and McClung, 2004; Harmer, 2009). It is unknown whether or 
not TOCl regulates CCAJ and LHY directly or through another factor (Salome and 
McClung, 2004; Harmer, 2009). Some studies have shown that TOC 1 may repress 
expression of CCAJ and LHY, indicating that more studies need to be done and that the 
circadian system in Arabidopsis is likely more complex than initially believed (Nagel and 
Kay, 2012). 
An unknown component Y may also positively regulate TOCJ expresson (Fig. 2, 
Loop B) (Harmer, 2009). ZEITLUPE (ZTL) protein is responsible for TOCl 
degradation, and it is regulated by GIGANTEA (GI) protein (Fig. 2, Loop D) (Salome 
and McClung, 2004; Harmer, 2009). Pseudo Response Regulators 7 and 9 (PRR7 and 
PRR9) are thought to form another feedback loop with CCAl and LHY (Fig. 2, Loop C) 
(Harmer, 2009; Nagel and Kay, 2012). CCAl and LHY promote expression of PRR7 
and P RR9 genes, and these proteins in turn repress expression of CCAJ and LHY 
(Harmer, 2009; Nagel and Kay, 2012). 
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These multiple feedback loops indicate that there are likely multiple oscillators 
controlling various processes in plants (Harmer, 2009). It is unclear how multiple 
oscillators are interacting and coordinating with each other, however environmental cues 
may be responsible for coupling oscillators together (Harmer, 2009). Blue-light 
photoreceptor proteins called CRYPTOCHROMES (CRYl, CRY2) have been 
discovered in Arabidopsis and are thought to help regulate the circadian rhythm 
(Cashmore et al., 1999). CRYl has been seen to cause shortening of the Arabidopsis 
hypocotyl and cotyledon expansion under blue light (Cashmore et al., 1999). Mutations 
in cry 1 cause an increase in the period of gene expression by approximately 4 hours, and 
cry2 mutants exhibit late flowering (Cashmore et al., 1999). 
There is recent evidence that melatonin in plants may play a role in the circadian 
rhythm in the same manner as it does in mammals (Paredes et al., 2009). In Eichhornia 
crassipes (Common Water Hyacinth), melatonin exhibits a daily circadian rhythm with 
levels peaking at sunset (Paredes et al., 2009). In Chenopodium rubrum (Red 
Goosefoot), melatonin also exhibits a daily rhythm but with levels peaking at night 
(Paredes et al., 2009). Melatonin was seen to represses flowering in C. rubrum and 
Arabidopsis thaliana (Paredes et al., 2009). Further studies are needed on melatonin in 
other plants and the exact role it plays in circadian rhythms (Paredes et al., 2009). 
1.4 Circadian rhythms in bacteria 
Cyanobacteria are one of the oldest groups of organisms on earth and currently 
the only prokaryotes that show evidence of a circadian rhythm mechanism (Dong et al., 
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2010; Tomita et al., 2005; Dvomyk et al., 2003). The most commonly studied is 
Synechococcus elongatus, a unicellular cyanobacterium which possesses a circadian 
clock mechanism (Dong et al., 2010; Johnson et al., 2008). Cyanobacteria are unique in 
the fact that they have a rhythm of phosphorylation and dephosphorylation of proteins, 
which does not require a TTFL typical of circadian systems (Brunner and Schafmeier, 
2006; Zhang and Kay, 2010). 
The main clock mechanism is made up of 3 proteins: KaiA, KaiB, and KaiC and 
is shown in Figure 3 (Dong et al., 2010; Brunner and Schafmeier, 2006; Tomita et al., 
2005; Johnson et al., 2008; Dvomyk et al., 2003). These 3 proteins along with ATP 
produce cyclic phosphorylation of KaiC with an approximate 24 hour period (Dong et al., 
2010; Brunner and Schafmeier, 2006). In constant darkness, KaiC will continue to 
produce rhythmic phosphorylation and dephosphorylation (Brunner and Schafmeier, 
2006). Disruption of the Kai genes results in a loss of the rhythm (Brunner and 
Schafmeier, 2006). This cycling will synchronize itself with the environment through 
light input sensed by the cyanobacteria (Dong et al., 2010). 
KaiC, upon stimulation by KaiA, will autophosphorylate itself, and will then 
undergo spontaneous dephosphorylation (Dong et al., 201 O; Brunner and Schafmeier, 
2006). KaiB will bind to dephosphorylated KaiC, which inactivates KaiA, causing 
further dephosphorylation ofKaiC (Dong et al., 2010; Brunner and Schafmeier, 2006). 
Mutations to residues in KaiC can abolish the circadian rhythm, and mutated forms of 
KaiA cause changes in phosphorylation levels of KaiC and a shorter period (Dong et al., 
10 
2010; Brunner and Schafmeier, 2006; Tomita et al., 2005). The phosphorylation cycle 
causes changes to the conformation ofKaiC protein, yet the exact role and purpose of this 
conformational change is unknown (Dong et al., 2010) 
Clock proteins SasA and RpaA act downstream ofKaiC to control the timing of 
cell division (Fig. 3) (Dong et al., 2010; Johnson et al., 2008). The rate of cell division 
does not have an effect on the clock as the circadian rhythm maintains an approximate 24 
hour rhythm regardless of the rate of cell division (Dong et al., 201 O; Kondo et al., 1997; 
Johnson et al., 2008). Gene transcription levels are also affected by KaiC, yet the 
mechanism is currently unknown (Dong et al., 2010; Brunner and Schafmeier, 2006). 
Input protein CikA binds quinone and represses KaiC activity (Fig. 3) (Dong et 
al., 2010). The pex gene, which encodes a repressor of the KaiA gene, is repressed by 
light input (Dong et al., 2010). Oxidized quinone also destabilizes KaiA by directly 
binding to it, but not in the reduced form, suggesting that the cyanobacteria sense light by 
changes in the oxidation or reduction states of quinone (Dong et al., 2010). 
Because Synechococcus elongatus is a photoautotroph, it was expected that in 
constant darkness (DD) gene expression and protein synthesis would halt, causing a 
disruption in the rhythm of Kai proteins (Tomita et al., 2005). KaiA, KaiB and KaiC 
proteins levels were constant and exhibited no rhythm after transfer to DD (Tomita et al., 
2005). However, KaiC phosphorylation showed a temperature-compensated rhythm in 
DD (Tomita et al., 2005). KaiA, KaiB, and KaiC proteins were incubated in vitro along 
with adenosine triphosphate (ATP) (Nakajima et al., 2005). KaiC exhibited rhythmic 
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phosphorylation with a period of approximately 24 hours (Nakajima et al., 2005). In 
addition, the period of phosphorylation rhythm was temperature compensated, ranging 
from 20-22 hours over a temperature of 25-35°C (Nakajima et al., 2005). This provided 
strong evidence that the KaiA, KaiB, and KaiC phosphorylation oscillator can run 
independently of any gene transcription and is the basis for circadian rhythms in 
cyanobacteria (Tomita et al., 2005; Johnson et al., 2008; Lakin-Thomas, 2006a; Lakin-
Thomas, 2006b; Nakajima et al., 2005). 
It has also been seen that if KaiC is halted at a particular phosphorylation state, 
rhythmic gene expression is still observed in the cyanobacteria, suggesting a TTFL may 
exist independently of the Kai-protein phosphorylation oscillator (Dong et al., 2010; 
Lakin-Thomas, 2006b). However, other researchers have noticed when KaiC 
phosphorylation is halted, a dampening of the gene expression rhythm is observed, 
suggesting that another oscillator may be involved and may interact in some way with the 
Kai protein oscillator (Dong et al., 201 O; Tomita et al., 2005; Johnson et al., 2008). 
Other cyanobacteria such as Synechocystis, Cyanothece, and 
Thermosynechococcus elongatus all have the KaiA, KaiB and KaiC genes (Dong et al., 
2010). Although the main circadian mechanism in cyanobacteria possibly does not 
directly involve a TTFL, regulation of circadian rhythm proteins by phosphorylation has 
been seen in many other organisms (Dong et al., 201 O; Brunner and Schafmeier, 2006). 
The cyanobacteria system brings up the possibility that circadian systems outside of the 
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TTFL may exist in other organisms such as eukaryotes (Johnson et al., 2008; Lakin-
Thomas, 2006a; Lakin-Thomas, 2006b ). 
1.5 Circadian rhythms in mammals 
Circadian rhythms in mammals are generally seen as being quite complex. It is 
believed that, like other organisms, there are multiple oscillators that control circadian 
rhythms in mammals (Swann and Turek, 1985; Mohawk et al., 2012; Zhang and Kay, 
2010). The circadian system controls activities such as feeding, rest, metabolism, body 
temperature, and hormone secretion (Mohawk et al., 2012; Reddy and O'Neill, 2010). 
The suprachiasmatic nucleus (SCN) in the brain hypothalamus is important for 
controlling circadian rhythms in mammals (Plautz et al., 1997; Mohawk et al., 2012; 
Reddy and O'Neill, 2010). It is made up of approximately 20,000 neurons which each 
have individual circadian oscillators that couple together to form a synchronous circadian 
rhythm (Mohawk et al., 2012; Zhang and Kay, 2010). The peripheral oscillators found in 
the fibroblasts, liver, kidneys, lungs and other tissues, are not as robust, and can be easily 
entrained by low-amplitude temperature cycles, whereas the SCN is more resistant to this 
type of entrainment (Mohawk et al., 2012). Mutations in rhythms seen in individual cells 
and tissues can be rescued by the SCN network, indicating that the SCN likely is coupled 
with individual peripheral oscillators to control and synchronize their rhythmicity 
(Mohawk et al., 2012; Zhang and Kay, 2010). 
It has been observed in rodents that food-anticipatory behaviour is rhythmically 
regulated and the circadian rhythm phase will adjust in accordance with the presence of 
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food (Mohawk et al., 2012; Fuller et al., 2008). In humans that are kept in isolation 
chambers, the body temperature and sleep-wake cycles have been observed to split and 
become out of phase with each other, running with different periods (Pickard et al., 
1984). This provides evidence that circadian rhythms controlling various physiological 
processes may be controlled by separate oscillators (Pickard et al., 1984; Pickard and 
Turek, 1982). In hamsters, unilateral ablation of the bilateral SCN was performed, and 
this resulted in the abolishment of the splitting phenomenon and single activity rhythms 
(Pickard and Turek, 1982). This indicated that each side of the bilaterial SCN may 
function as a separate oscillator, and is likely coupled with the other side to control 
circadian rhythms (Pickard and Turek, 1982). 
The circadian system of mammals is shown in Figure 4 (Mohawk et al., 2012). 
The core oscillator in the clock is a TTFL made up of proteins CLOCK (CLK) and Brain 
and Muscle ARNT-like 1 (BMALl) that bind to the E-box and activate transcription of 
period (per], per2) and cryptochrome (cryl, cry2) genes (Fig. 4) (Mohawk et al., 2012; 
Avivi et al., 2001; Zhang and Kay, 2010; Tsuchiya et al., 2009). PER and CRY in turn 
repress transcription of elk and bmal 1 genes, as well repressing their own gene 
transcription (Mohawk et al., 2012; Avivi et al., 2001; Zhang and Kay, 2010; Tsuchiya et 
al., 2009). Another protein called REV-ERBa activated by CLK and BMALl forms a 
negative feedback loop and represses bmall transcription (Mohawk et al., 2012; Zhang 
and Kay, 2010; Tsuchiya et al., 2009). 
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PER and CRY are phosphorylated by casein kinase 1and2 (CKl, CK2) and 
AMP kinase (AMPK), respectively, which targets them for degradation by the 
proteasome by ubiquitin ligases (Mohawk et al., 2012; Tsuchiya et al., 2009). As PER 
and CRY are degraded, their protein levels drop which repeats the cycle of their 
activation by CLK and BMALl (Zhang and Kay, 2010). It is believed that BMALl is 
responsible for entrainment of food-anticipatory behaviour (Fuller et al., 2008). 
Photoreceptors in the retinal ganglions, along with rods and cones, feed back into 
the SCN to provide input to the circadian rhythm for entrainment (Mohawk et al., 2012; 
A vi vi et al., 2001 ). In completely blind mammals, such as the subterranean mole rat, the 
retina is seen to still function in entraining locomotor activity and thermoregulation 
(A vi vi et al., 2001 ). 
1.5.1 Circadian rhythms and human health 
The cells and tissues in the body produce rhythmic outputs of glucose and 
hormone production, and fat storage, which feed back into the SCN (Mohawk et al., 
2012). Disruption of these rhythms may therefore affect metabolic activity. Circadian 
rhythm disruption in humans, seen often in shift workers, can produce serious long-term 
health risks such as increased risk of cancer, strokes and cardiovascular disease (O'Neill 
and Reddy, 2011; Reddy and O'Neill, 2010; Portaluppi et al., 2012). Disruptions to the 
cardiovascular system, such as cardiac arrhythmias, also follow a clear rhythmic pattern, 
occurring more often in the morning and daytime than at night (Portaluppi et al., 2012). 
In shift workers, there are higher risks of breast, colorectal, endometrial and prostate 
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cancers (Reddy and O'Neill, 2010). In addition, diabetes and obesity have also been 
linked to rotational shift work (Reddy and O'Neill, 2010). 
Disrupted sleep patterns in humans has been associated with Alzheimer's, 
Huntington's disease and dementia (Reddy and O'Neill, 2010). In mouse models, it was 
noticed that the disruption of the circadian rhythm via phase shifts produced retrograde 
amnesia, indicating that rhythms may play a role in memory loss and function {Tapp and 
Holloway, 1981). Children with autism have also exhibited severely disrupted sleep-
wake cycles, which may help in diagnosis and treatment of this disease (Glickman, 
2010). 
Sleep disorders have also been linked to substance abuse and addiction, which in 
tum can cause a disruption of the circadian rhythm (Hasler et al., 2012). Substance abuse 
may cause desynchrony in the circadian system, which can possibly lead to continual 
relapses of addictive behaviour (Hasler et al., 2012). Therapy involving sleep-wake 
cycles and light-dark entrainment of the circadian system may aid in treatment of 
addictions (Hasler et al., 2012). 
Increased cancer risks have been seen in humans and rodents that have rhythms 
which are not synchronized with the external environment (Reddy and O'Neill, 2010). 
The circadian system regulates cell division, and arrythmicity may be a factor in 
producing uncontrolled cell division in cancer (Reddy and O'Neill, 2010). In addition, 
many core clock genes such as CLK, BMAL 1, PERl and PER2 have been shown to have 
tumour suppressing abilities and provide protection against DNA damage by chemicals 
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and radiation (Reddy and O'Neill, 2010). Mice with CLK and BMALl mutations were 
more sensitive to treatment from anticancer drugs and exhibited greater body weight loss 
than those with wild type CLK and BMALl (Reddy and O'Neill, 2010). The reduction 
in the number of lymphocytes and neutrophils was also greater in CLK mutant mice 
(Reddy and O'Neill, 2010). Implanted tumours have been seen to grow more rapidly in 
animals that have disrupted rhythms via conditions that simulate jet-lag or shift work 
(Reddy and O'Neill, 2010). 
Peroxiredoxins (proteins in red blood cells) have been found to exhibit a free-
running, 24-hour circadian rhythm in constant conditions that is temperature 
compensated (O'Neill and Reddy, 2011). Levels ofNADH and NADPH in the red blood 
cells were also found to exhibit a 24-hour rhythm, indicating that the rhythmic activity of 
metabolic pathways may be important to their optimal function (O'Neill and Reddy, 
2011 ). Circadian rhythms of calcium and phosphate levels have also been found in the 
blood of healthy human adults (Markowitz et al., 1981 ). Children with 
hypoparathyroidism that are treated with daily Vitamin D doses exhibit blood calcium 
levels that do not follow a circadian rhythm or have a calcium rhythm with a lower 
amplitude (Markowitz et al., 1981 ). Deviations from these rhythmic levels at various 
stages of diseases may therefore be a target for treatment and prevention (Markowitz et 
al., 1981 ). Observing blood calcium levels may be important for detecting abnormalities 
in hormonal and mineral metabolism (Markowitz et al., 1981 ). 
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Circadian rhythm knowledge is now being used in cancer therapy, where the 
timing of drug dosage is controlled to specific times of day (Reddy and O'Neill, 2010). 
The toxic effect of several anticancer drugs has been seen to depend on the time of day it 
is administered (Reddy and O'Neill, 2010). In the case of Huntington's disease in mice, 
a daily sleep cycle has been shown to improve survival and cognitive abilities, leading to 
the possibility of controlling and improving disease symptoms via circadian rhythm 
restoration (Reddy and O'Neill, 2010). 
1.6 Circadian rhythms in Neurospora 
1.6.1 Neurospora as a model organism and life cycle 
Neurospora as a model organism 
Neurospora crassa is a bread mold first reported in Paris in the late 1800s by 
Payen (cited in Galagan et al., 2003). It is non-pathogenic and typically feeds on dead or 
decaying matter (Galagan et al., 2003). It is now extensively used as a model organism 
in genetic studies, specifically circadian rhythm research (Galagan et al., 2003; Liu and 
Bell-Pedersen, 2006). Neurospora provides an advantage since it can be used to easily 
study eukaryotic genetics as compared to using mammals or prokaryotic organisms 
(Galagan et al., 2003). It is a haploid organism which is very easy to grow and exhibits a 
rhythmic asexual spore formation ( conidiation) on petri dishes or long cylindrical glass 
tubes (race tubes) (Liu and Bell-Pedersen, 2006; Lakin-Thomas et al., 2011). Its genome 
consists of 7 chromosomes (or Linkage Groups) and approximately 10,000 genes 
(Galagan et al., 2003). Haploid genetics make Neurospora easier to study since 
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mutations can be observed without the complementation of other alleles as seen in 
diploids (Lakin-Thomas et al., 2011 ). 
Neurospora life cycle 
The life cycle of Neurospora includes an asexual and sexual cycle (Griffiths et al., 
1993; Metzenberg and Glass, 1990). The asexual cycle involves mitosis of haploid 
nuclei, and the formation of conidia from hyphae (long cellular threads) (Griffiths et al., 
1993). Multinucleate hyphae grow and produce multinucleate asexual spores, which 
germinate to form new mycelia (Griffiths et al., 1993). 
In the sexual cycle, protoperithecia are fertilized by the opposite mating type, 
designated either A or a (Metzenberg and Glass, 1990). Nuclear fusion of the haploid 
nuclei occurs, followed by meiosis and mitosis to produce asci inside the perithecia 
(Griffiths et al., 1993; Metzenberg and Glass, 1990; Lindegren, 1932). Each ascus 
contains 8 haploid ascospores (sexual spores), each containing a single nucleus (Griffiths 
et al., 1993; Metzenberg and Glass, 1990; Lindegren, 1932). 
The Neurospora clock 
Neurospora has been seen to have an endogenous rhythm of approximately 22 
hours in constant dark conditions (Ellman et al., 1984; Lakin-Thomas et al., 2011). The 
Neurospora circadian clock exhibits the standard traits of circadian rhythms: it has a 
rhythm close to 24 hours under constant conditions (i.e. constant darkness, DD), the 
period is temperature compensated between 16-30°C, and entrainable by light (Lakin-
Thomas et al., 2011). There is high conservation of function between Neurospora clock 
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genes and clocks in other organisms which allows research on Neurospora to be related 
to other circadian systems (Liu and Bell-Pedersen, 2006; Lakin-Thomas et al., 2011). 
On a genetic level, the main circadian systems in Neurospora, Drosophila, and 
mammals typically function using positive and negative regulation in a transcription-
translation feedback loop (Liu and Bell-Pedersen, 2006; Brunner and Schafmeier, 2006; 
Hardin, 2009). WC-1 and WC-2 proteins in Neurospora, dCLOCK ( dCLK) and CYCLE 
(CYC) proteins in Drosophila, and BMALl and CLOCK (CLK) proteins in mammals all 
positively regulate transcription of the FRQ protein in Neurospora, PERIOD (PER) and 
TIMELESS (TIM) proteins in Drosophila, and PERIOD (PER) and CRYPTOCHROME 
(CRY) proteins in mammals, respectively (Liu and Bell-Pedersen, 2006; Salome and 
McClung, 2004; Brunner and Schafmeier, 2006; Mohawk et al., 2012; Zhang and Kay, 
2010). These proteins in turn are negative regulators of the initial activating proteins, 
forming a positive-negative feedback loop (Liu and Bell-Pedersen, 2006; Brunner and 
Schafmeier, 2006). Proteins in the Neurospora, Drosophila, Arabidopsis and mammalian 
circadian rhythm loops are all regulated by phosphorylation and in some cases, even 
phosphorylated by the same kinases (Liu and Bell-Pedersen, 2006; Nagel and Kay, 2012; 
Brunner and Schafmeier, 2006). Therefore studying the circadian rhythms in Neurospora 
can shed light on the circadian rhythms and TTFLs occurring in other organisms. 
1.6.2 FRQ-WCC TTFL in Neurospora 
The main circadian system driving rhythms in Neurospora is the frequency-white 
collar complex (FRQ-WCC) transcription-translation feedback loop (TTFL) shown in 
20 
Figure 5 (Liu and Bell-Pedersen, 2006; Brunner and Schafmeier, 2006; Lakin-Thomas et 
al., 2011; Dunlap and Loras, 2006; Cheng et al., 2001). White collar proteins 1 and 2 
(WC-1, WC-2) are the positive regulators and will bind together to form the white collar 
complex (WCC) (Liu and Bell-Pedersen, 2006; Brunner and Schafmeier, 2006; Lakin-
Thomas et al., 2011; Dunlap and Loras, 2006; Cheng et al., 2001 ). WCC rhythmically 
binds to the clock box (C-box) or light response element (LRE) on the frequency (frq) 
gene promoter and initiates transcription, which in turn creates mRNA and FRQ protein 
(Liu and Bell-Pedersen, 2006; Brunner and Schafmeier, 2006; Lakin-Thomas et al., 2011; 
Dunlap and Loras, 2006; Cheng et al., 2001; Froehlich et al., 2003). 
FRQ protein binds to the FRH (FRQ interacting RNA helicase) which becomes the 
negative regulator and supresses WCC binding to thefrq gene (Liu and Bell-Pedersen, 
2006; Brunner and Schafmeier, 2006; Leloup et al., 1999; Lakin-Thomas et al., 2011; 
Aronson et al., 1994a; Dunlap and Loras, 2006; Dunlap and Loras, 2004). FRH is 
responsible for the interaction of FRQ and WCC, and without this, FRQ is unable to 
repress WCC binding to thefrq gene (Liu and Bell-Pedersen, 2006; Brunner and 
Schafmeier, 2006; Dunlap and Loras, 2006). 
FRQ protein repression is caused by phosphorylated WCC, which in turn is kept 
in an inactive state and will not bind to thefrq gene (Brunner and Schafmeier, 2006; 
Lakin-Thomas et al., 2011; Dunlap and Loras, 2006). This causes FRQ protein levels to 
drop and WCC suppression to be lifted via dephosphorylation (Liu and Bell-Pedersen, 
2006; Brunner and Schafmeier, 2006; Lakin-Thomas et al., 2011; Dunlap and Loras, 
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2006). FRQ protein, however, also increases expression of WC-1 and WC-2 themselves 
at either a post-transcriptional or post-translational level (Liu and Bell-Pedersen, 2006; 
Brunner and Schafmeier, 2006; Lakin-Thomas et al., 2011; Cheng et al., 2001). 
The levels of FRQ RNA and protein exhibit a circadian rhythm (Brunner and 
Schafmeier, 2006; Lakin-Thomas et al., 2011; Aronson et al., 1994a; Froehlich et al., 
2003). FRQ becomes phosphorylated and attached to FWD-I (a component ofubiquitin 
ligase ), which signals FRQ protein degradation by the proteasome (Liu and Bell-
Pedersen, 2006; Brunner and Schafmeier, 2006; Lakin-Thomas et al., 2011; Dunlap and 
Loros, 2004). Proteins responsible for phosphorylation in the FRQ-WCC TTFL are 
Calcium/calmodulin dependent kinase (CAMKI), casein kinase la and II (CK-la, CKII) 
(Liu and Bell-Pedersen, 2006; Brunner and Schafmeier, 2006; Lakin-Thomas et al., 2011; 
Dunlap and Loros, 2006; Dunlap and Loros, 2004). Dephosphorylation is achieved by 
protein phosphatases 1 and 2a (PPI, PP2a) (Liu and Bell-Pedersen, 2006; Brunner and 
Schafmeier, 2006; Lakin-Thomas et al., 2011). WC-I levels are found to be rhythmic, in 
an anti phase rhythm to FRQ (Brunner and Schafmeier, 2006; Lakin-Thomas et al., 2011 ). 
Deletion or mutation of.frq, wc-1 or wc-2 genes will cause an abolishment of the rhythm, 
indicating that the FRQ-WCC loop is the main mechanism driving the circadian rhythm 
(Liu and Bell-Pedersen, 2006; Lakin-Thomas et al., 2011). 
WC-1 also serves as a blue light photoreceptor which allows the fungus to sense 
the environment and reset the daily rhythm based on light cues (Liu and Bell-Pedersen, 
2006; Brunner and Schafmeier, 2006; Lakin-Thomas et al., 2011; Correa et al., 2003; 
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Crosthwaite et al., 1997; Dunlap and Loros, 2004; Froehlich et al., 2002). Light causes 
the wee to bind to the light response element on the frq promoter and activates 
transcription (Liu and Bell-Pedersen, 2006; Brunner and Schafmeier, 2006; Leloup et al., 
1999; Lakin-Thomas et al., 2011; Crosthwaite et al., 1997; Dunlap and Loros, 2004). 
Constant or long-term exposure to light increases WCC phosphorylation which in turn 
will decrease binding to thefrq promoter (Liu and Bell-Pedersen, 2006; Brunner and 
Schafmeier, 2006; Lakin-Thomas et al., 2011; Froehlich et al., 2002). 
1.6.3 FRQ-Less Oscillator (FLO) 
Althoughfrq, wc-1, and wc-2 mutants are generally observed to be arrhythmic, 
some rhythms can be seen in these null mutants under certain conditions (Lakin-Thomas 
et al., 2011; Aronson et al., 1994b; Dunlap and Loras, 2004). This oscillator has been 
dubbed thefrq-less oscillator (FLO) (Lakin-Thomas et al., 2011; Correa et al., 2003; 
Dunlap and Loros, 2004; Granshaw et al., 2003; Christensen et al., 2004; de Paula et al., 
2006). 
Some frequency null mutants (frq9 andfrq10) were seen to produce a rhythm on 
long race tubes (Lakin-Thomas et al., 2011; Loros and Feldman, 1986; Aronson et al., 
1994b ). The period varies to a greater degree in these rhythmic mutants and the 
temperature compensation of the period is abolished (Lakin-Thomas et al., 2011; 
Granshaw et al., 2003). frq10 strains are entrainable to high temperature pulses, which is 
a characteristic of circadian rhythms, and indicates the presence of a second oscillator (Li 
et al., 2011 ). Adding farnesol, geraniol, or menadione to the media was also seen to 
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produce a rhythm infrq, wc-1 and wc-2 null mutants (Lakin-Thomas et al., 2011; 
Granshaw et al., 2003). 
Rhythmic oscillations of nitrate reductase activity were also seen infrq9 and wc-1 
knockouts, indicating these rhythms are driven by something other than the FRQ-WCC 
loop (Christensen et al., 2004). Some clock-controlled genes (ccgs) such as ccg-16, have 
been seen to produce rhythmic mRNA levels in a frq knockout, indicating the presence of 
an alternate oscillator (Lakin-Thomas et al., 2011; Correa et al., 2003; de Paula et al., 
2006). ccg-16 rhythmic activity required WC-1 and WC-2, indicating that these proteins 
may be linked to, and possibly even regulate, the FLO (de Paula et al., 2006). Three 
other ccgs were discovered to have short-period rhythms in the mutated, long-periodfrq7 
strain (Correa et al., 2003). 
In addition, double mutants containing both the choline (chol-1) andfrq10 
mutations exhibit clear, long period rhythms with low choline concentrations in the 
media (Lakin-Thomas et al., 2011; Lakin-Thomas and Brody, 2000). Strains with a chol-
1 mutation are unable to produce normal levels of phosphatidylcholine and require 
choline in the media for normal growth (Lakin-Thomas, 1996; Lakin-Thomas and Brody, 
2000). Other double mutants, such as ult;frq10, vvd;frq10 and sod-l;frq10 also produced 
rhythms in thefrq null strains (Lakin-Thomas et al., 2011). 
Two period mutants (prd-1 and prd-2) were also tested in a chol-1; frq 10 strain 
and were discovered to disrupt the circadian rhythm on media containing low choline 
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(Lakin-Thomas et al., 2011; Li and Lakin-Thomas, 2010). prd-1 andprd-2 also greatly 
affected the heat entrainment seen in the frq10 strain (Li and Lakin-Thomas, 2010). 
Several genes and proteins have been discovered which appear to be a part of the 
FLO. 
However, the exact nature and all components of the FLO is not fully understood, nor is 
the nature of the relationship between the FLO and the FRQ-WCC loop (Lakin-Thomas 
et al., 2011; de Paula et al., 2006). Due to the overwhelming evidence that circadian 
rhythms are complex in other organisms, it stands to reason that the Neurospora clock is 
similarly complex and does not only involve the FRQ-WCC feedback loop. Discovering 
the function of multiple oscillators in Neurospora can shed light on similar mechanisms 
in other organisms. 
1.6.4 Novel mutation in the FLO (UV90): 
In order to determine the components of the FLO, a new mutation was introduced 
into a chol-1; frq 10 strain which displays a circadian rhythm without choline in the media 
(Li et al., 2011). A new mutant was created by subjecting ,..,600 conidiospores from a 
chol-1; frq 10 strain to ultraviolet light (Li et al., 2011). Spores were tested on race tubes 
and viable progeny that exhibited rhythm mutations were arbitrarily numbered. The 90th 
mutated spore, dubbed UV90, produced arrhythmic progeny in the typically rhythmic 
chol-1; frq 10 strain on low choline (Fig. 6A) (Li et al., 2011; Lakin-Thomas et al., 2011). 
In the absence of the choline mutation, UV+ and UV90 both appear arrhythmic infrq10 
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strains (Fig. 6B). This is an indication that UV90 is likely a part of, or affects the FLO 
(Li et al., 2011). 
The UV90 mutant was then crossed tofrq+ to test the phenotype of the UV90 
mutation in the presence of functionalfrq gene (Li et al., 2011). In chol-1; frq+ strains, 
UV90 exhibited a low amplitude rhythm with the addition of choline, and an arrhythmic 
pattern on media without choline (Fig. 6C). Infrq+ strains without the choline mutation, 
similar results were seen, as UV90 created a low amplitude rhythm (Fig. 6D). 
The FLO is possibly acting downstream of the FRQ-WCC feedback loop, as 
rhythms (perhaps from the same oscillator) were seen in bothfrq+ andfrq null strains 
(Lakin-Thomas et al., 2011 ). In addition to effects on the circadian rhythm, UV90 also 
exhibited a slightly slower growth rate than wild type and altered the temperature 
compensation of the period in the frq+ strains (Li et al., 2011 ). The heat-entrained 
rhythm present in thefrq10 strain was altered by the UV90 mutation more strongly infrq10 
than the frq+ strains, again indicating that UV90 affects the FLO (Li et al., 2011 ). UV90 
also lowered the amplitude ofFRQ protein levels (Li et al., 2011; Lakin-Thomas et al., 
2011 ). The FLO and UV90 may therefore have an interaction with the FRQ-WCC loop 
(Li et al., 2011; Lakin-Thomas et al., 2011). 
The UV90 gene was mapped to a region on Linkage Group VI by crossing it with 
strains with known mutations (Li et al., 2011). In the backcross to the band (bd) strain, 
UV90 was seen to have 50% recombination withfrq (Linkage Group (LG) VII), and 
48.9% recombination with chol-1 (LG IV) (Li et al., 2011). Recombination rates of 
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nearly 50% are an indication of genes that are located on separate chromosomes and 
therefore unlinked (Griffiths et al., 1993). 
In a cross to the a/coy tester strain which contains multiple mutations on known 
chromosomes, UV90 was 51.9% recombinant with cot-I (LG IVLNR), 40.7% with al-1 
(LG IR/IIL), and 16.7% withylo-1 (LG IIIRNIR) (Li et al., 2011). 
Bulked segregant analysis was performed according to the methods of Jin et al. 
(2007) and UV90 was found to be unlinked to marker 3-52 on LG III (Li et al., 2011). 
UV90 was determined to be linked (less than 10% recombination) to markers 6-39 and 6-
68, which are located on the left and right of the centromere on LG VI, respectively (Li et 
al., 2011). 
The conclusion was made that UV90 is likely located on LG VI, possibly on either side of 
the centromere. 
1. 7 Purpose of this study 
The long term goal of this project is to discover the components and mechanism 
of thefrq-less oscillator (FLO), specifically, what interaction the FLO may be having 
with the FRQ-WCC oscillator, and what roles FLO components such as prd-1, prd-2 and 
UV90 play in controlling the Neurospora circadian rhythm. Locating the UV90 gene will 
lead to a better understanding of one component of the FLO and how this specific 
mutation affects the circadian rhythm. 
The purpose of this study is to map the location of the gene causing the UV90 
phenotype, and to characterize the UV90 gene mutation. Cleaved Amplified 
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Polymorphic Sequence (CAPS) marker analysis and gene knockout screens will be used 
to map the location of the gene on LG VI, along with DNA sequencing to characterize 
the nature of the UV90 mutation. Complementation tests will also be performed on the 
UV90 strain to confirm the restoration of the UV90 phenotype with the wild type copy of 
the putative gene. 
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Figure 1. The circadian system of Drosophila melanogaster. 
Obtained from Hardin (2009). See Introduction, Section 1.2 for detailed description. 
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Obtained from Harmer (2009). See Introduction, Section 1.3 for detailed description. 
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Figure 3. The cyanobacteria circadian system in Synechococcus elongatus 
Obtained from Dong et al. (2010). See Introduction, Section 1.4 for detailed description. 
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Figure 4. The mammalian circadian system 
Obtained from Mohawk et al. (2012). See Introduction, Section 1.5 for detailed 
description. 
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Figure 5. The FRQ-WCC transcription translation feedback loop in Neurospora crassa 
Adapted from Liu and Bell-Pedersen (2006). See Introduction, Section 1.6.2 for detailed 
description. 
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Figure 6. UV90 phenotype in chol-1/chol+ andfrq+/frq10 backgrounds. Adapted from 
Li et al. (2011 ). + chol = the addition of 100 µM choline to the growth media. - chol = no 
choline added to the media. Growth is from left to right. White bars indicate average 
distance of 24 hr growth. Two replicates of each genotype are shown. All strains carry 
conidial separation ( csp-1) and band ( bd) mutations. 
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CHAPTER2 
MATERIALS AND METHODS 
2.1 Neurospora strains used 
All Neurospora erassa strains used were either Mauriceville (MV) or Oak Ridge 
(OR). Neurospora mating types are designated either A or a (Fincham et al., 1979). 
Strains kept in the laboratory are labelled with a silica gel number (sg #)corresponding to 
the order in which they were stored. To obtain progeny for genetic mapping, a cross was 
performed (previously by Dr. Kamyar Motavaze) between esp-I; bd; UV90 a (OR, sg 
#227) and esp+; bd+; UV+ A (wild type MV, sg #258). The band (bd) mutation is used 
to reduce carbon dioxide sensitivity and observe conidiation (spore formation) in closed 
areas such as test tubes, since carbon dioxide inhibits the appearance of rhythmic band 
formation (Granshaw et al., 2003; Lakin-Thomas and Brody, 2000). The conidial 
separation (esp- I) mutation is used to prevent spore separation from hyphae and prevents 
cross-contamination (Granshaw et al., 2003; Lakin-Thomas and Brody, 2000). Both bd 
and esp-I mutations have no effect on the circadian rhythm. 
Other strains used either for polymerase chain reaction (PCR) or in race tube 
analyses were: esp+; bd+; UV+ (wild type OR, sg #259), esp-I; bd (OR, sg #1), esp-I; 
bd+; UV90 (OR; progeny #131), esp-I; ehol-I bd;frq10 (OR, sg #80) and esp-I; ehol-I 
bd; UV90;frq10 (OR, sg #213). Strains with a choline mutation (ehol-I) are unable to 
produce normal levels of the phospholipid phosphatidylcholine and require choline in the 
medium for normal growth (Lakin-Thomas, 1996). The frequency gene (jrq) in 
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Neurospora is an important part of the circadian clock mechanism (Aronson et al., 
1994a). Strains which lack thefrq gene (frq10) are arrhythmic under some conditions 
(Aronson et al., 1994b ). 
DNA from progeny from a cross between esp-I; prd-I; bd (OR, sg #250) and MV 
(sg #258) was previously prepared by Nardin Nano. esp-I; prd-I; bd and esp-I; prd+; 
bd progeny were used for PCR. Neurospora strains that have a period (prd-I) mutation 
exhibit a disruption of the rhythm in the esp-I; ehol-I bd; frq10 strain (Li and Lakin-
Thomas, 2010). 
Strains used in transformation of Neurospora were esp-I; ehol-I bd (OR, sg #26) 
and esp-I; ehol-I bd; UV90 (OR, sg #224). The wild type copy of the putative UV90 
gene used for transformation was taken from esp-I; ehol-1 bd;frq10 (OR, sg #80). The 
Fungal Genetics Stock Center (FGSC) knockout strains used are listed in Table 1. 
2.2 Genetic Mapping of UV90 gene 
2.2.1 Genetic cross & spore picking 
To obtain UV90 progeny, a cross between esp-I; bd; UV90 a (OR, sg #227) and 
esp+; bd+; UV+ A (MV, sg #258) was performed using standard genetics techniques and 
spores were picked after approximately one month (Davis, 2000). A flame-sterilized 
scalpel was used to cut a piece of 4% agar (Appendix I) to fit a microscope slide. Half of 
the agar was scored into -100 squares and the other half was unscored and covered with 
1-2 drops of 10% bleach solution. Perithecia from the cross were picked using a flame-
sterilized wire and the spores were spread onto the agar containing bleach. Under a 
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dissecting microscope, 100 spores were picked and placed on individual agar squares. 
Care was taken to ensure only mature spores, which appear black and shiny, were picked. 
Each agar square was placed into a "baby" (10 x 75 mm) test tube containing 1 mL of 
minimal agar medium (Appendix I). The tubes were placed in a 58 °C water bath for 30 
min to heat-shock the spores and left at room temperature to germinate for approximately 
one week. 
2.2.2 csp-1 "tap test" & race tube analysis 
Progeny were tested for the presence of the csp-1 mutation by the "tap test". 
Baby tubes were "tapped" on a hard surface and the presence of flying spores appearing 
as a fine powder indicated the esp+ phenotype. Progeny that were determined to be csp-
1 were numbered and kept for race tube analyses. 
Progeny from baby tubes along with controls were inoculated on either short (30 
cm) or long (40 cm) race tubes (cylindrical glass tubes open at both ends) containing 
maltose-arginine (MA) medium (Appendix I). Race tubes were placed in constant light 
(LL) for 24 hours at 30 °C and then moved to constant darkness (DD) at 22 °C until 
growth finished. The growth front was marked on the race tubes daily under red light. 
For use in genetic mapping, progeny were determined to be either bd or bd+ and UV+ or 
UV90 through visual inspection of the race tubes. Growth rates and periods of progeny 
were determined through a mathematical program ("MacTau", developed by Dr. Patricia 
Lakin-Thomas) which compares growth front distances on scanned race tube pictures 
with daily marking times. 
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2.2.3 DNA extraction 
DNA extraction protocol from Jin et al. (2007) was performed on progeny from 
the aforementioned genetic cross. DNA extraction was also performed on the parental 
strains, 
esp-I; bd; UV90 (OR, sg #227) and esp+; bd+; UV+ (MV, sg #258). Progeny were 
inoculated into 24-well microtiter plates containing 1 mL each of liquid minimal medium 
(Appendix II) and left to grow at room temperature for 2-3 days. Progeny were also 
inoculated at the same time onto stock tubes containing minimal agar medium (Appendix 
I) and left to germinate for approximately one week before freezing. 
Mycelia from microtiter wells were rinsed in a vacuum filtration system with 
double distilled water (dd H20) using Whatman P8, 3.5 cm filter papers. Samples were 
placed into 1.5 mL eppendorf tubes, frozen in liquid nitrogen, and stored at -80 °C until 
DNA extraction was performed. 
Each sample was ground in a separate mortar and pestle pre-cooled with liquid 
nitrogen and the fungal powder was placed in a 1.5 mL tube. To each sample, 600 µL of 
DNA extraction buffer with 1 % SDS (Appendix II) and 3 µL Proteinase K (20 mg/mL in 
20 mM Tris-HCl, 1 mM CaCh, 50% glycerol, pH 7.5, obtained from New England 
Biolabs (NEB)) were added, mixed thoroughly and incubated at 65 °C for 1 hour. 
Samples were vortexed and 200 µL of 7 .5 M ammonium acetate was added, mixed 
thoroughly and left on ice for 5 minutes. Samples were centrifuged at 16,000g, 4 °C for 3 
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minutes, supernatant was removed into a fresh 1.5 mL tube, and RNase A (Appendix II) 
was added. Samples were vortexed and incubated at 37 °C for 1 hour. 
DNA was extracted from each sample with 500 µL chloroform followed by 
centrifugation at 14,000g, 4 °C for 5 minutes. Supernatant was again removed into a 
fresh 1.5 mL tube and DNA was precipitated with 650 µL isopropanol followed by 
centrifugation at 14,000g, 4 °C for 15 minutes. Isopropanol was removed and DNA 
pellet washed with 70% ethanol followed by centrifugation at 7 ,500g, 4 °C for 5 minutes. 
DNA pellet was dissolved in 100 µL TE Buffer (Appendix II). 
Each sample was diluted 1110 (10 µL stock DNA+ 90 µL dd H20) and DNA 
concentrations were determined using Beckman Coulter DU800 UVNisible 
spectrophotometer. Concentrations were read in µg/mL and each sample was diluted to a 
final concentration of 50 ng/µL, 50 µL total volume, for use in PCR. DNA 
concentrations (in ng/µL) for some undiluted samples were also determined using 
Thermo-Fisher Scientific Nanodrop2000 UV Nisible spectrophotometer. 
2.2.4 CAPS markers & primer design 
Single nucleotide polymorphisms (SNPs) between the Neurospora crassa Oak 
Ridge and Mauriceville strains were used to map the location of the UV90 gene. The 
cleaved amplified polymorphic sequence (CAPS) marker method uses specific SNPs that 
either remove or create an enzyme restriction (or cleavage) site in either the OR or MV 
strain (Lambreghts et al., 2009). In this study, CAPS markers were used to map the 
location of the UV90 gene as in Jin et al. (2007). 
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Locations of SNPs that create specific restriction enzyme cleavage sites in the OR 
strain are available on the FGSC website (Pomraning et al., 2010). To create CAPS 
markers approximately 500 base pairs (bp) in length, DNA sequences approximately 250 
bp upstream and downstream of individual SNP locations were retrieved from the Broad 
Institute Neurospora crassa database 
(www.broadinstitute.org/annotation/ genome/neurospora/Regions.html). The DNA 
sequence was checked to detect the location of multiple restriction enzyme sites. If 
multiple sites appeared for one particular restriction enzyme, another SNP and DNA 
sequence was chosen. Forward primers were designed to have GC contents of 50-55%, 
melting temperatures (Tm) of 58-65 °C, and lengths of20-22 nucleotides (nt) using 
Thermo-Fisher Scientific "Tm Calculator" 
(www.thermoscientificbio.com/webtools/tmc/). Tm's of primers received from 
Invitrogen and Integrated DNA Technologies (IDT) were approximately 5 and 10 °C 
lower than the calculated Tm's, respectively. Reverse primers were designed with the 
above criteria with the following additions: the reverse primer Tm was within 2 °C of the 
forward primer, length was within 1 nt of the forward primer, and the reverse and 
complement of the DNA sequence was determined using Attotron Biosensor Corporation 
"Nucleic Acid Sequence Massager" (www.attotron.com/cybertory/analysis/ 
seqMassager.htm). Primers were BLASTED against the Broad Institute Neurospora 
crassa OR genome to ensure there was only one match per primer 
(www.broadinstitute.org/annotation/genome/neurospora/Blast.html). An example of a 
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designed CAPS marker is shown in Appendix III. A complete list of primers, CAPS 
markers and SNPs designed for UV90 mapping are given in Tables 2 and 3. 
2.2.5 PCR, restriction enzyme digestion & gel electrophoresis 
For genetic mapping of UV90, polymerase chain reaction (PCR) was performed 
on all progeny from the cross between bd csp-1 UV90 x MV that underwent DNA 
extraction as described in Methods 2.2.3 (see Appendix IV, PCR). Taq DNA polymerase 
with ThermoPol Buffer (NEB) was used for genetic mapping. The lengths of CAPS 
markers are given in Table 3. 
Restriction enzyme digestion was performed on all PCR products based on the 
enzyme associated with each SNP and CAPS marker given in Table 3 (see Appendix IV, 
Restriction Enzymes). All restriction enzymes were obtained from NEB. 
Gel electrophoresis was performed on all undigested and digested PCR products 
(see Appendix IV, Gel Electrophoresis). A 1.5% agarose gel was used for PCR products 
less than 1,000 hp in size and 1.0% for all larger samples. Pictures of gels were taken 
using a UV light box at the York University Core Facility. Gel imaging system and 
software used was Alpha Innotech Corporation Alpha Ease FluorChem FC2 AIC. 
2.2.6 Sequencing putative UV90 gene 
For sequencing the suspected UV90 gene, PCR and gel electrophoresis were 
performed using sequencing primers listed in Table 4 and as described in Methods 2.2.5. 
Takara LA Taq DNA polymerase (Takara Bio Inc.) was used instead of Taq DNA 
polymerase (NEB) due to increased fidelity and improved PCR results with DNA 
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sequences larger than 1 kb (see Appendix IV, PCR). Number of cycles in PCR Step #2 
(Appendix IV, Table A4) was increased to 35 to increase the amount of product. Sizes of 
DNA sequences were determined based on the locations of sequencing primers used in 
Table 4. 
After gel electrophoresis, any successful PCR products were excised from the gel 
over a UV light using a scalpel and purified using QIAquick Gel Extraction Kit 
(QIAGEN). Purified PCR samples were given to the York University Core Facility for 
sequencing. 
PCR products obtained from Integrated DNA Technologies (IDT) primers (see 
Table 4) were sent to The Centre for Applied Genomics (Hospital for Sick Children, 
Toronto, Canada). DNA concentrations of these purified samples were determined using 
NanoDrop2000 UVNis spectrophotometer. PCR products under 1 kb in size were 
diluted to 50 ng in 7 µL. Products under 500 bp were diluted to 20 ng in 7 µL. Primers 
were diluted to 5 pmol in 0.7 µLand single primers added to individual PCR products. 
2-3 replicates of each sample were prepared. Sequences were compared to the 
Neurospora crassa OR genome using BLAST searches at the Broad Institute Neurospora 
database (www.broadinstitute.org/annotation/genome/neurospora/ Blast.html) and the 
online Swiss Institute of Bioinformatics LALIGN program (http://embnet.vital-
it.ch/software/LALIGN_form.html). 
42 
2.3 FGSC Knockouts 
2.3.1 Knockout UV90 screening 
FGSC knockout strains (shown in Table 1) to screen for the presence of the UV90 
mutation were ordered using gene loci searches in the FGSC Database 
(http://www.fgsc.net/ scripts/StrainSearchForm.asp). Gene loci (given as NCU#####) 
were discovered through a gene search between 3 .29 and 3 .3 7 Mbp on Linkage Group VI 
at the Broad Institute Neurospora database 
(www.broadinstitute.org/annotation/ genome/neurospora/F eatureSearch.html). Knockout 
strains were created as described in Colot et al. (2006). 
FGSC knockout strains were inoculated onto race tubes containing MA medium 
(Appendix I) as described in Methods 2.2.2 along with controls csp-1; bd+; UV90 (OR, 
progeny #131) and OR wild type (sg #259). 2-3 replicates of each strain were inoculated. 
Knockouts were compared by visual inspection of the race tubes and therefore period and 
growth rate data were not calculated. 
2.3.2 Cross between putative UV90 KO x #80 
FGSC knockout strain #18029 (gene NCU05950, Table 1) was chosen as a 
putative UV90 candidate. A cross was performed (previously by Dr. Patricia Lakin-
Thomas) between FGSC #18029 and csp-1; chol-1 bd;frq10 (OR, sg #80) to check for the 
UV90 phenotype in the knockout strain. Spores were picked as described in Methods 
2.2.1, and csp-1 "tap test" was performed as described in Methods 2.2.2. csp-1 progeny 
were inoculated onto race tubes containing MA medium both with and without 100 µM 
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choline (Appendix I) as described in Methods 2.2.2. Controls on "high choline" (with 
choline) were csp-1; chol-1 bd;frq10 (OR, sg #80) and csp-1; chol-1 bd; UV90;frq10 
(OR, sg #213). Controls on "low choline" (without choline) were csp-1; chol-1 bd (OR, 
sg #26), csp-1; chol-1 bd; UV90 (OR, sg #224), csp-1; chol-1 bd;frq10 (OR, sg #80) and 
csp-1; chol-1 bd; UV90;frq10 (OR, sg #213). 
2.4 Neurospora transformation 
2.4.1 Creation of "AD" CAPS marker & Hygromycin B gene 
Transformation of Neurospora crassa was performed to test the complementation 
of UV90 candidate gene NCU05950 (FGSC #18029, Table 1) in the UV90 mutant strain. 
Some Neurospora transformation procedures were repeated by Sareh Ahmadi. 
A wild type copy of the NCU05950 gene was amplified from csp-1; chol-1 bd; 
frq 10 (OR, sg #80) with PCR and gel electrophoresis (as described in Methods 2.2.5) 
using Takara LA Taq DNA polymerase (Takara Bio Inc.). Primers used are listed in 
Appendix V and Tables 4 and 5. This was labelled as CAPS marker "AD". In addition, 
an EcoRI restriction enzyme site was created in the "AD" CAPS marker based on the 
overlapping-PCR procedure by Heckman and Pease (2007) to create a method of 
ensuring the gene is transformed into Neurospora. The CAPS marker and primers 
designed to create the Eco RI restriction site are shown in Appendix V. 
Smaller "AB" and "CD" PCR products (Appendix V) were purified using 
QIAquick Gel Extraction Kit (QIAGEN) and DNA concentrations checked using 
NanoDrop2000 UV Nis spectrophotometer. Concentration of final "AD" piece was 
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estimated by visual inspection of the gel by comparison to NEB values given for PCR 
ladders. Restriction enzyme digestion was also performed on "AD" using EcoRI to 
ensure the overlapping PCR method produced a second restriction site (Appendix IV, 
Restriction Enzymes). 
To screen for transformants, the Hygromycin resistance gene (hyg) was also 
amplified by Dr. Keyur Adhvaryu from the pCSN44 plasmid (obtained from FGSC). 
Methods for using Hygromycin B in Neurospora transformation were derived from 
Staben et al. (1989). 
2.4.2 Harvesting & washing conidia 
For harvesting conidia (spores), csp-1; chol-1 bd (OR, sg #26) and csp-1; chol-1 
bd; UV90 (OR, sg #224) were previously prepared on stock tubes with minimal medium 
(Appendix I) and left to grow at 30 °C, LL for 3-7 days. 10 flasks for csp-1; chol-1 bd; 
UV90 were prepared with minimal medium for transformation (Appendix VI), inoculated 
from the stock tubes and placed in 30 °C, LL for 3-7 days. csp-1; chol-1 bd flasks were 
prepared and harvested by Sareh Ahmadi. 
50 mL of cold IM sorbitol (Appendix VI) was added to each flask and conidia 
were scraped vigorously using a sterile loop. Contents of one flask were combined with a 
second and strained into a beaker covered with 3 layers of sterile cheesecloth. This was 
repeated for the remaining flasks (5 beakers total). Strained liquid from each beaker was 
poured into two sterile 50 mL conical tubes and kept on ice. Tubes were centrifuged at 
3,000 rpm, 4 °C for 10 min. 
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Supernatant was discarded and I 0 mL IM sorbitol was added to one pellet and 
resuspended. Resuspended pellet was added to a second tube, shaken, and repeated with 
all conical tubes to concentrate all ten pellets into a single tube. Final pellet was 
centrifuged, washed and resuspended with I 0 mL sorbital two more times. After final 
wash and centrifugation, conidia pellet was suspended in 500 µLIM sorbitol and 
transferred to I .5 mL screw-cap tubes and stored at -80 °C. 
To prepare the spores for transformation, I 00 µL of each strain was transferred to 
I .5 mL tubes. I mL IM sorbitol was added and mixed. Samples were centrifuged at 
5,000 rpm, 4 °C for 5 min. Supernatant was removed and 40 µLIM sorbitol was added 
and mixed gently. 
2.4.3 DNA precipitation, electroporation and plating 
DNA for use in transformation was precipitated. Concentrations of PCR products 
"AD" and hygromycin resistance gene (hyg) were estimated by visual inspection after gel 
electrophoresis. My "AD" PCR products were combined with Sareh Ahmadi' s for a total 
amount of2500 ng (in I25 µL). This was divided into two equal I.5 mL tubes and I.6 
µL of hyg (750 ng/µL) was added to each for a I:I ratio of AD:hyg DNA. Water was 
added to each sample for a total of IOO µL. To precipitate the DNA, IO µL of 3.0 M 
sodium acetate pH 8.0 was added followed by 200 µL absolute (IOO%) ethanol. Samples 
were stored at -80 °C overnight. DNA was centrifuged at I3,000 rpm, 4 °C for 5 min. 
Supernatant was removed, DNA washed with 300 µL of 75% ethanol, and centrifuged 
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agam. Supernatant was removed and pellet air dried for 15-20 min at room temperature. 
Final DNA pellet was dissolved in 15 µL dd H20. 
For the transformation, electroporation cuvettes were pre-cooled on ice. DNA 
was added 
to prepared conidia, mixed gently and left on ice for 5 min. Conidia was transferred to 
the cuvette and placed into BioRAD Gene Pulser II (conditions: 1.5 kV, 7.5 kV/cm, 
capacitance: 25 µF; resistance: 600 ohms). UV+ strain was electroporated for 13.4 
milliseconds, UV90 for 10.3 milliseconds. 1 mL recovery medium (Appendix VI) was 
immediately added to each strain, gently mixed and transferred into 1.5 mL tubes. Tubes 
were placed horizontally on a shaker platform for 1 hour at 150 rpm to recover. 
After recovery, 1110 (100 µL spores+ 900 µL recovery medium) and 11100 (100 
µL of 1110 dilution + 900 µL recovery medium) dilutions were prepared for each strain. 
1 mL of each dilution (including original, undiluted transformed spores) was placed into 
15 mL top agar and poured into three plates (5 mL each) containing bottom agar with 
hygromycin (Appendix VI). Plates were incubated face up at 30 °C, LL for 3-7 days. 
2.4.4 Race tube & PCR analysis of transformants 
Transformants from the petri plates were inoculated onto minimal agar stock 
tubes (Appendix I) with the addition of 1.5 mL choline (2 mg/mL) and 0.4 mL 
hygromycin (50 mg/mL) per 100 mL added after autoclaving, and incubated at 30 °C, 
LL. They were also tested for the ability to grow on hygromycin using liquid minimal 
medium in microtiter wells (Appendix II). 1 mL choline (10 mM) and 0.4 mL 
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hygromycin (50 mg/mL) per 100 mL were added after autoclaving. Wells were 
inoculated and placed in 30 °C, LL. 
Transformants were grown on race tubes containing MA medium with choline as 
described in Methods 2.2.2, with the addition of 0.4 mL hygromycin (50 mg/mL) per 100 
mL added after autoclaving. Parental controls (esp-I; chol-1 bd and esp-I; chol-1 bd; 
UV90) did not receive the addition of hygromycin. 
DNA was extracted from transformants as described in Methods 2.2.3. PCR, 
restriction enzyme digestion with EcoRI, and gel electrophoresis was performed as 
described in Methods 2.2.5 using Takara LA Taq polymerase. PCR was performed with 
F4, R4, Fl and Rl primers (Table 4) on transformants as well as csp-1; chol-1 bd;frq10 
(OR, sg #80), csp-1; chol-1 bd; UV90;frq10 (OR, sg #213), and csp-1; bd; UV90 (OR, sg 
#227). 
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Table 1. 
Fungal Genetics Stock Center (FGSC) knockout strains used to screen for the UV90 
mutation 
FGSC#* Mating Type Genotype (gene Linkage Group Race Tube# 
locus)** (chromosome) 
# 
17842 A NCU05958.2 VI 
13721 A NCU05957.2 VI 
17841 A NCU05954.2 VI 
17839 A NCU05952.2 VI 
18085 a NCU05951.2 VI 
17845 A NCU05962.2 VI 
11909 A NCU05961.2 VI 
11310 A NCU05956.2 VI 
13535 A NCU05955.2 VI 
18029 A NCU05950.2 VI 
17838 A NCU05949.2 VI 
18213 A NCU05948.2 VI 
18028 A NCU05947.2 VI 
17836 A NCU05946.2 VI 
17835 A NCU05945.2 VI 
13533 A NCU05944.2 VI 
*FGSC numbers were determined through the FGSC Strain Database 
(http://www.fgsc.net/scripts/StrainSearchForm.asp) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
**Genotypes were determined through gene searches at the Broad Institute Neurospora 
crassa database 
(http://www.broadinstitute.org/annotation/genome/neurospora/FeatureSearch.html) 
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Table 2. 
Primers designed for CAPS markers and genetic mapping of the UV90 gene on Linkage 
Group VI 
Primer Sequence Location Length GC Tm 
Name 5' -> 3' (hp) and (nt)* content (oC)* 
strand (%)* 
(+/-) 
F3** ACCTACTTGCGACAGCGTGCTTG 2,059,068- 23 56.52 71.6 
090 (-) 
R3** TTGTCCACTTACACTCGGCACG 2,057,830- 22 54.55 69.6 
851 (+) 
F6** TTCACGAGTGTCCCGGATGTG 2,141,366- 21 57.14 70.9 
386 (-) 
R6** GCATTGTCATCTCGTTGGTGC 2,140,152- 21 52.38 68.2 
172 (+) 
F9** AAGGTCGGGTTGTTAGACGA 2,410,071- 20 50 63.8 
090 (-) 
R9** GGCTGAGGGTGGATAGCTAGA 2,409,630- 21 57.14 64.8 
650 (+) 
LCFl CGGCCGTGTAGCAGAATACA 2,726,641- 20 55 66.32 
660 (+) 
LCRl ATAATGGCGATGGCGATGTG 2,727,065- 20 50 68.10 
084 (-) 
LCF2 GGGCGCCATCAATTTCACTT 2,734,610- 20 50 68.36 
629 (+) 
LCR2 TTTGAGCTCGGGATTTGCTG 2,735,067- 20 50 67.72 
086 (-) 
RCF3 CTTTTCGGAGCTGGTCAGCA 3,127,818- 20 55 68.06 
837 (+) 
RCR3 ACCCAGGACATGCAAGGGTT 3,128,243- 20 55 68.09 
262 (-) 
RCF4 ATCCAGTACCCGTCCCCAAA 3,153,328- 20 55 67.71 
347 (+) 
RCR4 CAACCCAAGCTCAACTGCCA 3,153,772- 20 55 68.85 
791 (-) 
FlO TCATCGAGTTACCTGCCAAGC 2,547,480- 21 52.38 66.68 
500 (+) 
RIO TTGGGTGTTCGTTGGACTCC 2,547,877- 20 55 67.55 
896 (-) 
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Primer Sequence Location Length GC Tm 
Name 5' -> 3' (hp) and (nt)* content (oC)* 
strand (%)* 
(+/-) 
Fll GGTAACTATGTACATGCCCCGTG 2,559,077- 23 52.17 66.26 
099 {+) 
Rll CGATACGATTCTTGGCATCAGC 2,559,500- 22 50 67.9 
521 (-) 
RCF5 GCGAATTGGAAATCTCCAAGGG 3,102,391- 22 50 69.62 
412 (+) 
RCR5 ATCTCCCACGTAGCCTTGGCTT 3,102,900- 22 54.55 69.08 
921 (-) 
RCF6 TTTGGCCTGGGCTCATGTTAGT 3,133,754- 22 50 68.82 
775 (+) 
RCR6 CTCACCATGATGGGGGAAGAT 3,134,286- 21 52.38 67.44 
306 (-) 
668F ATGTCTTGGGTGTTTGGCAT 3,293,478- 20 45 64.57 
*** 497 (+) 
668R TCCTCAAGATCGTCACTCAGC 3,294,181- 21 52.38 64.98 
*** 201 (-) 
F15 TCCAGCAGCACTAGCACAACGT 3,476,119- 22 54.55 69.49 
140 (+) 
R15 GAAATGGACGTAGCAACCGAGG 3,476,554- 22 54.55 68.82 
575 (-) 
F16 ATCCAATCTCTTCCCGGTGTG 3,483,486- 21 52.38 67.52 
506 (+) 
R16 TCTTGGTTAGTGTAGCCGCACC 3,483,923- 22 54.55 67.45 
944 (-) 
3317F CTCGGACGACAAGTCACCAACA 3,317,357- 22 54.55 69.88 
378 (+) 
3317R CGTCCCTCTGATGCCCAAAGTA 3,317,838- 22 54.55 69.45 
859 (-) 
3346F CTTGAACGAGTTCCAGCCCTGA 3,346,503- 22 54.55 69.91 
524 (+) 
3346R CAGTGGTTGATCACCCAACCAA 3,346,963- 22 50 69.30 
984 (-) 
3368F GAAATACCGGGCGCATTACCA 3,368,165- 21 52.38 69.67 
185 (+) 
3368R TGTTGATTGGCTGTCGGTGG 3,368,673- 20 55 69.72 
692 (-) 
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Primer Sequence Location Length GC Tm 
Name 5' -> 3' (hp) and (nt)* content (oC)* 
strand (%)* 
(+/-) 
3395F TTGCTTGCTTTGTCTCGGACG 3,395,402- 21 52.38 69.87 
422 (+) 
3395R ACAGAGTTGGGTGTTCACGTGG 3,395,890- 22 54.55 68.69 
911 (-) 
3436F GGACAGCTTCTCCGAGCGATTT 3,436,787- 22 54.55 69.91 
808 (+) 
3436R CGTTGACGGACTCTGAATGAGG 3,437,239- 22 54.55 68.33 
260 (-) 
3451F TCCCGCCAGTAGTGAAACCTTC 3,451,512- 22 54.55 68.54 
533 (+) 
3451R CGTCAGCTTCGTCCTCATCAAC 3,451,989 22 54.55 68.47 
-3,452,010 
(-) 
3333F CGACCACCATACTTGCGGTTGT 3,332,973- 22 54.55 70.18 
994 (+) 
3333R TGGGCATTGTCCTCACTCCTGA 3,333,417- 22 54.55 71.47 
438 (-) 
3352F TTCTTACCTTTGCCTGTCGCCG 3,352,740- 22 54.55 71.19 
761 (+) 
3352R ACTGGGGCAAAGAGAAAAGCGC 3,353,183- 22 54.55 71.43 
204 (-) 
*Calculated using "Tm calculator" (http://www.thermoscientificbio.com/webtools/tmc/); 
All primers ordered from Invitrogen 
**Designed by Dr. Kamyar Motavaze 
***Sequence obtained from Jin et al. (2007) 
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Table 3. 
Linkage Group VI CAPS markers, single nucleotide polymorphisms (SNPs) and 
restriction enzymes for mapping of UV90 gene 
CAPS Total size SNP location Base pair (bp) 
marker (bp) change in OR -> 
(see Table 2 MV 
for primers) 
F6-R6 1,235 Unknown* Cut in OR 
UncutinMV 
F9-R9 461 Unknown* Cut in OR 
UncutinMV 
LCFl-LCRl 444 2,726,773 T->A 
LCF2-LCR2 477 2,734,761 C->T 
RCF3-RCR3 445 3,127,958 G->A 
RCF4-RCR4 464 3,153,461 C->T 
FlO-RlO 417 2,547,621 C->A 
Fll-Rll 445 2,559,175 G->A 
RCF5-RCR5 531 3,102,537 G->A 
RCF6-RCR6 553 3,133,969 C->T 
668F-668R 724 Unknown** Uncut in OR 
CutinMV 
F15-R15 457 3,476,241 G->T 
F16-R16 459 3,483,592 G->A 
3317F-3317R 503 3,317,544 A->G 
3346F-3346R 482 3,346,642 C->T 
3368F-3368R 528 3,368,360 T->C 
3395F-3395R 510 3,395,716 G->A 
3436F-3436R 474 3,436,987 T->C 
3451F-3451R 499 3,451,692 A->G 
3333F-3333R 466 3,333,091 C->G 
3352F-3352R 465 3,352,908 T->C 
*Designed by Dr. Kamyar Motavaze; SNP is unknown 
**Sequence obtained from Jin et al. (2007); SNP is unknown 
SNP restriction 
enzyme 
Eco RI 
Taqal 
Taqal 
Hae III 
Hae III 
Taqal 
Hae III 
Taqal 
Taqal 
Mspl 
Mspl 
Taqal 
Hae III 
Taqal 
Taqal 
Msel 
Taqal 
Taqal 
Msel 
Hae III 
Taqal 
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Table 4. 
Primers designed for sequencing of Broad Institute gene "NCU05950" ( UV90 gene 
candidate) on Linkage Group VI 
Primer Sequence Location Length GC 
Name 5' -> 3' (hp) and (nt)* content 
strand (%)* 
(+/-) 
F6 GACATTGGCCGCAGATGGAT 3,345,920- 20 55 
939 (+) 
F5 GGAACCTCCGAAGAAAGGAAGG 3,346,404- 22 54.55 
425 (+) 
F4 CCGGATGACTTCATCTTCCCTG 3,346,862- 22 54.55 
883 (+) 
F3 CTTGGAACCGCGCAGTAACAT 3,348,428- 21 52.38 
448 (+) 
F2 TACTTCGACGACGTCTGGCTTC 3,347,890- 22 54.55 
911 (+) 
Fl CCGTGACACATTTGTTGCTGC 3,347,371- 21 52.38 
391 (+) 
Rl TCCGGAACAGCATCAGGAAAG 3,348,966- 21 52.38 
986 (-) 
R2 CATGGGTTTATCATGCGGGAC 3,348,468- 21 52.38 
488 (-) 
R3 CCGTCGCGAAGAGATGAAACTC 3,347,852- 22 54.55 
873 (-) 
R4 AAATGGCTGTGGTCGCATCTC 3,349,471- 21 52.38 
491 (-) 
R5 ATGAGGAAGCCGAGAGCATCTC 3,349,938- 22 54.55 
959 (-) 
R6 CCGGTATGAGCGTCGGAATTT 3,350,451- 21 52.38 
471 (-) 
R7 GCCCGGATGTTTGTTTCGTTC 3,350,986- 21 52.38 
3,351,006 
(-) 
R8 TCAGTCTTTTTGGTCACGGACG 3,351,543- 22 50 
564 (-) 
R9 ACTCGCACATGCATACTCGCA 3,352,122- 21 52.38 
142 (-) 
UV90A ACGTGGACTGTTGCGTGACAC 3,348,179- 21 57.14 
For** 199 (+) 
Tm 
(oC)* 
69.68 
68.17 
69.11 
68.38 
67.90 
69.08 
68.76 
68.44 
69.39 
68.73 
68.25 
69.12 
69.70 
68.6 
69.33 
69.0 
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Primer Sequence Location Length GC Tm 
Name 5' -> 3' (hp) and (nt)* content (oC)* 
strand (%)* 
(+/-) 
UV90A GTGTCACGCAACAGTCCACGT 3,348,179- 21 57.14 69.0 
Rev** 199 (-) 
UV90B AACTTTACCGATGCCGCTGC 3,348,687- 20 55 68.5 
For** 706 (+) 
UV90B GCAGCGGCATCGGTAAAGTT 3,348,687- 20 55 68.5 
Rev** 706 (-) 
FlipRl CTTTCCTGATGCTGTTCCGGA 3,348,966- 21 52.38 68.8 
For ** 986 (+) 
FlipR4 GAGATGCGACCACAGCCATTT 3,349,471- 21 52.38 68.7 
For ** 491 (+) 
*Calculated using "Tm calculator" (http://www.thermoscientificbio.com/webtools/tmc/) 
**Primers ordered from Integrated DNA Technologies (IDT); all others ordered from 
Invitrogen 
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Table 5. 
Mutagenic primers designed for PCR-driven overlap extension in the transformation of 
Neurospora crassa 
Primer Sequence Length GC Tm 
Name 5' -> 3' (nt)* content (oC)* 
(%)* 
Fore- GCGTTCAGCGAATTCGATAGGT 21 52.38 67.6 
NCU5950 
RevB- ACCTATCGAATTCGCTGAACGC 21 52.38 67.6 
NCU5950 
For2C- TCAGCGAATTCGATAGGTCTGCGGCCAG 27 59.26 79.48 
NCU5950 
Rev2B- CTGGCCGCAGACCTATCGAATTCGCTGA 27 59.26 79.48 
NCU5950 
For3C- CTTTCCTGATGCTGAATTCCGGA 21 52.38 68.76 
NCU5950 
Rev3B- TCCGGAATTCAGCATCAGGAAAG 21 52.38 68.76 
NCU5950 
AD-Rp ACCGGACAAGATGGCTTGGTA 21 52.38 67.91 
*Calculated using "Tm calculator" (http://www.thermoscientificbio.com/webtools/tmc/); 
Criteria for mutagenic primers were calculated for correctly matched sequences only 
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CHAPTER3 
RESULTS 
3.1 Genetic Mapping of UV90 gene 
3.1.1 Genetic mapping using CAPS markers 
Progeny from the csp-1; bd; UV90 x Mauriceville cross were initially sorted via 
race tube analyses into UV90 or UV+ phenotypes, and therefore contained either UV90 or 
UV+ DNA at the mutated gene. However, progeny may contain either Oak Ridge (OR) 
or Mauriceville (MV) DNA sequences at other random locations in the genome. Genes 
farther away from the UV90 gene have greater rates of recombination (chromosomal 
crossover events between OR and MV parental strains), whereas genes next to UV90 will 
exhibit very few recombination events. Genes closer together are linked and experience 
fewer recombination rates between them due to the close physical distance (Griffiths et 
al., 1993). Recombinant progeny will exhibit the UV90 (OR) or UV+ (MV) phenotype 
on the race tubes but show opposing parental DNA at other locations on the genome, 
indicating a crossover event between UV90 and the other location. Recombination rates 
between the UV90 gene and specific DNA sequences, called Cleaved Amplified 
Polymorphic Sequence (CAPS) markers will be used to determine the UV90 gene 
location through PCR and restriction enzyme digestion. Left-right mapping will be 
performed to map the specific location of the UV90 gene between CAPS markers. The 
CAPS markers contain single nucleotide polymorphisms (SNPs) between the OR and 
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MV strains to distinguish which parental DNA each progeny has at a particular location, 
and therefore determines which progeny are recombinant. 
3.1.2 CAPS markers F6-R6, F9-R9 andprd-1 progeny 
Classification of progeny: 
To determine the location of the UV90 gene, genetic mapping was performed 
using PCR and restriction enzyme digestion on progeny resulting from the cross between 
esp-1; bd; UV90 (Oak Ridge (OR), sg #227) and Mauriceville (MV) wild type (sg #258). 
This cross was previously performed by Dr. Kamyar Motavaze. 192 spores were picked 
and placed in test tubes with minimal agar medium and allowed to germinate, as 
described in Methods 2.2.1. Progeny cultures were visually inspected for the esp+ or 
esp-1 phenotype by the "tap" test (Methods 2.2.2). 87 progeny were found to be esp-1, 
93 were esp+, and 12 did not germinate (Table 6). 
esp-1 progeny were numbered and inoculated onto maltose-arginine medium in 
race tubes as described in Methods 2.2.2. The first growth mark on the race tubes (Fig. 
7) denotes the moment the tubes were transferred from constant light (LL) to constant 
darkness (DD). Replicate tubes of the following controls were also inoculated: esp-1; bd 
(sg #1), esp-1; bd; UV90 (sg #227) and esp+; bd+; UV+ (MV, sg #258). Through visual 
inspection, 44 out of 87 were determined to be esp-I; bd; UV+ or UV90 by resembling 
either sg #1 or sg #227 (Fig. 7; Table 7). bd strains have slower growth rates than bd+ 
which is seen by the growth fronts marked daily on the tubes (Fig. 7). 42 progeny were 
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classified as csp-1; bd+ by having faster rates of growth and resembling sg #258 (Fig. 8; 
Table 7). One race tube was unclassifiable as either bd+ or bd (Fig. 8; Table 7). 
25 csp-1; bd progeny were visually determined to be csp-1; bd; UV90 due to 
weak, low amplitude rhythms (Fig. 9; Table 8). 14 showed clear, strong rhythms and 
were determined to be csp-1; bd; UV+ (Fig. 10; Table 8), and 5 were unclassifiable as 
either UV+ or UV90 (Table 8). Only csp-1; bd progeny were kept for further use in PCR 
and restriction enzyme analysis. 
A few unclassifiable progeny are typically seen in a genetic cross due to minor 
genetic variations between the parental strains. Also, a few mutations may collect in the 
nuclei in the parental strains which show up in the progeny after being put through a 
cross. There is the possibility that recombination events occurred in some progeny 
bringing together variant genes that can cause slow growth rates and unusual phenotypes 
on the race tubes. The low numbers of unclassifiable progeny in the cross suggest that 
this is merely a chance occurrence and not related to the UV90 gene. 
Out of 44 csp-1; bd progeny, 25 (56.8%) exhibited the UV90 phenotype and 14 
(31 %) were UV+ (Table 8). The approximate 50% segregation of UV90 from UV+ 
follows Mendelian genetic ratios and confirms the presence of a single gene mutation 
(Griffiths et al., 1993). However, since fewer than 50% UV+ progeny were observed, a 
chi-square test was performed to determine if the observed values fall within chance 
deviations. For Table 8, the p value was determined to be non-significant (p = 0.0685), 
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indicating that the slightly lower UV+ values observed are likely due to chance 
deviations, and not linked genes (Appendix X). 
The periods and growth rates of the final 39 UV+ and UV90 progeny were 
determined through a mathematical program ("MacTau", developed by Dr. Patricia 
Lakin-Thomas) which compares growth front distances on scanned pictures with daily 
marking times to determine the period lengths and growth rates (Table 9). The mean 
growth rate for the csp-1; bd; UV90 progeny was 0.99 (± 0.014) mm/hr, while csp-1; bd; 
UV+ progeny had a mean growth rate of 1.09 (± 0.036) mm/hr and a period of23.19 (± 
0.486) hr (Table 9). Although both the csp-1; bd; UV90 and UV+ growth rates are lower 
than the previously reported values of 1.16 and 1.29 mm/hr, respectively, and the UV+ 
period is slightly slower than the reported 21.2 hrs., results confirm that UV90 is slower 
growing than the wild type (Li et al., 2011). 
CAPS markers F6-R6 and F9-R9: 
DNA extraction was performed on the 39 csp-1; bd; UV+ and UV90 progeny 
along with parental strains csp-1; bd; UV90 and MV wild type as described in Methods 
2.2.3. The DNA concentrations ranged from 193-712 µg/mL (data not shown). CAPS 
markers F6-R6 and F9-R9 were designed and obtained by Dr. Kamyar Motavaze (Tables 
2 and 3, Materials and Methods). PCR, restriction enzyme digestion and gel 
electrophoresis were performed on the parental strains and 39 UV+ and UV90 progeny as 
described in Methods 2.2.5. 
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PCR and restriction enzyme digestion was performed on the UV+ and UV90 
progeny using CAPS markers F9-R9 and F6-R6. F9-R9 produced 2 UV+ recombinants 
(Fig. 11) and 5 UV90 recombinants (Fig. 12). Additional UV90 progeny for F9-R9 are 
shown in Appendix VII (Fig. Al). F6-R6 produced identical recombinant progeny, 2 for 
UV+ and 5 for UV90 (Figs. 13 and 14). Additional UV90 progeny for F6-R6 are shown 
in Appendix VII (Fig. A2). 
A list of the PCR results for F6-R6 and F9-R9 CAPS markers are listed in Table 
10. 7 out of 39 progeny were recombinant for both CAPS markers (Table 10). Primers 
F6, R6, F9 and R9 were re-ordered from Invitrogen and PCR was repeated for all 
progeny. Identical results were obtained (data not shown). To re-test the phenotypes, all 
39 progeny were re-inoculated onto race tubes containing maltose-arginine medium as 
described above along with controls csp-1; bd (sg #1) and csp-1; bd; UV90 (sg #227). 5 
UV+ and 5 UV90 progeny produced unclear phenotypes (Fig. 15) and were removed 
from further analyses, reducing the number of recombinants to 3 out of 29 (Table 10). 
prd-1 progeny: 
Due to the identical recombinant progeny and zero recombination seen between 
markers F6-R6 and F9-R9, it was suspected that the markers were possibly binding to an 
incorrect location, or that there possibly was an inversion between those markers. 
Therefore, the CAPS markers were tested using another Oak Ridge strain with a period 
mutation (prd-1) on a different chromosome than UV90. 
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DNA from progeny from a cross between csp-1; prd-1; bd (OR, sg #250) and MV 
(sg #258) was previously prepared by Nardin Nano. PCR and restriction enzyme 
digestion on csp-1; prd-1; bd andprd+ progeny were performed with F6-R6 and F9-R9 
CAPS markers. Gel electrophoresis of csp-1; prd-1; bd progeny #1-64A with F9-R9 
primers is shown in Fig. 16. csp-1; prd-1; bdprogeny #1-64A with F6-R6 primers is 
shown in Fig. 17. Gels from remaining esp-I; prd-1; bd and prd+ progeny are not 
shown. A complete list of PCR results for prd-1 and prd+ progeny using F6-R6 and F9-
R9 CAPS markers is given in Table 11. 12 out of 25 prd-1, and 9 out of 20 prd+ 
progeny were recombinant for F6-R6 and F9-R9 (Table 11). The prd-1 gene is located 
on Linkage Group III (Li and Lakin-Thomas, 2010), and therefore high recombination 
values were expected with CAPS markers F6-R6 and F9-R9 which are located on 
Linkage Group VI. Unlinked genes should produce recombination rates close to 50% 
(Griffiths et al., 1993), which was observed with the prd-1/prd+ progeny with both 
markers. This confirmed that the primers were binding to the correct locations and that 
there is reduced recombination between markers F6-R6 and F9-R9. 
Figure 18 shows a schematic of Linkage Group VI with primers F3, F6, F9 and 
668F. Dr. Kamyar Motavaze also performed genetic mapping on a different set of UV+ 
and UV90 progeny from the cross between csp-1; bd; UV90 (OR, sg #227) and MV wild 
type (sg #258). CAPS marker F3-R3 produced 10 out of 49 recombinants, while F6-R6 
and F9-R9 produced 7 out of 49 recombinants (data from Dr. Kamyar Motavaze). My 
UV90 progeny produced 3 out of 29 recombinants with F6-R6 and F9-R9. No 
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recombination was seen between F6-R6 and F9-R9 CAPS markers in either case. 
Genetic mapping of progeny from the same cross by Daniel Rubinger produced 4 out of 
54 recombinants with 668F-668R. The decreasing numbers of recombinants moving 
from marker F3-R3 to F9-R9 suggest that UV90 is further downstream to the right ofF9-
R9, yet its exact location on either side of the centromere is unknown (Fig. 18). 
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Table 6. esp+ and esp-1 progeny from cross between esp-1; bd; UV90 (OR, sg #227) 
and esp+; bd+; UV+ (MV, sg #258) 
Total spores csp-1 progeny esp+ progeny* Non-germinating 
picked progeny* 
192 87/192 (45.3%) 93/192 (48.4%) 12/192 (6.3%) 
*esp+ and non-germinating progeny were excluded from further analysis 
Table 7. esp-1 progeny from cross between esp-1; bd; UV90 (OR, sg #227) and esp+; 
bd+; UV+ (MV, sg #258) 
csp-1; bd progeny 
44/87 (50.6%) 
(progeny#: 3, 5, 6, 
8, 9, 12, 13, 15, 17, 
19, 21, 23, 27-29, 
31, 32, 35, 36, 41, 
44' 4 7-51, 5 3' 5 5' 
57, 58, 61, 65, 67, 
68, 70, 71, 74, 75, 
78-81, 83, 87 
Unclassifiable 
(progeny#: 1, 2, 4, (progeny #54) 
7, 10, 11, 14, 16, 18, 
20, 22, 24-26, 30, 
33, 34, 37-40, 42, 
43, 45, 46, 52, 56, 
59, 60, 62-64, 66, 
69, 72, 73, 76, 77, 
82, 84-86 
*bd+ and unclassifiable progeny were excluded from further analysis 
Table 8. esp-1; bd; UV90 and UV+ progeny from cross between esp-1; bd; UV90 (OR, 
sg #227) and esp+; bd+; UV+ (MV, sg #258) 
csp-1; bd; UV90 
(progeny#: 3, 5, 6, 
8, 15, 23, 28, 29, 
31, 32, 35, 36, 41, 
48, 50, 51, 57, 67, 
68, 71, 74, 78, 81, 
83,87 
csp-1; bd; UV+ 
(progeny#: 9, 12, 
13, 17,21,27,53, 
55, 58, 61, 70, 75, 
79, 80) 
Unclassifiable 
(progeny#: 19, 44, 
47,49,65) 
*Unclassifiable progeny were excluded from PCR and restriction enzyme analysis 
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Table 9. Periods and growth rates of csp-1; bd; UV90 and csp-1; bd; UV+ progeny 
csp-1; bd; UV90 pro ~eny csp-1; bd; UV+ progeny 
Progeny# Growth Rate Period (hr) Progeny# Period Growth 
(mm/hr) (hr) Rate 
(mm/hr) 
csp-1; bd; 1.12 NIA* csp-1; bd 21.95 1.26 
UV90 (control) 
(control) 
3 0.92 9 22.07 1.04 
5 1.07 12 21.85 1.19 
6 1.06 13 26.01 1.18 
8 1.06 17 21.38 1.08 
15 0.97 21 20.97 1.18 
23 1.04 27 25.80 1.05 
28 0.94 53 25.20 1.10 
29 0.95 55 23.63 1.11 
31 0.95 58 21.92 0.86 
32 0.93 61 21.16 1.20 
35 1.05 70 23.22 0.95 
36 1.03 75 22.02 1.30 
41 1.11 79 24.20 0.84 
48 1.06 80 25.33 1.20 
50 1.05 Mean Mean 
51 1.13 Period: Growth 
57 1.01 23.19 ± Rate: 
67 0.95 0.486 1.09± 
68 1.00 (S.E.M.) 0.036 
71 0.98 (S.E.M.) 
74 0.86 
78 0.88 
81 0.94 
83 1.05 
87 0.94 
Mean 
Growth 
Rate: 
0.99 ± 0.014 
(S.E.M) 
*Not applicable: progeny showed low amplitude, unclear rhythms; period was not 
calculated 
65 
#227 
#227 
#1 
#1 
#3 
#5 
#6 
#8 
#9 
#12 
Figure 7. Examples of esp-I; bd; UV90 or UV+ progeny obtained from esp-I; bd; UV90 
x esp+; bd; UV+ (Mauriceville wild type) cross. 
#1 (esp-I; bd) and #227 (esp-I; bd; UV90) served as controls. Progeny #3 through #12 
were placed first into the bd category. Progeny showed similar band patterns, growth 
rates (marked growth fronts) and physical appearance when compared to either of the bd 
controls. 
Growth on all race tubes is from left to right. Vertical marks show the position of the 
growth front at daily intervals. 
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#258 
#258 
#54 
#1 
#2 
#4 
#7 
#10 
#11 
Figure 8. Examples of csp-1; bd+; UV90 or UV+ progeny obtained from csp-1; bd; 
UV90 x esp+; bd+; UV+ (Mauriceville wild type) cross. 
#258 (Mauriceville wild type) served as a control. Progeny #1 through #11 were placed 
into the bd+ category first. Progeny showed similar band patterns, growth rates (marked 
growth fronts) and physical appearance in comparison to bd+ control. #54 was 
unclassifiable due to abnormal growth rate and physical appearance. 
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A 
#48 
#41 
#36 
#35 
#32 
#29 
#28 
#23 
#15 
#8 
#227 
#227 
B 
#48 
#41 
#36 
#35 
#32 
#29 
#28 
#23 
#15 
#8 
#227 
Figure 9. Examples of esp-1; bd; UV90 progeny with (A) and without (B) marked 
growth fronts, obtained from esp-1; bd; UV90 x esp+; bd+; UV+ (Mauriceville wild 
type) cross. #227 (esp-I; bd; UV90) served as a control. Progeny #8 through #48 
showed either low amplitude rhythms or constant conidiation, and similar physical 
appearance as the control. 
68 
A 
#I 
#1 
#12 
#17 
#21 
#27 
#53 
#61 
#70 
#75 
#80 
B 
#80 
#75 
#70 
#61 
#53 
#27 
#21 
#17 
#12 
#1 
#1 
Figure 10. Examples of csp-1; bd; UV+ progeny with (A) and without (B) marked 
growth fronts, obtained from csp-1; bd; UV90 x esp+; bd+; UV+ (Mauriceville wild 
type) cross. #1 (csp-1; bd) served as a control. Progeny #12 through #80 showed strong 
rhythmic conidiation and similar physical appearance as the control. 
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A 
B 
9U 9C 12U 12C 13U 13C 17U 17C 21U 21C 27U 27C S3U S3C S5U SSC 
58U SSC 61U 61C 70U 70C 75U 7SC 79U 79C SOU 80C UV90 MV 
9U 9C 12U 12C UV90 
' f ,~,µ b&~'f't'·:~,~'''-'"~'• 
MV IOObp 
I kb 
-- 500bp 
1 kb 
SOObp 
1 kb 
soo bp 
Figure 11. PCR results from csp-1; bd; UV+ progeny using F9-R9 primers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal restriction enzyme. 
"Cut" OR DNA exhibits two overlapping bands, each ~250 bp in size. UV90 (csp-1; bd; 
UV90) and MV (Mauriceville, esp+; bd+; UV+) served as controls. Progeny #9 and #12 
were repeated in (B). Most UV+ progeny resembled MV after digestion with the 
exception of#l 7 and #75 which resembled UV90, and thus were determined to be 
recombinants. 
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3U 3C SU SC 6U 6C 8U 8C 15U ISC 23U 23C 28U 28C 29U 29C 100 bp ladder 
31U 31C 32U 32C 35U 35C 36U 36C 41U 41C 48U 48C UV90 
I kb 
500 bp 
1 kb 
soo bp 
Figure 12. PCR results from csp-1; bd; UV90 progeny #3-48 using F9-R9 primers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal restriction enzyme. 
"Cut" OR DNA exhibits two overlapping bands, each-250 bp in size. UV90 (csp-1; bd; 
UV90) and MV (Mauriceville, esp+; bd+; UV+) served as controls. 
Most UV90 progeny resembled UV90 control after digestion with the exception of#5, #6 
and #31 which resembled MV, and thus were determined to be recombinants. Progeny 
#50 through #87 are shown in Appendix VII, Fig. Al. 
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9U 9C 12U 12C 13U 13C 17U 17C 21U 21C 27U 27C 53U 53C 55U 55C I kb 
Figure 13. PCR results from esp-I; bd; UV+ progeny using F6-R6 primers. 
2kb 
1.5 kb 
I kb 
500 hp 
U ="uncut", undigested DNA; C ="cut", DNA digested with EcoRI restriction enzyme. 
UV90 (esp-I; bd; UV90) and MV (Mauriceville, esp+; bd+; UV+) served as controls. 
Most UV+ progeny resembled MV control after digestion with the exception of# 17 and 
#75 which resembled UV90, and thus were determined to be recombinants. 
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50U 50C 51U 51C 57U 57C 67U 67C 68U 68C 71U 71C 74U 74C I kb ladder 
78U 78C 81 U 81 C 83U 83C 87U 87C UV90 MV I kb 
Figure 14. PCR results from csp-1; bd; UV90 progeny using F6-R6 primers. 
2kb 
--I.5kb 
--1kb 
-- 500bp 
U ="uncut", undigested DNA; C ="cut", DNA digested with EcoRI restriction enzyme. 
UV90 ( csp-1; bd; UV90) and MV (Mauriceville, esp+; bd+; UV+) served as controls. 
Most progeny resembled UV90 control after digestion with the exception of #83 and #87 
which resembled MV, and thus were determined to be recombinants. Progeny #3 
through #48 are shown in Appendix VII, Fig. A2. 
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Table 10. Recombination frequencies of esp-1; bd; UV90 and esp-1; bd; UV+ progeny 
with F6-R6 and F9-R9 CAPS markers 
Pro2eny tested with F6 & R6 primers Pro2eny tested with F9 & R9 primers 
esp-1; bd; UV90 esp-1; bd; UV+ esp-1; bd; UV90 esp-1; bd; UV+ 
Progeny Recom. Progeny Recom. Progeny Recom. Progeny Recom. 
# (YesN, # (YesN, # (YesN, # (YesN, 
No/N)* No/N)* No/N)* No/N)* 
3** N 9** N 3** N 9** N 
5** y 12 N 5** y 12 N 
6** y 13** N 6** y 13** N 
8 N 17 y 8 N 17 y 
15 N 21 N 15 N 21 N 
23 N 27 N 23 N 27 N 
28 N 53 N 28 N 53 N 
29 N 55** N 29 N 55** N 
31** y 58** N 31** y 58** N 
32 N 61 N 32 N 61 N 
35 N 70 N 35 N 70 N 
36 N 75 y 36 N 75 y 
41 N 79** N 41 N 79** N 
48 N 80 N 48 N 80 N 
50 N 50 N 
51 N 51 N 
57 N 57 N 
67 N 67 N 
68 N 68 N 
71 N 71 N 
74 N 74 N 
78 N 78 N 
81 N 81 N 
83 y 83 y 
87** y 87** y 
Total Total Total Total 
UV90: UV+: UV90: UV+: 
5/25 2/14 5/25 2/14 
Total recombinant progeny: 7/39 (17.9%) Total recombinant progeny: 7/39 (17.9%) 
Adjusted total: 3/29 (10.3%)** Adjusted total: 3/29 (10.3%)** 
*Recom. = recombinant. Recombinant progeny are highlighted in red 
**10 progeny were disregarded due to unclassifiable race tube phenotypes (see Fig. 15) 
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A 
Suspect UV+ progeny 
#79 
#58 
#55 
#13 
#9 
Suspect UV90 progeny 
#87 
#31 
#6 
#5 
#3 
B 
Suspect UV+ progeny 
#9 
#13 
#55 
#58 
#79 
Suspect UV90 progeny 
#3 
#5 
#6 
#31 
#87 
Figure 15. Unclassifiable csp-1; bd; UV+ and UV90 progeny obtained from csp-1; bd; 
UV90 x esp+; bd+; UV+ (Mauriceville wild type) cross. Shown with (A) and without 
(B) marked growth fronts. Progeny did not show clear UV+ or UV90 phenotypes when 
compared to other progeny and controls (Figs. 9 & 10) and were excluded from further 
analyses (Tables 10 & 12). 
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I 00 bp ladder 
I kb 
500 bp 
I kb 
500 bp 
Figure 16. PCR results from esp-I; prd-I; bd progeny #1-64A using F9-R9 primers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal restriction enzyme. 
"Cut" OR DNA exhibits two overlapping bands, each --250 bp in size. 
prd-I (esp-I; prd-I; bd) and MV (Mauriceville wild type, esp+; prd+; bd+) served as 
controls. 
Progeny #1, 7, 21, 33, 45 and 46 showed no DNA cleavage after digestion, resembling 
the MV control, and were therefore determined to be recombinants. 
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lU IC 2U 2C 7U 7C 16U 16C 21U 21C 26U 26C 32U 32C 33U 33C 
45U 45C 46U 46C 47U 47C 52U 52C 55U 55C 64U 64C prd-1 MV 
I kb ladder 
I kb ladder 
2kb 
1.5 kb 
1 kb 
0.5 kb 
Figure 17. PCR results from csp-1; prd-1; bd progeny #1-64A using F6-R6 primers. 
U = "uncut", undigested DNA; C = "cut", DNA digested with EcoRI restriction enzyme. 
prd-1 (csp-1; prd-1; bd) and MV (Mauriceville wild type, esp+; prd+; bd+) served as 
controls. 
Progeny #1, 7, 21, 33, 45 and 46 showed no DNA cleavage after digestion, resembling 
the MV control, and were therefore determined to be recombinants. 
77 
Table 11. Recombination frequencies of csp-1; prd-1; bd and csp-1; prd+; bd progeny 
with F6-R6 and F9-R9 CAPS markers 
Progeny tested with F6 & R6 primers Progeny tested with F9 & R9 primers 
csp-1; prd-1; bd csp-1; prd+; bd csp-1; prd-1; bd csp-1; prd+; bd 
Progeny Recom. Progeny Recom. Progeny Recom. Progeny Recom. 
# (YesN, # (YesN, # (YesN, # (YesN, 
No/N)* No/N)* No/N)* No/N)* 
lA y 17A y lA y 17A y 
2A N 19A N 2A N 19A N 
7A y 28A N 7A y 28A N 
16A N 29A N 16A N 29A N 
21A y 30A y 21A y 30A y 
26A N 34A N 26A N 34A N 
32A N 35A y 32A N 35A y 
33A y 41A y 33A y 41A y 
45A y 44A y 45A y 44A y 
46A y 49A y 46A y 49A y 
47A N 50A N 47A N 50A N 
52A N 54A y 52A N 54A y 
55A N 34B N 55A N 34B N 
64A N 36B y 64A N 36B y 
2B N 41B N 2B N 41B N 
3B N 55B N 3B N 55B N 
llB y 56B y llB y 56B y 
12B y 57B N 12B y 57B N 
13B y 59B N 13B y 59B N 
14B y 64B N 14B y 64B N 
15B y 15B y 
16B N 16B N 
19B y 19B y 
23B N 23B N 
26B N 26B N 
Total Total Total Total 
prd-1: prd+: prd-1: prd+: 
12/25 9120 12/25 9120 
Total recombinant progeny: 21/45 (46.7%) Total recombinant progeny: 21/45 (46.7%) 
*Recom. = recombinant. Recombinant progeny are highlighted in red 
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20.4% 
7.4% 7.4% 
T T T ~•;o IOI 618 
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1.5 2 2.5 3 3.5 
UV90 
? 
1111111111111111 
4 Mbp 
Figure 18. Schematic of Neurospora crassa Linkage Group VI displaying primer 
locations, UV90 progeny recombination and suspected location of UV90 mutation. 
Scale is in Mega basepairs (Mbp ). Primers F3, F6, F9 and 6-68 are located at 2.06, 2.14, 
2.41, and 3.29 Mbp, respectively. 
0 = centromere, located at 2.8- 3.1 Mbp. I UV90? I =potential location of UV90 
gene. 
Primer F3 showed 10/49 (20.4%) recombinant progeny. F6 and F9 primers produced 
7/49 (14.3%) and 3/29 (10.3%) identical recombinant progeny. Recombination between 
F6 and F9 primers was zero. Recombination between F3 and F6 primers was 3/49 
progeny (6.1 %). Primer 6-68 showed 4/54 (7.4%) recombinant progeny. Data in red 
obtained from Dr. Kamyar Motavaze. Data in green obtained from Daniel Rubinger. 
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3.1.3 Left centromere CAPS markers: LCF2-LCR2 and Fll-Rll 
Six CAPS markers were designed as described in Methods 2.2.4: LCFl-LCRl, 
LCF2-LCR2, RCF3-RCR3, RCF4-RCR4, FlO-RlO, Fl 1-Rl 1 (Tables 2 and 3, Materials 
and Methods). New 50 ng/µL dilutions of all 39 UV90 progeny and parental strains (csp-
1; bd; UV90 and MV) were made from extracted stock DNA. PCR, restriction enzyme 
digestion and gel electrophoresis was performed on the parental strains as described in 
Methods 2.2.5 (Fig. 19). CAPS markers LCFl-LCRl and FlO-RlO were not used further 
due to undesirable or no results with the parental strains. RCF3-RCR3 and RCF4-RCR4 
produced identical banding patterns for both parents due to multiple restriction enzyme 
locations which were not checked for during primer design. LCF2-LCR2 and Fl 1-Rl 1 
produced distinct bands for OR and MV and were used to perform PCR on the UV90 
progeny. PCR on parental strains was repeated with CAPS markers LCFl-LCRl, LCF2-
LCR2, FlO-RlO and Fl 1-Rl 1 and identical results were obtained (data not shown). 
PCR was performed using LCF2 and LCR2 primers on all 39 UV90 and UV+ 
progeny. Two recombinants were seen with UV+ progeny (Fig. 20). Four recombinants 
were seen with UV90 progeny (Fig. 21 ). Only UV90 progeny #50-87 are shown in 
Figure 21. PCR was performed using primers Fl 1 and Rl 1. Identical results were 
obtained as with LCF2 and LCR2. Two recombinants were seen with UV+ progeny and 
four with UV90 progeny (Figs. 22 and 23). Only UV90 progeny #50-87 are shown in 
Figure 23. 
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PCR results with CAPS markers LCF2-LCR2 and Fl 1-Rl 1 are listed in Table 12. 
Six out of 39 progeny were recombinant with both CAPS markers (Table 12). 
Disregarding the unclassifiable race tubes (Fig. 15) resulted in 2 out of 29 recombinants 
(Table 12). The decreasing number ofrecombinants with LCF2-LCR2 and Fl 1-Rl 1 (2 
out of29) as compared to F6-R6 and F9-R9 (3 out of29) suggest that UV90 is further 
downstream and pos~ibly to the right of the centromere. 
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LCFl-LCRl LCF2-LCR2 I RCF3-RCR3 I RCF4-RCR4 
OR OR MV MV OR OR MV MV OR OR MV MV OR OR MV MV 100 bp ladder 
FlO-RlO Fll-Rll 
1 kb 
500 bp 
Figure 19. PCR results from UV90 parental strains using CAPS marker pairs: LCFl-Rl, 
LCF2-R2, RCF3-R3, RCF4-R4, Fl 0-Rl 1 and Fl 1-Rl 1. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal (LCFl-Rl; RCF4-
R4; Fl 1-Rl 1), and Haelll (LCF2-R2; RCF3-R3; FlO-RlO) restriction enzymes. OR= 
Oak Ridge esp-I; bd; UV90 parent; MV = Mauriceville wild type, esp+; bd+; UV+ 
parent. 
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9U 9C 12U 12C 13U )3C 17U 17C ,21U 21C 27U 27C 53U 53C 55U 55C 100 bp ladder 
---~ ' ·v..; 
I kb 
500 bp 
58U 58C 61U 61C 70U 70C 75U 75C 79U 79C SOU SOC UV90 MV ) c,.-, 
Figure 20. PCR results showing csp-1; bd; UV+ progeny using LCF2-LCR2 primers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Haelll restriction enzyme. 
"Cut" OR DNA exhibits two overlapping bands, each ..... 250 bp in size. 
UV90 ( csp-1; bd; UV90) and MV (Mauriceville wild type, esp+; bd+; UV+) served as 
controls. 
Most UV+ progeny resembled MV after digestion with the exception of#l 7 and #75 
which resembled UV90 and were determined to be recombinants. 
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. 50U 50C 51U 51C 57U 57C 67U 67C 68U 68C 71U 71C 74U 74C 100 bp ladder 
" 
-
1 kb 
500 bp 
ladder 
Figure 21. PCR results showing csp-1; bd; UV90 progeny using LCF2-LCR2 primers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Haelll restriction enzyme. 
"Cut" OR DNA exhibits two overlapping bands, each ~250 bp in size. 
UV90 (csp-1; bd; UV90) and MV (Mauriceville wild type, esp+; bd+; UV+) served as 
controls. 
Most progeny resembled UV90 control after digestion with the exception of #87 which 
resembled MV and was determined to be recombinant. 
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I kb 
500 bp 
ladder 
Figure 22. PCR results showing csp-1; bd; UV+ progeny using Fl 1-Rl 1 primers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal restriction enzyme. 
UV90 (csp-1; bd; UV90) and MV (Mauriceville wild type, esp+; bd+; UV+) served as 
controls. 
Most progeny resembled MV after digestion with the exception of#l 7 and #75 which 
resembled UV90 and were determined to be recombinants. Progeny #55 was repeated 
and resembled MV (data not shown). 
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Figure 23. PCR results showing esp-I; bd; UV90 progeny using Fl 1-Rl 1 primers. 
1 kb 
500 bp 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal restriction enzyme. 
UV90 (esp-1; bd; UV90) and MV (Mauriceville wild type, esp+; bd+; UV+) served as 
controls. 
Most progeny resembled UV90 after digestion with the exception of #87 which 
resembled MV and was determined to be recombinant. 
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Table 12. Recombination frequencies of esp-I; bd; UV90 and esp-I; bd; UV+ progeny 
with LCF2-LCR2 and Fl 1-Rl 1 CAPS markers 
Progeny tested with LCF2 & LCR2 Progeny tested with Fl 1 & Rl 1 primers 
primers 
esp-I; bd; UV90 esp-I; bd; UV+ esp-I; bd; UV90 esp-I; bd; UV+ 
Progeny Recom. Progeny Recom. Progeny Recom. Progeny Recom. 
# (YesN, # (YesN, # (YesN, # (YesN, 
No/N)* No/N)* No/N)* No/N)* 
3** N 9** N 3** N 9** N 
5** y 12 N 5** y 12 N 
6** y 13** N 6** y 13** N 
8 N 17 y 8 N 17 y 
15 N 21 N 15 N 21 N 
23 N 27 N 23 N 27 N 
28 N 53 N 28 N 53 N 
29 N 55** N 29 N 55** N 
31** y 58** N 31** y 58** N 
32 N 61 N 32 N 61 N 
35 N 70 N 35 N 70 N 
36 N 75 y 36 N 75 y 
41 N 79** N 41 N 79** N 
48 N 80 N 48 N 80 N 
50 N 50 N 
51 N 51 N 
57 N 57 N 
67 N 67 N 
68 N 68 N 
71 N 71 N 
74 N 74 N 
78 N 78 N 
81 N 81 N 
83 N 83 N 
87** y 87** y 
Total Total Total Total 
UV90: UV+: UV90: UV+: 
4125 2/14 4/25 2/14 
Total recombinant progeny: 6/39 (15.38%) Total recombinant progeny: 6/39 (15.38%) 
Adjusted total: 2/29 (6.9%)** Adjusted total: 2/29 (6.9%)** 
*Recom. = recombinant. Recombinant progeny are highlighted in red 
**10 progeny were disregarded due to unclassifiable race tube phenotypes (see Fig. 15) 
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3.1.4 New UV90 progeny and right centromere CAPS markers: RCFS-
RCRS, 668F-668R and F16-R16 
New UV90 progeny: 
To increase the number of UV90 progeny for PCR, approximately 400 spores 
were picked from the cross between esp-I; bd; UV90 (OR, sg #227) and MV wild type 
(sg #258) as described in Methods 2.2.1. The "tap test" was performed on the baby tubes 
to visually check for esp-1 and esp+ progeny as described in Methods 2.2.2. 194 were 
found to be esp-1, 165 were esp+ and 41 did not germinate (Table 13). 
100 esp-1 progeny were numbered and inoculated onto maltose-arginine medium 
in race tubes as described in Methods 2.2.2. Replicate tubes of the following controls 
were also inoculated: esp-I; bd (sg #1), esp-1; bd; UV90 (sg #227) and esp+; bd+; UV+ 
(MV, sg #258). Progeny were visually separated into bd+ or bd phenotypes based on 
growth fronts marked daily on the tubes in comparison to controls esp-I; bd (sg #1) and 
MV wild type (sg #258) (Figs. 24 and 26). bdtubes were then sorted into UV+ by the 
presence of clear, rhythmic bands (Fig. 24) or UV90 by exhibiting a low amplitude 
rhythm (Fig. 25). bd+ tubes were sorted into UV+ by exhibiting bands as in the MV wild 
type control (Fig. 26) or UV90 by the presence of constant, arrhythmic conidiation (Fig. 
27). 
21 progeny were found to be esp-I; bd; UV90, 19 were esp-I; bd; UV+, 25 were 
esp-I; bd+; UV90, 21 were esp-I; bd+; UV+ and 14 were unclassifiable (Table 14). 
Unclassifiable progeny were not used further in DNA extraction or PCR. Progeny 
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generally fall into a 1: 1: 1: 1 ratio for all 4 classes (Table 14), which indicates again that a 
single gene is responsible for the UV90 phenotype and is segregating independently 
(Griffiths et al., 1993). A chi-square test was performed and the p value was determined 
to be non-significant (p = 0.4368), which confirms that the slight variations observed in 
the number of progeny were due to chance deviations (Table 14, Appendix X). 
Periods and growth rates of all progeny are listed in Tables 15 and 16. csp-1; 
bd+; UV+ progeny exhibited a mean growth rate of2.12 (± 0.088) mm/hr and a period of 
22 (± 0.444) hr (Table 15). csp-1; bd+; UV90 progeny had a mean growth rate of 1.65 (± 
0.027) mm/hr (Table 15). These values match the previously reported values for bd+ 
progeny (Li et al., 2011 ). Although the mean growth rate matches the reported values, 
there appears to be a larger variation among the growth rates for bd+ progeny (Table 15). 
This is likely due to small nucleotide polymorphisms (SNPs) between the parental OR 
and MV strains as well as the bd+ strains being faster growing than bd strains. csp-1; 
bd; UV+ progeny had a mean growth rate of 1.28 (± 0.020) mm/hr and a period of 21.86 
(± 0.139) hr (Table 16). csp-1; bd; UV90 progeny had a mean growth rate of 1.09 (± 
0.013) mm/hr (Table 16). The previously reported growth rate for csp-1; bd; UV90 is 
slightly higher at 1.16 mm/hr, yet it confirms again that the UV90 phenotype is slower 
growing than the wild type (Li et al., 2011). The csp-1; bd; UV+ growth rate and period 
were very close to the reported rates of 1.29 mm/hr and 21.2 hr (Li et al., 2011 ). 
DNA extraction was performed on the 86 UV+ and UV90 progeny along with 
parental strains csp-1; bd; UV90 and MV wild type as described in Methods 2.2.3. The 
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DNA concentrations ranged from 90-418 µg/mL for UV+ progeny and 79-288 µg/mL for 
UV90 progeny (data not shown). esp-I; bd; UV90 progeny # 198 did not produce a DNA 
pellet, leaving 85 progeny. CAPS markers RCF5-RCR5, RCF6-RCR6, F15-Rl5 and 
F16-R16 were designed as described in Methods 2.2.4. Primer sequences for 668F and 
668R were obtained from Jin et al. (2007) (Tables 2 and 3, Materials and Methods). 
PCR, restriction enzyme digestion and gel electrophoresis were performed on the parental 
strains and all UV+ and UV90 progeny as described in Methods 2.2.5. 
CAPS markers RCF5-RCR5. 668F-668R and F16-R16: 
PCR was performed on the parental strains esp-I; bd; UV90 (sg #227) and MV 
wild type with CAPS markers RCF5-RCR5, RCF6-RCR6 and 668F-668R (Fig. 28). 
RCF6-RCR6 did not produce any PCR product when repeated twice (Fig. 28, A and B). 
RCF5-RCR5 and 668F-668R both produced distinct bands for each parent after digestion 
(Fig. 28) and were used for PCR. PCR was performed on the previous 39 UV+ and 
UV90 progeny with RCF5-RCR5 primers and no PCR products were obtained. It is 
believed the DNA had degraded due to multiple freezing and thawing during use. PCR 
was then continued with the new 85 UV+ and UV90 progeny. 
6 out of 40 UV+ progeny and 2 out of 45 UV90 progeny were recombinant with 
RCF5-RCR5 (Figs. 29 and 30). Only digested esp-I; bd+; UV+ and esp-I; bd+; UV90 
progeny are shown in Figs. 29 and 30. 2 out of 40 UV+ and 1 out of 45 UV90 progeny 
were recombinant with 668F-668R (Figs. 31 and 32). Only digested esp-I; bd; UV+ and 
esp-1; bd+; UV90 progeny are shown in Figs. 31and32. A complete list of PCR results 
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with RCF5-RCR5 and 668F-668R is shown in Table 17. 8 out of 85 total progeny were 
recombinant with RCF5-RCR5 and 3 out of 85 total progeny were recombinant with 
668F-668R (Table 17). 
PCR was performed on the parental strains esp-I; bd; UV90 (sg #227) and MV 
wild type with CAPS markers F15-R15 and F16-R16 (Fig. 33). F16-R16 was chosen for 
the progeny. 4 out of 40 UV+ progeny and 4 out of 45 UV90 progeny were recombinant 
with F16-R16 (Figs. 34 and 35). Only digested esp-I; bd+; UV+ and esp-I; bd+; UV90 
progeny are shown in Figs. 34 and 35. A complete list of PCR results with F16-R16 
primers is shown in Table 18. 8 out of 85 total progeny were recombinant with F16-R16 
(Table 18). 
A map showing the number of recombinants and locations of primers F6 through 
F16 is shown in Fig. 36. The number of recombinant progeny decreased to its lowest 
amount, 3 out of 85 (3.53%) at CAPS marker 668F-668R, suggesting that the 668F-668R 
marker is closer to UV90. The progeny that were recombinant with marker 668F-668R 
(#143, 184, and 122) were also recombinant with RCF5-RCR5 (Table 17; Fig. 41). This 
indicates that the crossover event which caused these progeny to appear recombinant with 
both markers occurred to the right of 668F-668R, but prior to the UV90 gene. The 
number ofrecombinants increased to 8 out of 85 (9.41 %) at F16-Rl6, which indicates the 
marker is farther away from UV90. This suggests the UV90 gene is located between 
markers 668F-668R and F16-R16 (Fig. 36; Fig. 41). 
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Table 13. Second group of esp+ and esp-I progeny from cross between esp-I; bd; UV90 
(OR, sg #227) and esp+; bd+; UV+ (MV, sg #258) 
Total spores csp-1 progeny esp+ progeny* Non-germinating 
picked pro2eny* 
400 194/400** (48.5%) 165/400 (41.25%) 41/400 (10.25%) 
*esp+ and non-germinating progeny were excluded from further testing 
**Four esp-I test tubes were broken, only 190 esp-I progeny remained for race tube 
analysis 
Table 14. Second group of esp-I; bd; UV+/UV90, and esp-I; bd+; UV+/UV90 progeny 
from cross between esp-I; bd; UV90 (OR, sg #227) and esp+; bd+; UV+ (MV, sg #258) 
Number csp-1; bd; csp-1; bd; csp-1; bd+; csp-1; bd+; U nclassifiabl 
of csp-1 UV90 UV+ UV90 UV+ e progeny* 
141100 (14%) 
(strains: 
(strains: (strains: (strains: (strains: #101, 102, 
#100, 103, #104, 110, #106, 109, #105, 108, 107, 114, 
111, 118, 117,121, 116,125, 112, 113, 124, 142, 
119,120, 122, 128, 130, 131, 115, 123, 148, 152, 
127, 129, 136, 137, 133, 134, 126, 132, 154, 157, 
140, 146, 141, 149, 135, 139, 138, 143, 172, 177, 
151, 158, 153, 155, 144, 145, 147, 163, 178, 180) 
159, 160, 156, 161, 150, 166, 167, 169, 
162, 164, 165, 171, 168, 170, 174, 182, 
176, 187, 181, 183, 173, 175, 185, 191, 
189, 197, 196) 179, 184, 193, 194, 
198) 186, 188, 199) 
190, 192, 
195 
*Unclassifiable progeny were excluded from further analysis 
**100 out of 190 esp-I progeny were tested on race tubes and used for DNA extraction & 
PCR 
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#I 
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Figure 24. Examples of csp-1; bd; UV+ progeny with (A) and without (B) marked 
growth fronts, obtained from csp-1; bd; UV90 x esp+; bd+; UV+ (Mauriceville wild 
type) cross. # 1 ( csp-1; bd) served as a control. Progeny were classified as bd phenotype 
based on marked growth rates in (A), and classified as UV+ in (B) based on strong, 
rhythmic conidiation. 
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Figure 25. Examples of esp-I; bd; UV90 progeny with (A) and without (B) marked 
growth fronts, obtained from esp-I; bd; UV90 x esp+; bd+; UV+ (Mauriceville wild 
type) cross. #227 (esp-I; bd; UV90) served as a control. Progeny were classified as bd 
phenotype based on marked growth rates in (A), and classified as UV90 in (B) based on 
low amplitude rhythms. 
94 
A 
#258 
#258 
#163 
#167 
#169 
#174 
#182 
#185 
#191 
#193 
#194 
#199 
B 
#258 
#258 
#163 
#167 
#169 
#174 
#182 
#185 
#191 
#193 
#194 
#199 
Figure 26. Examples of esp-I; bd+; UV+ progeny with (A) and without (B) marked 
growth fronts, obtained from esp-I; bd; UV90 x esp+; bd+; UV+ (Mauriceville wild 
type) cross. #258 (esp+; bd+; UV+) served as a control. Progeny were classified as bd+ 
phenotype based on marked growth rates in (A), and classified as UV+ in (B) based on 
similar conidiation as control. 
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A 
#258 
#258 
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#131 
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B 
#258 
#258 
#184 
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Figure 27. Examples of esp-I; bd+; UV90 progeny with (A) and without (B) marked 
growth fronts, obtained from esp-I; bd; UV90 x esp+; bd+; UV+ (Mauriceville wild 
type) cross. #258 (esp+; bd+; UV+) served as a control. Progeny were classified as bd+ 
phenotype based on marked growth rates in (A), and classified as UV90 in (B) based on 
arrhythmic conidiation. 
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Table 15. Growth rates and periods of second group of esp-1; bd+; UV+ and UV90 
progeny 
csp-1; bd+; UV+ csp-1; bd+; UV90 
Progeny# Growth Period (hr) Progeny# Growth Rate Period 
Rate (mm/hr) (hr) 
(mm/hr) 
esp+; bd+; UV+ 1.72 22.52 -- -- NIA** 
(control) 
esp+; bd+; UV+ 1.69 21.24 -- --
(control) 
105 1.64 27.54 106 1.58 
108 2.79 20.14 109 1.59 
112 1.66 22.21 116 1.55 
113 2.24 21.52 125 1.54 
115 1.66 20.06 130 1.68 
123 2.32 20.50 131 1.70 
126 1.66 24.40 133 1.74 
132 2.77 18.40 134 1.75 
138 2.29 21.00 135 1.56 
143 1.61 25.02 139 1.52 
147 2.14 22.48 144 1.79 
163 1.77 22.52 145 1.81 
167 2.30 NIA* 150 1.67 
169 2.43 20.41 166 1.80 
174 1.78 22.54 168 1.70 
182 1.75 22.73 170 1.37 
185 2.23 21.38 173 1.70 
191 1.83 21.86 175 1.72 
193 2.54 22.64 179 1.69 
194 2.58 21.22 184 1.76 
199 2.52 21.46 186 1.28 
188 1.76 
Mean Growth Mean 190 1.75 
Rate: 2.12 ± Period: 192 1.77 
0.088 (S.E.M.) 22.00 ± 195 1.55 
0.444 Mean Growth 
(S.E.M.) Rate: 1.65 ± 
0.027 (S.E.M.) 
*Progeny # 167 showed only one large band, making a period calculation unattainable 
**Not applicable: bd+; UV90 progeny were arrhythmic; period was not calculated 
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Table 16. Growth Rates and periods of second group of csp-1; bd; UV+ and UV90 
progeny 
csp-1; bd; UV+ csp-1; bd; UV90 
Progeny# Growth Rate Period (hr) Progeny Growth Rate Period 
(mm/hr) # (mm/hr) (hr) 
csp-1; bd; 1.31 21.62 csp-1; bd; 1.11 NIA* 
UV+ UV90 
(control) (control) 
csp-1; bd; 1.25 21.44 csp-1; bd; 1.11 
UV+ UV90 
(control) (control) 
104 1.25 21.63 100 1.13 
110 1.21 21.89 103 1.09 
117 1.07 22.12 111 1.11 
121 1.36 21.73 118 1.14 
122 1.28 22.38 119 1.12 
128 1.33 22.63 120 1.14 
136 1.34 21.64 127 1.10 
137 1.32 22.50 129 0.97 
141 1.34 21.22 140 1.14 
149 1.37 19.91 146 1.11 
153 1.33 22.38 151 1.10 
155 1.18 22.25 158 0.98 
156 1.33 22.31 159 1.02 
161 1.44 21.88 160 1.17 
165 1.30 21.54 162 1.03 
171 1.15 22.06 164 0.99 
181 1.21 22.23 176 1.06 
183 1.34 21.66 187 1.07 
196 1.26 22.13 189 1.05 
197 1.17 
198 1.07 
Mean Mean Mean Growth 
Growth Period: Rate: 1.09 ± 0.013 
Rate: 21.86 ± (S.E.M.) 
1.28 ± 0.020 0.139 
(S.E.M.) (S.E.M.) 
*Not applicable: bd; UV90 progeny showed low amplitude rhythms; period was not 
calculated 
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Figure 28. PCR results from UV90 parental strains using CAPS marker pairs: RCF5-
RCR5, RCF6-RCR6 and 668F-668R. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal (RCF5-RCR5) or 
Mspl (RCF6-RCR6, 668F-668R) restriction enzymes. OR= Oak Ridge csp-1; bd; UV90 
parent; MV = Mauriceville wild type, esp+; bd+; UV+ parent. 
(A) shows parents with all CAPS markers. (B) shows digested RCF5-RCR5 and repeated 
RCF6-RCR6 and 668F-668R. (C) shows digested 668F-668R. 
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105 108 112 113 115 123 126 132· 138 143 147 163 100 bp ladder 
1 kb 
500 bp 
Figure 29. PCR results showing digested esp-I; bd+; UV+ progeny using RCF5-RCR5 
primers. All progeny digested with Taqal restriction enzyme. Digested OR DNA 
exhibits two overlapping bands, each --100 bp in size. UV90 ( esp-1; bd; UV90) and MV 
(Mauriceville wild type, esp+; bd+; UV+) served as controls. 
Most progeny resembled MV after digestion with the exception of #115, 132, 143 and 
194 which resembled UV90 and were determined to be recombinant. 
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106 109 116 125 130 131 133 134 135 139 144 145 150 166 100 bp ladder 
168 170 173 175 179 184 186 188 190 192 195 UV90MV 100 hp ladder 
Figure 30. PCR results showing digested csp-1; bd+; UV90 progeny using RCF5-RCR5 
primers. All progeny digested with Taqal restriction enzyme. Digested OR DNA 
exhibits two overlapping bands, each -100 bp in size. UV90 ( csp-1; bd; UV90) and MV 
(Mauriceville wild type, esp+; bd+; UV+) served as controls. 
Most progeny resembled UV90 after digestion with the exception of# 170 and # 184 
which resembled MV and were determined to be recombinant. 
101 
Figure 31. PCR results showing digested esp-I; bd; UV+ progeny using 668F-668R 
pnmers. 
1 kb 
500 bp 
All progeny digested with Mspl restriction enzyme. UV90 (esp-I; bd; UV90) and MV 
(Mauriceville wild type, esp+; bd+; UV+) served as controls. 
Most progeny resembled MV after digestion with the exception of# 122 which resembled 
UV90 and was determined to be recombinant. 
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106 109 116 125 130 131 133 134 135 139 144 145 150 166 100 bp ladder 
1 kb 
500bp 
dder 
Figure 32. PCR results showing digested csp-1; bd+; UV90 progeny using 668F-668R 
primers. 
All progeny digested with Mspl restriction enzyme. UV90 ( csp-1; bd; UV90) and MV 
(Mauriceville wild type, esp+; bd+; UV+) served as controls. 
Most progeny resembled UV90 after digestion with the exception of# 184 which 
resembled MV and was determined to be recombinant. 
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Table 17. Recombination frequencies of esp-1; bd+; UV+/UV90 and esp-1; bd; 
UV+/UV90 progeny with RCF5-RCR5 and 668F-668R CAPS markers 
Progeny tested with RCF5 & RCR5 Progeny tested with 668F & 668R 
primers primers 
esp-1; bd+; UV90 esp-1; bd+; UV+ esp-1; bd+; UV90 esp-1; bd+; UV+ 
Progeny Recom. Progeny Recom. Progeny Recom. Progeny Recom. 
# (YesN, # (YesN, # (YesN, (YesN, 
No/N)* No/N)* No/N)* No/N)* 
106 N 105 N 106 N 105 N 
109 N 108 N 109 N 108 N 
116 N 112 N 116 N 112 N 
125 N 113 N 125 N 113 N 
130 N 115 y 130 N 115 N 
131 N 123 N 131 N 123 N 
133 N 126 N 133 N 126 N 
134 N 132 y 134 N 132 N 
135 N 138 N 135 N 138 N 
139 N 143 y 139 N 143 y 
144 N 147 N 144 N 147 N 
145 N 163 N 145 N 163 N 
150 N 167 N 150 N 167 N 
166 N 169 N 166 N 169 N 
168 N 174 N 168 N 174 N 
170 y 182 N 170 N 182 N 
173 N 185 N 173 N 185 N 
175 N 191 N 175 N 191 N 
179 N 193 N 179 N 193 N 
184 y 194 y 184 y 194 N 
186 N 199 N 186 N 199 N 
188 N 188 N 
190 N 190 N 
192 N 192 N 
195 N 195 N 
esp-1; bd; UV90 esp-]; bd; UV+ esp-1; bd; UV90 esp-1; bd; UV+ 
100 N 104 N 100 N 104 N 
103 N 110 N 103 N 110 N 
111 N 117 N 111 N 117 N 
118 N 121 N 118 N 121 N 
119 N 122 y 119 N 122 y 
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Progeny tested with RCF5 & RCR5 Progeny tested with 668F & 668R 
primers primers 
120 N 128 N 120 N 128 N 
127 N 136 N 127 N 136 N 
129 N 137 N 129 N 137 N 
140 N 141 N 140 N 141 N 
146 N 149 N 146 N 149 N 
151 N 153 N 151 N 153 N 
158 N 155 y 158 N 155 N 
159 N 156 N 159 N 156 N 
160 N 161 N 160 N 161 N 
162 N 165 N 162 N 165 N 
164 N 171 N 164 N 171 N 
176 N 181 N 176 N 181 N 
187 N 183 N 187 N 183 N 
189 N 196 N 189 N 196 N 
197 N 197 N 
Total Total Total Total 
UV90: UV+: UV90: UV+: 
2145 6140 1/45 2/40 
Total recombinant progeny: 8/85 (9.41 %) Total recombinant progeny: 3/85 (3.53%) 
*Recom. = recombinant. Recombinant progeny are shown in red 
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Figure 33. PCR results from UV90 parental strains using CAPS markers F15-R15 and 
F16-R16. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal (Fl5-Rl5) or 
HaeIII (F16-Rl6) restriction enzymes. Digested MV DNA (F15-R15) exhibits two 
overlapping bands, each -250 bp in size. UV90 = csp-1; bd; UV90 parent; MV = 
Mauriceville wild type, esp+; bd+; UV+ parent. 
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105 108 112 113 115 123 126 132 138 143 147 163 167 100 bp ladder 
1 kb 
500 bp 
Figure 34. PCR results showing digested csp-1; bd+; UV+ progeny using F16-R16 
primers. 
All progeny digested with Haelll restriction enzyme. UV90 ( csp-1; bd; UV90) and MV 
(Mauriceville wild type, esp+; bd+; UV+) served as controls. 
Most progeny resembled MV after digestion with the exception of#l43 which resembled 
UV90 and was determined to be recombinant. 
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106 109 116 125 130 131 134 135 139 144 145 150 166 168 100 bp ladder 
1 kb 
500 bp 
173 175 179 184 186 188 192 195 UV90MV 100 hp ladder 
Figure 35. PCR results showing digested esp-I; bd+; UV90 progeny using F16-R16 
primers. 
All progeny digested with Haelll restriction enzyme. UV90 (esp-I; bd; UV90) and MV 
(Mauriceville wild type, esp+; bd+; UV+) served as controls. 
Most progeny resembled UV90 after digestion with the exception of# 106 and # 145 
which resembled MV and were determined to be recombinant. 
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Table 18. Recombination frequencies of esp-1; bd+; UV+/UV90 and esp-1; bd; 
UV+/UV90 progeny with F16-R16 CAPS marker 
Progeny tested with F16 & R16 primers 
esp-1; bd+; UV90 esp-1; bd; UV90 esp-J; bd+; UV+ esp-]; bd; UV+ 
Progeny Recom. Progeny Recom. Progeny Recom. Progeny Recom. 
# (YesN, # (YesN, # (YesN, (YesN, 
No/N)* No/N)* No/N)* No/N)* 
106 y 100 N 105 N 104 N 
109 N 103 N 108 N 110 y 
116 N 111 N 112 N 117 N 
125 N 118 N 113 N 121 N 
130 N 119 N 115 N 122 N 
131 N 120 N 123 N 128 N 
133 N 127 N 126 N 136 N 
134 N 129 N 132 N 137 N 
135 N 140 y 138 N 141 y 
139 N 146 N 143 y 149 N 
144 N 151 N 147 N 153 N 
145 y 158 N 163 N 155 N 
150 N 159 N 167 N 156 N 
166 N 160 y 169 N 161 N 
168 N 162 N 174 N 165 N 
170 N 164 N 182 N 171 N 
173 N 176 N 185 N 181 N 
175 N 187 N 191 N 183 y 
179 N 189 N 193 N 196 N 
184 N 197 N 194 N 
186 N 199 N 
188 N 
190 N 
192 N 
195 N 
Total UV90: 4145 Total UV+: 4140 
Total recombinant progeny: 8/85 (9.41 %) 
*Recom. =recombinant. Recombinant progeny are shown in red 
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3/29 
(10.3%) 
2129 2129 
(6.9%) (6.9%) 
3/29 
(10.3%) 
8/85 3/85 8/85 
(9.41%) (3.53%) (9.41%) 
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UV90 
? 
3.75 Mbp 
Figure 36. Schematic of Neurospora crassa Linkage Group VI displaying primers F6 
through F 16, UV90 progeny recombination and suspected location of UV90 mutation. 
Scale is in Mega basepairs (Mbp). Primers F6, F9, Flt, LCF2, RCF5, 668F and F16 
are located at 2.14, 2.41, 2.56, 2.73, 3.10, 3.29 and 3.48 Mbp, respectively. 
I UV90 ? I = potential location of UV90 gene. 
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3.1.5 CAPS markers between 668F-668R and Fl6-R16 and potential UV90 
genes 
To further narrow down the location of the UV90 gene, 8 pairs of CAPS markers 
were designed between 668F-668R and F16-R16 as described in Methods 2.2.4: 3317F 
through 3352R (Tables 2 and 3, Materials and Methods). Primers were named based on 
their Mega basepair locations on Linkage Group VI. PCR and restriction enzyme 
digestion were performed on the parental strains csp-1; bd; UV90 (sg #227) and MV wild 
type as described in Methods 2.2.5 (Fig. 37). CAPS markers 3317F-3317R, 3395F-
3395R, 3436F-3436R, 3368F-3368R and 3451F-3451R produced different patterns after 
digestion for UV90 and MV and were chosen for PCR (Fig. 3 7, A and B). CAPS markers 
3346F-3346R, 3333F-3333R and 3352F-3352R did not produce any PCR product for 
UV90 and were disregarded for further use (Fig. 37, A and C). PCR was repeated twice 
more on the parental strains with the disregarded CAPS markers and identical results 
were obtained (data not shown). 
PCR was performed using the new CAPS markers only on progeny which were 
recombinant with markers 668F-668R and F16-R16 (Tables 17 and 18). Those progeny 
were chosen since only the recombinants have a crossover event between markers 668F-
668R and F16-R16 and can be used for mapping. The recombinants are as follows: 
UV90 progeny #106, 140, 145, 160 and 184; UV+ progeny #110, 122, 141, 143, 183. 
CAPS marker 3317F-3317R produced 1 recombinant (Fig. 38). CAPS marker 3395F-
3395R produced 4 recombinants (Figs. 38 and 39). CAPS marker 3436F-3436R 
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produced 6 recombinants (Fig. 39). CAPS marker 3368F-3368R produced 2 
recombinants (Fig. 40). A list of CAPS markers between 668F-668R and F16-R16 and 
recombinant progeny is shown in Table 19 & Figure 41. CAPS marker 3451F-3451R 
was not used due to obtaining sufficient data with the other markers. The number of 
recombinant progeny decreased from 3 to 1 at markers 668F-668R and 3317F-3317R, 
and increased to 2 at marker 3368F-3368R, suggesting UV90 is likely somewhere in 
between 668F-668R and 3368F-3368R (Fig. 41). 
It was noted on the Broad Institute Neurospora crass a database in March 2013 
(http://www.broadinstitute.org/annotation/genome/neurospora/News.html) that a 
correction to the DNA sequence was made to a region on Linkage Group VI. A new 
BLAST search of all primers 
(http://www.broadinstitute.org/annotation/ genome/neurospora/Blast.html) revealed new 
locations for primers to the left of the centromere. All affected primers with their 
previous and new locations are listed in Table 20. Other primers used for genetic 
mapping to the right of UV90 were not affected by the sequence change. The primers 
used for mapping on the left of the centromere were in reverse order than previously 
thought, and were moving away from the centromere as opposed to towards it. This 
indicates that the recombination rates were decreasing as the primers were moving away 
from the centromere. It is unknown why the recombination rates decreased as the 
markers moved farther away from UV90. 
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A list of candidate UV90 genes between CAPS markers 668F-668R and 3368F-
3368R were determined through a gene search at the Broad Institute Neurospora crassa 
database 
(http://www.broadinstitute.org/annotation/ genome/neurospora/F eatureSearch.html) and 
are shown in Table 21. Knockouts of each candidate gene were ordered from the Fungal 
Genetic Stock Center (FGSC) (see Table 1, Materials and Methods). These were 
screened to check for the presence of the UV90 gene phenotype. 
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Figure 37. PCR results from UV90 parental strains using CAPS marker pairs: 3317F-
3317R through 3352F-3352R. U ="uncut", undigested DNA; C ="cut", DNA digested 
with Taqal (3317F-R, 3346F-R, 3395F-R, 3436F-R, 3352F-R), Msel (3368F-R, 3451F-
R) or Haelll (3333F-R) restriction enzymes. OR= Oak Ridge csp-1; bd; UV90 parent; 
MV = Mauriceville wild type, esp+; bd+; UV+ parent. 
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3317F-3317R 
UV+ progeny 
1 
UV90 progeny 
110 110 141 141 183 183 122 122 143 143 140 140 160 160 109 106 145 145 100 bp 
U C U C U C ·u C U C U C U C lJ C U C ladder 
' 
UV+ progeny UV90 progeny 
110 110 141 141 183 183 122 122 143 143 140 140 100 bp 
Figure 38. PCR results showing 668F-668R and F16-R16 UV+ and UV90 recombinants 
using 3317F-3317R and 3395F-3395R CAPS markers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal restriction enzyme. 
UV90 (esp-I; bd; UV90) and MV (Mauriceville wild type, esp+; bd+; UV+) served as 
controls. 
*=denotes recombinant progeny. 
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Figure 39. PCR results showing 668F-668R and Fl6-Rl6 UV+ and UV90 recombinants 
using 3395F-3395R and 3436F-3436R CAPS markers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal restriction enzyme. 
UV90 (csp-1; bd; UV90) and MV (Mauriceville wild type, esp+; bd+; UV+) served as 
controls. 
* = denotes recombinant progeny. 
116 
UV+ progeny I 
122 122 110 110 141 141 183 183 143 143 140 140 
ucucucucucuc 
UV90 progeny 
160 160 184 184 106 106 145 
100 bp ladder 
1 kb 
500 bp 
Figure 40. PCR results showing 668F-668R and F16-R16 UV+ and UV90 recombinants 
using 3368F-3368R CAPS markers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Msel restriction enzyme. 
UV90 ( csp-1; bd; UV90) and MV (Mauriceville wild type, esp+; bd+; UV+) served as 
controls. UV+ progeny #183 was repeated and resembled UV90, and was determined to 
be recombinant (data not shown). 
* = denotes recombinant progeny. 
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RCFS 668 3317 3368 3395 3436 F16 
143 ------------------------------------------------------
122 ------
184------
115-
132-
170 -
194 -
155 -
Total 8 
Recombinants 
3 1 
------------------------------- 183 
--------------------- 110 
----------------------145 
------141 
------100 
- 140 
-106 
2 4 6 8 
Figure 41. Recombinant progeny with primers RCF5 through F16. 
All primers between RCF5 and F16 are shown on the top row. Left and right values are 
recombinant progeny. Red lines denote which primers the progeny were recombinant 
with. Total number of recombinants are listed at the bottom row. 
Number of recombinant progeny decreases to the right of 668 and increases towards 
3368. 
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Table 19. Number ofrecombinant progeny with CAPS markers between 668F-668R and 
F16-R16 
CAPS 668F- 3317F- 3368F- 3395F- 3436F- F16-R16 
marker 668R 3317R 3368R 3395R 3436R 
Marker 3.293 3.317 3.368 3.395 3.436 3.483 
location* 
Number of 3 1 2 4 6 8 
recombinant (#122, (#143) (#143, (#110, 143, (#110, (#106, 110, 
progeny 143, 184) 183) 145, 183) 141, 143, 140, 141, 
145, 160, 143, 145, 
183) 160, 183) 
*In Mega base pairs, Linkage Group VI 
Table 20. Previous and new locations of Linkage Group VI primers to the left of the 
centromere 
Primer Sequence Previous location New Location (bp) 
Name 5' -> 3' (bp) and strand and strand(+/-) 
(+/-) 
F3* ACCTACTTGCGACAGCGTGCTTG 2,059,068-090 (-) 2,576,160-182 (+) 
R3* TTGTCCACTTACACTCGGCACG 2,057,830-851 (+) 2,577,399-420 (-) 
F6* TTCACGAGTGTCCCGGATGTG 2,141,366-386 (-) 2,493,864-884 {+) 
R6* GCATTGTCATCTCGTTGGTGC 2,140,152-172 (+) 2,495,078-098 (-) 
F9* AAGGTCGGGTTGTTAGACGA 2,410,071-090 (-) 2,225,160-179 (+) 
R9* GGCTGAGGGTGGATAGCTAGA 2,409,630-650 (+) 2,225,600-620 (-) 
FlO TCATCGAGTTACCTGCCAAGC 2,547,480-500 (+) 2,087,750-770 (-) 
RlO TTGGGTGTTCGTTGGACTCC 2,54 7 ,877-896 (-) 2,087,354-373 (+) 
Fll GGTAACTATGTACATGCCCCGTG 2,559,077-099 (+) 2,076,151-173 (-) 
Rll CGATACGATTCTTGGCATCAGC 2,559,500-521 (-) 2,075,729-750 (+) 
LCFl CGGCCGTGTAGCAGAATACA 2, 726,641-660 ( +) 1,908,590-609 (-) 
LCRl ATAATGGCGATGGCGATGTG 2,727,065-084 (-) 1,908,166-185 (+) 
LCF2 GGGCGCCATCAATTTCACTT 2,734,610-629 (+) 1,900,621-640 (-) 
LCR2 TTTGAGCTCGGGATTTGCTG 2,735,067-086 (-) 1,900,164-183 (+) 
*Designed by Dr. Kamyar Motavaze 
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Table 21. List of 21 Neurospora crass a candidate UV90 genes located on Linkage 
Group (chromosome) VI, from 3 .293 to 3 .369 Mbp. 
Locus Gene Name Location (Mbp, Oak Length (hp) 
Ridge strain, 
Superconti2 6) 
NCUl 7127.7* hypothetical protein 3294468-3295683 + 1216 
NCU05962.7 hypothetical protein 3303139-3303378 - 240 
NCU05961.7 DUF572 domain- 3304910-3306530 + 1621 
containing protein 
GPI 3032 
NCU05960.7* mannosyltransferase 3306630-3309661 -
2 
vesicle transport V - 1566 
NCU05959.7* SNARE protein 3311937-3313502 -
VTII 
NCU05958.7 hypothetical protein 3315098-3318376 + 3279 
NCU05957.7 hypothetical protein 3319864-3322467 + 2604 
NCU05956.7 glycosylhydrolase 3322517-3326426 - 3910 family 2-2 
NCU05955.7 Cel74a 3326807-3330420 + 3614 
NCU05954.7 hypothetical protein 3332004-3334639 - 2636 
NCU05953. 7* hypothetical protein 3339700-3340998 - 1299 
NCU05952.7 hypothetical protein 3341267-3343308 - 2042 
NCU05951.7 hypothetical protein 3344579-3346273 + 1695 
NCU05950.7 hypothetical protein 3347867-3348756 + 890 
NCU05949.7 hypothetical protein 3349464-3350054 + 591 
NCU05948.7 hypothetical protein 3353034-3355088 - 2055 
NCU05947.7 hypothetical protein 3355960-3356454 - 495 
NCU12130.7* hypothetical protein 3362030-3364815 + 2786 
NCU05946.7 hypothetical protein 3364883-3365627 - 745 
NCU05945.7 hypothetical protein 3366104-3367798 - 1695 
NCU05944.7 hypothetical protein 3368035-3369538 + 1504 
*Knockout strains of these genes are currently unavailable 
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3.2 FGSC Knockouts 
3.2.1 Knockout screening for UV90 
FGSC knockout strains (see Table 1) were ordered as described in Methods 2.3.1. 
Knockout strains were inoculated onto race tubes containing maltose-arginine medium as 
described in Methods 2.2.2. 2-3 replicates of each knockout along with controls csp-1; 
bd+; UV90 (OR, progeny #131) and OR wild type (sg #259) were inoculated. Race 
tubes are shown in Figures 42-44. All knockouts resembled the OR wild type with the 
exception ofrace tube #10 which resembled the UV90 control (Fig. 43). Race tube #10 
corresponded to FGSC strain #18029 and gene NCU05950 {Table 1). It was confirmed 
in the lab by Amanda Mohabeer through PCR that NCU05950 was indeed the correct 
gene which was knocked out (data not shown). 
3.2.2 Cross between putative UV90 KO x #80 (csp-1; chol-1 bd;frq1°) 
FGSC knockout strain #18029 (gene NCU05950) was chosen as a potential UV90 
gene candidate. A cross was performed (previously by Dr. Patricia Lakin-Thomas) 
between #18029 and csp-1; chol-1 bd;frq10 (OR, sg #80) to determine if the FGSC 
knockout behaves as UV90 does in a genetic cross, and affects the rhythm in the chol-1; 
frq 10 double mutant. The knockout was also crossed with sg #80 to place it into the same 
genetic background with other strains that contain the esp-I, chol-1, bd and .frq10 
mutations. 
186 spores were picked as described in Methods 2.2.1, and csp-1 "tap test" was 
performed as described in Methods 2.2.2. 105 were determined to be esp-I, 49 were 
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esp+ and 32 did not germinate (Table 22). esp-1 progeny were numbered and inoculated 
onto race tubes containing maltose-arginine medium both with and without 100 µM 
choline (labelled as high and low choline) as described in Methods 2.2.2. The controls on 
high choline were esp-I; ehol-1 bd;frq10 (OR, sg #80) and esp-1; ehol-1 bd; UV90;frq10 
(OR, sg #213). Controls on low choline were esp-1; ehol-1 bd (OR, sg #26), esp-1; ehol-
1 bd; UV90 (OR, sg #224), esp-1; ehol-1 bd;frq10 (OR, sg #80) and esp-1; ehol-1 bd; 
UV90;frq10 (OR, sg #213). 
Progeny were separated into bd and bd+ through visual inspection. The bd strains are 
slower growing than bd+ as detected by the marked growth fronts (Fig. 45). 50 were 
found to be bd+ and 55 were bd (Table 23). 
The bd race tubes were further separated into the following groups based on 
visual comparisons to the controls: 18 were found to be esp-I; bd, 8 were esp-I; bd; 
UV90, 16 were esp-1; bd;frq10, 7 were esp-1; bd; UV90;frq10 and 6 were unclassifiable 
(Figs. 46-47, Table 24). 
The number of UV90 progeny was fewer than expected, and did not fall into a 1 : 1 : 1 : 1 
ratio for all 4 classes (Table 24). A chi-square test was performed and the p value was 
non-significant (p = 0.0601) (Table 24, Appendix X). Since the knockout andfrq10 genes 
are located on separate chromosomes, this test showed normal segregation of the 
knockout when placed through a genetic cross. Only 7 out of 55 progeny were ehol+ 
(Table 24), which was expected due to the fact that the ehol-1 and bd genes are on the 
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same chromosome and therefore are linked (http://www.broadinstitute.org/annotation/ 
genome/neurospora/F eatureSearch.html). 
The periods and growth rates of the 5 5 esp-I; bd progeny on high choline are 
shown in Tables 25 and 26. The growth rate and period of esp-1; bdprogeny was 1.18 (± 
0.023) mm/hr and 21.6 (± 0.152) hr (Table 25). esp-1; bd;frq10 progeny had a growth 
rate of 1.26 (± 0.020) mm/hr (Table 25). These values were very close to reported 
growth rates and periods: 1.18 mm/hr and 21.2 hr for esp-1; ehol-1 bd, and 1.28 mm/hr 
for esp-1; ehol-1 bd; frq 10 (Li et al., 2011). Reported values of ehol-1 strains were used 
for comparison since most progeny carried the ehol-1 mutation, and growth rates and 
periods were calculated on media supplied with 100 µM choline. csp-1; bd; UV90 
growth rate was 1.06 (± 0.041) mm/hr, and 1.10 (± 0.014) mm/hr for csp-1; bd; UV90; 
frq 10 (Table 26). These values were also close to reported growth rates: 1.07 mm/hr for 
esp-1; ehol-1 bd; UV90 and 1.19 for csp-1; chol-1 bd; UV90;frq10 (Li et al., 2011). 
These data confirm that FGSC knockout # 18029 has similar growth rates and periods in a 
cross with esp-1; ehol-1 bd;frq10 (sg #80). 
Figure 46 shows the esp-I; bd; UV+ and UV90 progeny on high choline. The 
UV+ progeny show a clear, robust rhythm of conidiation, while the UV90 progeny show 
a dampened, low amplitude rhythm, consistent with the UV90 phenotype (Li et al., 2011 ). 
Figure 47 shows esp-1; bd;frq10; UV+ and UV90 progeny on high choline. UV+;frq10 
progeny show arrhythmic conidiation and a fluffy appearance. UV90; frq 10 progeny also 
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show arrhythmic conidiation, yet the physical appearance is grainy and not fluffy as in 
UV+ strains. 
Figure 48 shows csp-1; bd; UV+ and UV90 progeny on low choline. UV+ 
progeny have a weak, but clear rhythm of conidiation, and UV90 progeny appear 
arrhythmic. Figure 49 shows csp-1; bd; frq 10; UV+ and UV90 progeny on low choline. 
In the chol-1; frq 10 background, UV+ progeny appear to have rhythmic conidiation, 
whereas UV90 progeny appear arrhythmic. Abolishing the rhythm in a chol-1; .frq10 
strain on low choline is a characteristic of the UV90 mutation (Li et al., 2011 ). This is a 
strong indicator that the knocked out gene in FGSC # 18029 is UV90, as it appears and 
behaves identical to UV90 when placed through a cross. 
Marked growth fronts were used to distinguish chol+ from chol-1 strains, as 
chol + strains have fast growth rates on both high and low choline media (data not 
shown). csp-1; bd; UV90 progeny #58, 83, 97 and csp-1; bd progeny #13, 63, 72, 98 
were determined to be chol+ (Table 24). 
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Figure 42. FGSC knockout strains #1-5 and controls csp-1; bd+; UV90 and Oak Ridge 
wild type. 
#131 (csp-1; bd+; UV90) and #259 (Oak Ridge wild type, esp+; bd+; UV+) served as 
controls. #1=FGSC17842; #2 = FGSC 13721; #3 = FGSC 17841; #4 = FGSC 17839; 
#5 = FGSC 18085. 
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#131 
#131 
#259 
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#6 
#6 
#6 
#7 
#7' 
#7 
#8 
#8 
#8 
#9 
#9 
#9 
#10 
#IO 
#IO 
Figure 43. FGSC knockout strains #6-10 and controls esp-I; bd+; UV90 and Oak Ridge 
wild type. 
#131 (esp-1; bd+; UV90) and #259 (Oak Ridge wild type, esp+; bd+; UV+) served as 
controls. #6 = FGSC 17845; #7 = FGSC 11909; #8 = FGSC 11310; #9 = FGSC 13535; 
#10 = FGSC 18029. 
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Figure 44. FGSC knockout strains #11-6 and controls esp-I; bd+; UV90 and Oak Ridge 
wild type. 
#131 (esp-I; bd+; UV90) and #259 (Oak Ridge wild type, esp+; bd+; UV+) served as 
controls. #11=FGSC17838; #12 = FGSC 18213; #13 = FGSC 18028; #14 = FGSC 
17836; #15 = FGSC 17835; #16 = FGSC 13533. 
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Table 22. esp+ and esp-1 progeny from cross between FGSC #18029 and esp-1; ehol-1 
10 bd; frq (OR, sg #80) 
Total spores picked csp-1 progeny esp+ progeny* Non-germinating 
pro2eny* 
186 105 (56.45%) 49 (26.34%) 32 (17.2%) 
*esp+ and non-germinating progeny were excluded from further analysis 
Table 23. esp-1 progeny from cross between FGSC #18029 and esp-1; ehol-1 bd;frq10 
(OR, sg #80) tested on 100 µM choline 
Total csp-1 progeny csp-1; bd progeny csp-1; bd+ progeny* 
analyzed 
105 55 (52.4%) 50 (47.6%) 
#l,4,5,6,7,8,9,l l,l2,13,15,17,1 #2,3, 10,14,16,24,26,30,33,34,3 
8, 19,20,21,22,23,25,27,28,29,3 6,3 7 ,40,41,43 ,44,45,46,4 7 ,484 
l ,32,35,38,39,42,52,54,55, 9,50,51,53,56,57,59,60,61,626 
58,63,64,65,67,68, 71, 72, 73, 75 6,69, 70, 74, 77-81,84,85,89, 
76,82,83,86,87 ,88,90,91,97 ,98 92,93 ,94,95,96,99'101, 102 
100,103, 104,105 
* bd+ progeny were excluded from further analysis 
Table 24. esp-1; bdprogeny from cross between FGSC #18029 and esp-1; ehol-1 bd; 
10 frq (OR, sg #80) tested on 100 µM choline 
Total csp-1; bd csp-1; bd; csp-1; bd; csp-1; bd; Unclassifiable 
csp-1; bd progeny UV90 frq10 progeny UV90; 
progeny progeny jrqlO 
analyzed pro2eny 
55 18 (32.7%) 8 (14.5%) 16 (29.0%) 7 (12.7%) 6 (10.9%) 
(progeny (progeny (progeny # 1, (progeny# (progeny# 11, 
#4,6, 7,8,9,13* ,19, #22,52,58* ,64, 5,17,21,31,35 15,18,23, 12,27,86,100, 
20,28,54,55,63*' 83* ,87,91,97*) ' 38,39,42,67, 25,29,32, 103) 
65,72* ,88,98*' 68,71,73,76, 75) 
104, 105) 82,90) 
*all progeny contain ehol-1 mutation except esp-1; bd; UV90 #58,83,97 and esp-1; bd 
#13,63,72,98 which were determined to be ehol+ by fast growth on both high & low 
choline 
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Table 25. Periods and growth rates of csp-1; bd and csp-1; bd;frq10 progeny from cross 
between FGSC #18029 and csp-1; chol-1 bd;frq10 (OR, sg #80) tested on 100 µM 
choline 
csp-1; bd pro2eny csp-1; bd;_frq1u pro ~eny 
Progeny# Growth Period (hr) Progeny# Growth Period (hr) 
Rate Rate 
(mm/hr) (mm/hr) 
4 1.23 21.13 csp-1; bd; 
frqJO 
1.23 NIA* 
(control) 
6 1.25 21.27 csp-J · bd· frqlO' ' 1.26 
(control) 
7 1.31 21.31 1 1.35 
8 1.28 21.62 5 1.39 
9 1.14 22.03 17 1.37 
13 1.25 21.07 21 1.26 
19 1.19 21.34 31 1.22 
20 1.24 21.25 35 1.32 
28 1.22 21.40 38 1.37 
54 0.95 21.73 39 1.16 
55 1.19 21.79 42 1.16 
63 1.21 23.74 67 1.15 
65 1.15 21.88 68 1.31 
72 1.20 21.55 71 1.24 
88 1.18 21.95 73 1.31 
98 1.21 21.67 76 1.23 
104 1.02 20.56 82 1.18 
105 0.99 21.51 90 1.22 
Mean Mean Mean 
Growth Period: Growth 
Rate: 1.18 21.60 ± Rate: 1.26 
± 0.023 0.152 ± 0.020 
(S.E.M.) (S.E.M.) (S.E.M.) 
.JU 
*Not applicable. frq progeny were arrhythmic, penod was not calculated 
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Table 26. Periods and growth rates of csp-1; bd; UV90 and csp-1; bd; UV90;frq10 
progeny from cross between FGSC #18029 and csp-1; chol-1 bd;frq10 (OR, sg #80) 
tested on 100 µM choline 
csp-1; bd; UV90 pro2eny csp-1; bd; UV90; frq1° 1ro2eny 
Progeny# Growth Period (hr) Progeny# Growth Period (hr) 
Rate Rate 
(mm/hr) (mm/hr) 
22 1.11 NIA* esp-I· bd· UV90;fr~1o 1.19 NIA* 
(control) 
52 0.96 csp-1; bd; 
UV90;frq10 
1.12 
(control) 
58 1.20 15 1.09 
64 1.10 18 1.07 
83 1.13 23 1.07 
87 0.84 25 1.18 
91 1.12 29 1.08 
97 0.99 32 1.09 
Mean 75 1.10 
Growth 
Rate: 1.06 
± 0.041 
(S.E.M.) 
Mean 
Growth 
Rate: 1.10 
± 0.014 
(S.E.M.) 
*Not applicable: progeny exhibited either low amplitude rhythms or were arrhythmic; 
period was not calculated 
130 
#80 
#80 
#213 
#213 
#2 
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#30 
Figure 45. Examples of csp-1; bd+ progeny obtained from cross between FGSC #18029 
and csp-1; chol-1 bd; frq 10 (OR, sg #80) on 100 µM choline. 
#80 ( csp-1; chol-1 bd; frq 10) and #213 ( csp-1; chol-1 bd; UV90; frq 10) served as controls. 
bd+ progeny #2 through #30 showed faster growth rates than bd controls as seen by the 
marked growth fronts. 
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Figure 46. Examples of csp-1; bd; UV+ and UV90 progeny obtained from cross 
between FGSC #18029 and csp-1; chol-1 bd;frq10 (OR, sg #80) on 100 µM choline. (A) 
csp-1; bd; UV+ progeny showed strong rhythmic conidiation, similar growth rates and 
appearance. (B) csp-1; bd; UV90 progeny showed low amplitude rhythms and similar 
physical appearance. 
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Figure 47. Examples of csp-1; bd;frq10; UV+ and UV90 progeny obtained from cross 
between FGSC #18029 and csp-1; chol-1 bd;frq10 (OR, sg #80) on 100 µM choline. #80 
(esp-I; chol-1 bd; frq 10) and #213 ( csp-1; chol-1 bd; UV90; frq1°) served as controls. (A) 
csp-1; bd; UV+; frq 10 progeny showed arrhythmic conidiation and similar physical 
appearance as the control. (B) csp-1; bd; UV90;frq 10 showed arrhythmic conidiation and 
similar appearance to control. 
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Figure 48. Examples of csp-1; bd; UV+ and UV90 progeny obtained from cross 
between FGSC #18029 and csp-1; chol-1 bd;frq10 (OR, sg #80) on low choline. #26 
( csp-1; chol-1 bd) and #224 ( csp-1; chol-1 bd; UV90) served as controls. (A) csp-1; bd; 
UV+ progeny showed rhythmic conidiation and similar appearance as the control. (B) 
csp-1; bd; UV90 progeny showed arrhythmic conidiation and similar appearance as the 
control. Only UV90 progeny that were determined to be chol-1 are displayed. 
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Figure 49. Examples of csp-1; bd;frq10; UV+ and UV90 progeny obtained from cross 
between FGSC #18029 and csp-1; chol-1 bd;frq1° (OR, sg #80) on low choline. #80 
( csp-1; chol-1 bd; frq 10) and #213 ( csp-1; chol-1 bd; UV90; frq 10) served as controls. (A) 
csp-1; bd; UV+;frq10 progeny showed rhythmic conidiation and similar appearance as 
the control. (B) csp-1; bd; UV90;frq10 progeny showed arrhythmic conidiation and 
similar appearance as the control. 
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3.3 Transformation of Neurospora crassa 
3.3.1 "AD" CAPS marker and Hygromycin B gene 
Transformation was performed in order to test the complementation of UV90 
candidate gene NCU05950 (FGSC #18029, Table 1) in the UV90 mutant strain. The wild 
type NCU05950 gene along with the Hygromycin B resistance gene (hyg) were 
transformed into both UV90 and UV+ Neurospora strains. It is believed that if 
Neurospora was transformed with the NCU05950 gene, it would have taken up the hyg 
gene as well. The hyg gene was therefore used as a marker to detect transformants. The 
UV90 strain was used to determine ifthe NCU05950 gene could restore the wild type 
phenotype, and the UV+ strain was used to determine if there were any effects of having 
multiple copies of the wild type gene. 
A PCR product labelled "AD" was created using genomic DNA from the csp-1; 
chol-1 bd; frq 10 (OR, sg #80) strain as described in Methods 2.4.1. In order to ensure the 
AD fragment was received by the transformed Neurospora strain, an extra EcoRI 
restriction enzyme site ( GAA TTC) was inserted into the AD sequence based on the 
overlapping-PCR procedure by Heckman and Pease (2007) (Appendix V) to create a 
CAPS marker in the AD product. To achieve this, mutagenic primers were designed as 
described in Methods 2.2.4 with the addition of extra nucleotides to create an EcoRI 
restriction enzyme site (Table 5, Materials and Methods; Appendix V). PCR was 
performed as described in Methods 2.2.5 on #80 (csp-1; chol-1 bd;frq1°) using 
mutagenic overlapping primers Rev2B and For2C along with primers F4 and R4 (Tables 
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4 and 5, Materials and Methods) to create two DNA fragments, "AB" and "CD" (Fig. 50 
A). PCR was performed using F4 and R4 primers with overlapping fragments "AB" and 
"CD" as DNA templates to create the final AD product containing a CAPS marker (Fig. 
50 B). Only "AB" and "CD" fragments obtained using primers Rev2B and For2C 
created the final AD product (Fig. 50 B). To confirm that the AD sequence contained the 
extra EcoRI restriction enzyme site, digestion was performed as described in Methods 
2.2.5 on the final AD fragment as well as the fragment from #80 (esp-I; ehol-I bd;frq10) 
with F4 and R4 primers (Fig. 50 C). #80 showed fragments that were 1.0 and l .5kb in 
size, while product AD showed fragments 1.0 and 0.5 kb in size, indicating the presence 
of a second EcoRI restriction enzyme site. Sareh Ahmadi repeated the above PCR and 
restriction enzyme procedures to obtain her own AD product for transformation. The 
Hygromycin resistance gene (hyg) was amplified by Dr. Keyur Adhvaryu from the 
pCSN44 plasmid (obtained from FGSC). The above DNA samples were precipitated and 
prepared as described in Methods 2.4.3. 
3.3.2 Race tube and PCR analysis of transformants 
Transformation: 
Conidia (spores) from strain esp-I; ehol-I bd; UV90 (sg #224) were harvested as 
described in Methods 2.4.2. Strain esp-I; ehol-I bd (sg #26) was harvested by Sareh 
Ahmadi. Strains esp-I; ehol-I bd; UV90;frq10 (sg #213) and esp-I; ehol-I bd;frq10 (sg 
#80) were not used in this transformation due to the presence of the frq 10 mutation. This 
mutation is created by replacing the frq gene with a cassette containing the Hygromycin 
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resistance gene (Co lot et al., 2006), making it impossible to detect if the transformed 
strains contained our inserted hyg gene. 
Transformation and plating of spores was performed on both strains as described 
in Methods 2.4.3. Sareh Ahmadi repeated the transformation procedure with both strains. 
One transformant was seen with esp-I; ehol-I bd; UV90 and 13 transformants with esp-
I; ehol-I bd (1 from the 1/10 spore dilution, and 12 from the undiluted spores; data not 
shown). Sareh Ahmadi had 3 transformants with esp-I; ehol-I bd (with undiluted spores) 
and none with UV90 (data not shown). These transformants indicated the presence of the 
hyg gene. 
Race tube analysis: 
Transformants from the petri plates were inoculated onto minimal agar stock 
tubes and microtiter wells containing choline and Hygromycin as described in Methods 
2.4.4. All transformants grew in the microtiter wells, confirming further the resistance to 
Hygromycin. Replicates of all transformants were inoculated from the stock tubes onto 
maltose-arginine race tubes containing choline and Hygromycin as described in Methods 
2.4.4. Controls esp-I; ehol-I bd and esp-I; ehol-I bd; UV90 were also inoculated onto 
race tubes but did not receive the addition of Hygromycin. Sareh Ahmadi also inoculated 
my single UV90 transformant as well as her esp-I; ehol-I bd transformants onto race 
tubes. 
Race tubes are shown in Fig. 51-53. UV90 transformant (Fig. 51) did not grow 
well on the race tube and appeared arrhythmic. esp-I; ehol-I bd transformants (Fig. 51-
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53) appeared to grow initially with rhythmic conidiation and healthy growth rates, yet 
lost the rhythm and displayed a very slow growth rate after several days. csp-1; chol-1 
bd transformant 26-6 appeared to have a healthy rhythm and growth rate throughout the 
length of the tube (Fig. 52). The periods and growth rates of the transformants are shown 
in Table 27. UV90 transformant had a mean growth rate of 0.32 (± 0.015) mm/hr, which 
was much slower than the control mean of 1.10 mm/hr. csp-1; chol-1 bdtransformants 
had a mean growth rate and period of 0.675 (± 0.035) mm/hr and 25.07 (± 0.943) hr, 
respectively. The growth rate is much slower than the control mean of 1.12 mm/hr, and 
the period is longer than the control mean of 22.23 hr. Sareh Ahmadi obtained similar 
results with her transformants (data not shown). 
PCR analysis: 
DNA was extracted from the transformants as described in Methods 2.2.3. PCR 
and restriction enzyme digestion was performed as described in Methods 2.4.4 using 
primers F4, R4, Fl and Rl (Table 4) on the transformants as well as strains csp-1; chol-1 
bd;.frq10 (sg #80), csp-1; chol-1 bd; UV90;frq10 (sg #213), and csp-1; bd; UV90 (sg 
#227). 
Figure 54 shows the PCR results on the transformants using F4-R4 primers. csp-
1; chol-1 bd; UV90 transformant, as well as csp-1; chol-1 bd transformant #26-8 did not 
produce a PCR product. PCR products were expected in the csp-1; chol-1 bd 
transformants, as they carry the wild type copy of the UV90 candidate gene. 
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Figure 55 shows the transformants cleaved with EcoRI restriction enzyme as well 
as PCR on csp-1; chol-1 bd;frq10 (sg #80) and the csp-1; chol-1 bd; UV90 transformant 
with Fl-Rl primers. Most #26 transformants resembled the control (#80) with the 
exception of26-6, 26-7, 27-11and26-12 which showed a PCR fragment of0.5 kb in 
size, suggesting these transformants have picked up the AD CAPS marker (see Fig. 50 
C). Fl-Rl primers were tested on #80 as well as the UV90 transformant to detect for the 
presence of any copies of the wild type NCU05950 gene. A PCR product the same size 
as the control appears, however this result was unrepeatable when PCR was attempted 
again (Fig. 56). 
Figure 56 shows the UV90 transformant as well as controls #80 (esp-I; chol-1 bd; 
frq1°), #213 (csp-1; chol-1 bd; UV90;frq10) and UV90 (csp-1; bd; UV90) with Fl-Rl and 
F4-R4 primers. Fl-Rl primers failed to produce a band similar to #80, 1.5 kb in size, in 
any of the UV90 controls or transformant, whereas F4-R4 primers produced faint bands 
of 2.5 kb in size (Fig. 56 A). Products from the F4-R4 primers were digested with EcoRI 
restriction enzyme (Fig. 56 B). Control #80 showed the expected cleavage and produced 
bands that were 1.5 and 1.0 kb in size. UV90 controls and transformant did not show any 
cleavage in the PCR product, suggesting that the F4-R4 primers likely did not amplify the 
correct region and the UV90 transformant also did not receive the AD CAPS marker. 
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A Primers 2B & 2C 
B 
Primers 3B & 3C 
3kb 
2kb 
1.5 kb 
1 kb 
Figure 50. PCR showing creation and EcoRI digestion of AD product from csp-1; chol-
1 bd; frq 10 (#80) strain. 
(A) shows "AB" and "CD" DNA fragments created by primers F4-Rev2B and R4-For2C 
(Primers 2B & 2C), and primers F4-Rev3B and R4-For3C (Primers 3B & 3C). (B) 
shows the AD product using AB & CD pieces from (A) along with primers F4-R4 on 
control #80 (csp-1; chol-1 bd;frq1°). (C) shows EcoRI digestion of DNA from (B). 
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A 
#224 
#224 
#26 
#26 
UV90-T 
UV90-T 
26-1/10 
26-1/10 
26-1 
26-1 
26-2 
26-2 
B 
#224 
#224 
#26 
#26 
UV90-T 
UV90-T 
26-1/10 
26-1/10 
26-1 
26-1 
26-2 
26-2 
Figure 51. UV90 and #26 transformants from the transformation of Neurospora crassa 
with (A) and without (B) marked growth fronts. #224 (csp-1; chol-1 bd; UV90) and #26 
( csp-1; chol-1 bd) served as controls. UV90-T = csp-1; chol-1 bd; UV90 transformant. 
26-1/10 = csp-1; chol-1 bd transformant from 1/10 spore dilution. 26-1 and 26-2 are esp-
1; chol-1 bd transformants from undiluted spores. 
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A 
26-3 
26-4 
26-4 
26-5 
26-5 
26-6 
26-6 
26-7 
26-8 
26-8 
B 
26-3 
26-3 
26-4 
26-5 
26-5 
26-6 
26-6 
26-7 
26-7 
26-8 
26-8 
Figure 52. UV90 and #26 transformants from the transformation of Neurospora crassa 
with (A) and without (B) marked growth fronts. 26-3 through 26-8 are csp-1; chol-1 bd 
transformants from undiluted spores. 
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A 
26-9 
26-9 
26-10 
26-10 
26-11 
26-12 
26-12 
B 
26-9 
26-9 
26-1 
Figure 53. UV90 and #26 transformants from the transformation of Neurospora crassa 
with (A) and without (B) marked growth fronts. 26-9 through 26-12 are csp-1; chol-1 bd 
transformants from undiluted spores. 
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Table 27. Periods and growth rates from csp-1; chol-1 bd; UV90 and csp-1; chol-1 bd 
trans formants 
csp-1; chol-1 bd; UV90 transformants csp-1; chol-1 bd transformants 
Progeny# Growth Period (hr) Progeny# Growth Period (hr) 
Rate Rate 
(mm/hr) (mm/hr) 
csp-1; chol- 1.10 NIA* csp-1; chol- 1.18 22.0 
1 bd; UV90 1 bd 
(control) (control) 
csp-1; chol- 1.10 csp-1; chol- 1.13 22.46 
1 bd; UV90 1 bd 
(control) (control) 
UV90-T 0.30 26-1/10 0.70 28.6 
UV90-T 0.33 26-1/10 0.52 24.84 
Mean 26-1 0.83 22.19 
Growth 26-1 0.89 22.41 
Rate: 0.32 26-2 0.74 NIA* 
± 0.015 26-2 0.65 NIA* 
(S.E.M.) 26-3 0.55 NIA* 
26-3 0.57 NIA* 
26-4 0.86 25.86 
26-4 0.78 34.42 
26-5 0.77 22.47 
26-5 0.78 22.75 
26-6 1.08 21.97 
26-6 1.14 21.91 
26-7 0.48 NIA* 
26-7 0.57 NIA* 
26-8 0.64 26.13 
26-8 0.61 35.14 
26-9 0.54 24.31 
26-9 0.52 22.16 
26-10 0.60 NIA* 
26-10 0.56 NIA* 
26-11 0.62 25.21 
26-11 0.63 24.98 
26-12 0.47 24.25 
26-12 0.45 21.57 
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Mean Mean 
Growth Period: 
Rate: 25.07 ± 
0.675 ± 0.943 
0.035 (S.E.M.) 
(S.E.M.) 
*Not applicable: transformants were arrhythmic; the period was not calculated 
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#26 strains 
6 7 8 9 10 11 12 
3 kb 
2kb 
1 kb 
1 kb ladder 
Figure 54. PCR results from UV90 and #26 transformants using F4-R4 primers. 
#80 (csp-1; chol-1 bd;frq1°) served a~ a control. UV90-T 1 & 2 =replicates of csp-1; 
chol-1 bd; UV90 transformant. 26-1110 = esp-I; chol-1 bd transformant from 1110 spore 
dilution. 26-1through26-12 are csp-1; chol-1 bd transformants from undiluted spores. 
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#26 strains 
5 6 7 9 1 kb ladder 
3 kb 
2kb 
1 kb 
Figure 55. PCR results from UV90 and #26 transformants cleaved with EcoRI restriction 
enzyme and #80 and UV90 transformant with Fl-Rl primers. 
#80 (csp-1; chol-1 bd;frq1°) served as a control. 26-1/10 = csp-1; chol-1 bdtransformant 
from 1/10 spore dilution. 26-1through26-12 are csp-1; chol-1 bdtransformants from 
undiluted spores. #80 and all transformants were cleaved with EcoRI restriction enzyme. 
Lower half of gel: Fl-Rl primers were used on #80 (csp-1; chol-1 bd;frq1°) and csp-1; 
chol-1 bd; UV90 transformant (UV90-T). 
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A Fl-Rl primers 
#80 #213 UV90 UV90-T 
B 
#80 #213 UV90 
F4-R4 primers 
#80 #213 UV90 UV90-T 
UV90-T 
I kb ]adder 
I kb ladder 
3 kb 
2kb 
1 kb 
-lkb 
Figure 56. PCR results from controls and UV90 transformant with Fl-RI and F4-R4 
primers (A) and after EcoRI restriction enzyme digestion (B). 
(A) shows #80 (csp-1; chol-1 bd;frq1°), #213 (csp-1; chol-1 bd; UV90;frq1°), UV90 
(csp-1; bd; UV90), and UV90-T (csp-1; chol-1 bd; UV90 transformant) with Fl-RI and 
F4-R4 primers. 
(B) shows products from F4-R4 in (A) after EcoRI restriction enzyme digestion. 
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3.4 Sequencing of UV90 candidate, NCU05950 
3.4.1 PCR and sequencing of NCU05950 
Sequencing of the NCU05950 gene was performed to compare the sequence to 
the published Oak Ridge Neurospora genome. This was attempted to discover the exact 
nature of the UV90 gene mutation and to confirm the identity of the gene. 
Figure 57 shows a map of the primers used to sequence the putative UV90 gene, 
NCU05950. Primers were designed as described in Methods 2.2.4 and locations are 
listed in Table 4 (Materials and Methods). DNA was also extracted as described in 
Methods 2.2.3 from csp-1; chol-1 bd;frq10 (sg #80) and csp-1; chol-1 bd; UV90;frq10 
(sg #213) for use as controls. PCR was performed as described in Methods 2.2.6 using 
Fl-Rl primers on sg #213 as well as csp-1; bd; UV90 progeny #189 from previous cross 
between csp-1; bd; UV90 and Mauriceville wild type. No PCR products were obtained 
from both UV90 strains (data not shown). The same UV90 strains were tested with Fl-
R3, F2-R2 and F3-Rl primers and no products were obtained (data not shown). 
Figure 58 shows Fl-Rl, F2-R2, F4-R4, F5-F5 and F6-R6 primers on csp-1; bd; 
UV90 (sg #227), Oak Ridge wild type, csp-1; chol-1 bd; UV90;frq10 (sg #213) and csp-
1; chol-1 bd;frq10 (sg #80). Only Oak Ridge and #80 strains exhibited PCR products of 
the appropriate sizes. Figure 58B shows a faint product for Fl-Rl primers, yet as seen in 
Figure 58A, these results were often not repeatable. Figure 58C shows incorrect product 
size for F5-R5 primers in all strains, suggesting these are products from non-specific 
binding of primers. Figure 59 shows R3-F4, R3-F5, R3-F6, F3-R4, F3-R5 and F3-R6 
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primers with strains #227, Oak Ridge, #213 and #80. The UV90 strains again often failed 
to produce PCR products. 
Some product of a slightly larger size was seen in #213 and csp-1; bd; UV90 with 
F3-R6, however, I was unable to obtain any PCR product for sequencing when it was 
repeated. PCR product was also seen in #213 and csp-1; bd; UV90 with F6-R3 primers, 
and these were purified as described in Methods 2.2.6 and sent to the York University 
Core Facility for sequencing. Sequences were compared to the Oak Ridge genome as 
described in Methods 2.2.6. Base pair changes appearing in the first or last 20 
nucleotides of the sequence were ignored due to inaccuracy. csp-1; bd; UV90 (sg #227) 
product was sent for sequencing with F6, FS, F4, Fl and R3 primers. Only F6 and FS 
primers produced a sequence which was compared to Oak Ridge using LALIGN program 
as described in Methods 2.2.6 (Appendix VIII). csp-1; chol-1 bd; UV90;frq10 (sg #213) 
was sent for sequencing with F6, FS, F4, Fl and R3 primers. Only F6, FS and Fl primers 
produced a sequence (Appendix VIII). Any base pair changes seen in the sequences were 
not repeatable and disregarded. Therefore no changes to the DNA sequence were 
observed in the F6-R3 PCR product with either csp-1; bd; UV90 or csp-1; chol-1 bd; 
UV90;frq10 (Appendix VIII). 
Primers F6-R7, F6-R8 and F6-R9 were tested with strains csp-1; bd; UV90 (sg 
#227), csp-1; chol-1 bd; UV90;frq10 (sg #213) and csp-1; chol-1 bd;frq10 (sg #80). No 
PCR products were seen in the UV90 strains (data not shown). Primers Fl, F2 and F3 
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were tested with reverse primer ADRp (Table 5, Materials and Methods) on strains #227, 
#80 and #213. UV90 strains again failed to produce any PCR products (data not shown). 
New primers were designed as described in Methods 2.2.4 and ordered from IDT 
(Table 4, Materials and Methods). PCR was performed as described in Methods 2.2.6 
and results are shown in Figure 60. Most PCR products were the same size as control 
#80 (esp-1; ehol-1 bd;frq1°), with the exception ofUV90AFor-R2 which produced a 
larger 1 kb fragment, and UV90BFor-Rl which produced a larger 500 bp fragment (Fig. 
60). These larger fragments were purified and prepared as described in Methods 2.2.6 
and sent for sequencing to The Centre for Applied Genomics (Hospital for Sick Children, 
Toronto, Canada). PCR was repeated 3 more times in an attempt to produce more DNA 
for the other fragments. However, not enough PCR products were obtained to submit for 
sequencing. 
Sequences from the larger fragments were compared to the Oak Ridge genome 
using BLAST searches at the Broad Institute database (http://www.broadinstitute.org/ 
annotation/genome/neurospora/Blast.html) (Appendix VIII). The 500 bp fragment from 
UV90BFor-Rl primers matched a sequence on Linkage Group II, around 2.046 Mbp, for 
both esp-I; bd; UV90 and esp-I; ehol-I bd; UV90;frq10 (sg #213) (Appendix VIII). The 
1 kb fragment from UV90AFor-R2 primers matched a sequence on Linkage Group VI, 
around 2.655 Mbp, for both strains. A BLAST search ofUV90BFor, UV90AFor, Rl and 
R2 primers against the Oak Ridge database did not produce any partial matches to these 
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regions on Linkage Group II or VI, ruling out the possibility of non-specific binding by 
the primers. 
3.4.2 Protein prediction of NCU05950 
In order to determine a possible function for the protein product of gene 
NCU05950, the amino acid sequence obtained from Broad Institute Neurospora crassa 
database 
(http://www.broadinstitute.org/annotation/ genome/neurospora/F eatureSearch.html) was 
run through two programs: PHYRE2 Protein Fold Recognition Server (Kelley and 
Sternberg, 2009) and JPred3 Secondary Structure Prediction Server (Cole et al., 2008). 
PHYRE2 protein program produced a possible model of the NCU05950 protein 
product (Fig. 61) with 33.3% confidence. (Confidence represents the probability of the 
protein product being homologous to the model). The secondary structure prediction is 
shown in Appendix IX, Figure A3. The top 5 protein templates which match NCU05950 
are shown in Appendix IX, Figure A4. The remaining predicted protein templates had 
confidence values less than 11. 7% (data not shown). 
JPred3 protein program produced a list of similar proteins and the organisms in 
which they are found (Table 28). All of the similar proteins are located in fungi, yet their 
functions are currently unknown. The UniProt protein database entries and sequence 
similarities of the other proteins compared to NCU05950 are shown in Appendix IX. 
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UV90 UV90 
AF or BF or 
Flip Flip 
F6 FS F4 Fl Fl F3 R4For I I I I I . I . RlFor 
111111111111111111111~1' II 11111111111111111111 
R3 R2 Rl R4 RS R6 R7 R8 R9 
UV90 UV90 
ARev BRev 
Figure 57. Schematic of primers used to sequence putative UV90 gene, NCU05950 on 
Neurospora crassa Linkage Group VI. 
NCU05950 is located at 3,347,867-3,348,756. Neighbouring gene, NCU05949 is located 
at 3,349,464-3,350,054. Primer locations are listed in Table 4 (Materials and Methods). 
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A Fl-Rl primers 
Fl-Rl primers 
B 
c 
F5-R5 primers 
F2-R2 primers 
F4-R4 primers 
F6-R6 primers 
I kb 
500 hp 
3 kb 
2 kb 
1.5 kb 
1 kb 
Figure 58. PCR showing attempted sequencing ofNCU05950 with Fl through F6 
primers. UV90 = csp-1; bd; UV90. OR= Oak Ridge wild type. #213 = csp-1; chol-1 bd; 
UV90;.frq10• #80 = csp-1; chol-1 bd;frq10. 
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F4-R3 primers 
UV90 #213 
UV90 #213 
F3-R4 primers 
F5-R3 primers I F6-R3 primers 
UV90 #213 UV90 #213 
UV90 #213 UV90 #213 
F3-R5 primers F3-R6 primers 
1 kb 
1 kb 
2 kb 
1.5 kb 
1.0 kb 
Figure 59. PCR showing attempted sequencing of NCU05950 with F4, F5, F6-R3 and 
R6, RS, R4-F3 primers. 
UV90 = csp-1; bd; UV90. OR= Oak Ridge wild type. #213 = csp-1; chol-1 bd; UV90; 
frq10• #80 = csp-1; chol-1 bd; frq10• 
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F2-UV90ARev UV90AFor-R2 
UV90BFor-Rl FlipRIFor-R4 
F3-UV90BRev 
FlipR4For-R5 
1 kb 
500 bp 
300 bp 
100 bp 
Figure 60. PCR showing attempted sequencing across NCU05950 with IDT primers. 
UV90 = csp-1; bd; UV90. #213 = csp-1; chol-1 bd; UV90;frq10. #80 = csp-1; chol-1 bd; 
frq10. 
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(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) 
Figure 61. Predicted 3D model of protein product of Neurospora crassa gene 
NCU05950. 
Model predicted with 33.3% confidence (Appendix IX, Figs. A3 and A4). 
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Table 28. Proteins similar to protein product of Neurospora crassa gene NCU05950 
UniProtKB/ Protein Name & Organism Locus & Location 
UniRef90 Function (if 
Entry* relevant/available) 
Q2GRJ7 Hypothetical Chaetomium globosum CHGG 09407** 
protein (soil fungus) Supercontig 6 
3,364,696-3,365,34 7 
+ 
11RMZ9 Conserved Fusarium FGSG 05355** 
(previously hypothetical graminearum Chromosome 3 
UPI000023E1El) protein ( Gibberella zeae; 1,992,968-l ,994,032 
wheat head blight + 
fungus) 
B2AQ67 Hypothetical Podospora anserina Chromosome 4, 
protein (filamentous fungus) Supercontig 4 
2,087,746-2,088,377 
A7EA02 Hypothetical Sclerotinia SSlG 02132** 
protein sclerotiorum (white Chromosome 4, 
mold) Supercontig 3 
49,801-50,485 + 
B6GXY1 Hypothetical Penicillium Pc12g08110 
protein chrysogenum 1,915,643-1,916,272 
(Penicillin fungus) 
A2QWY4 Hypothetical Aspergillus niger (fruit Anl lg06890 
protein (weak & vegetable black 183,872-184,599 
similarity to PDZ mold) 
domain protein 
MUPP 1 - Rattus 
norvegicus) 
Q5BCG8 Conserved Aspergillus nidulans ANID 01762.1 ** 
hypothetical (filamentous fungus) Chromosome 7; 
protein Contig 27 
110,537-111,223 -
A1DMW4 Conserved Neosartorya fischeri NFIA 054830 
hypothetical (fungal pathogen) 2,304,209-2,304,920 
protein 
QOCill Conserved Aspergillus terreus ATEG 06673 * * 
hypothetical (fungus) Supercontig 9 
protein 1,133,008-
1,133,654+ 
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UniProtKB/ Protein Name & Organism Locus & Location 
UniRef90 Function (if 
Entry* relevant/available) 
B8NPB4 Conserved Aspergillus flavus AFLA 128970 
hypothetical (pathogenic fungus) 1,568, 173-1,568,868 
protein 
B6Q423 Conserved Penicillium marneffei PMAA 030110 
hypothetical (fungus, causes 3,998,847-3,999,546 
protein Penicilliosis in 
humans) 
COS031 Predicted protein P aracoccidioides PABG 01789** 
brasiliensis Supercontig 2 
(pathogenic fungus) 2,657,423-2,660,152 
+ 
A6RA59 Predicted protein Ajellomyces capsulatus HCAG 05847** 
(Histoplasma Supercontig 7 
capsulatum; Darling's 694,509-695,321 -
disease fungus) 
B2W9B9 Hypothetical Pyrenophora tritici- PTRG 06577 
protein repentis (Wheat tan 1,073,374-1,073,951 
spot fungus) 
QOU774 Hypothetical P haeosphaeria SNOG 12390 
protein nodorum (Glume 254,347-255,417 
blotch fungus) 
*Entries searched at the UniProt Protein Database (http://www.uniprot.org/) 
**Also located at the Broad Institute Database (http://www.broadinstitute.org/) 
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CHAPTER4 
DISCUSSION 
Genetic mapping of UV90 gene location 
Mapping the UV90 gene location was initiated following previous mapping done 
on Linkage Group VI by Dr. Kamyar Motavaze and Daniel Rubinger (Fig. 18). 
Recombination frequencies of progeny are typically used for genetic mapping in 
Neurospora crassa (Jin et al., 2007). Neurospora genetic mapping is often performed 
using tester strains, where the mutated strain is crossed against strains with known 
mutations on specific chromosomes, and recombination frequencies are observed (Jin et 
al., 2007). Genes located on different chromosomes are unlinked and will typically 
segregate independently in crosses with a recombination frequency of 50%, whereas 
genes closer together are linked and will segregate together in a cross with a lower 
recombination frequency (Griffiths et al., 1993). The method in this study similarly uses 
recombination frequencies, but instead is based on the segregation of specific regions of 
DNA (CAPS markers) that distinguish between Oak Ridge and Mauriceville strains (Jin 
et al., 2007). The CAPS marker method is also much faster by using DNA extraction and 
PCR to analyze dozens of progeny as opposed to performing multiple test crosses which 
often takes several months (Jin et al., 2007). There is the additional advantage of being 
able to create the CAPS marker at any desired location in the chromosome, eliminating 
the need for finding and obtaining tester strains with specific mutations near the mutated 
gene of interest (Jin et al., 2007). 
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CAPS markers F3-R3 produced 20.4% recombination, whereas F6-R6 and F9-R9 
produced 14.3% recombination for Dr. Motavaze (Fig. 18). The decreasing values of 
recombinants moving to the right on the chromosome suggested that the UV90 gene 
mutation was further downstream, specifically to the right of F9-R9 marker. My progeny 
produced 3/29 (10.3%) recombinants with both F6-R6 and F9-R9 markers (Table 10, Fig. 
18). Daniel Rubinger also tested marker 668F-668R (sequence obtained from Jin et al., 
2007) with UV+ and UV90 progeny from the same cross and obtained 4 out of 54 (7.4%) 
recombinants (Fig. 18). The low recombination frequency indicated that the UV90 gene 
was likely close to marker 668F-668R, yet it was unknown whether or not UV90 was to 
the right or the left of the centromere (Fig. 18). 
Dr. Motavaze and I both had identical recombinant progeny, and thus zero 
recombination, between F6-R6 and F9-R9 markers (Table 10). This initially led me to 
suspect that there was potentially an inversion or deletion between those markers in 
UV90, or the possibility that the PCR primers were binding to an alternate, incorrect 
location. To check these possibilities, I tested prd-1 and prd+ progeny from a cross 
between csp-1; prd-1; bd and Mauriceville wild type (previously performed by Nardin 
Nano) with F6-R6 and F9-R9 markers. The period (prd-1) mutation is a long period 
rhythm mutation found on Linkage Group III (Li and Lakin-Thomas, 2010). Genes 
located on separate chromosomes are unlinked and thus should produce recombination 
frequencies of approximately 50% (Griffiths et al., 1993).prd-1 andprd+ progeny 
produced 21/45 (46.7%) identical recombinants with both F6-R6 and F9-R9 markers 
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(Table 11 ). The recombination frequency close to 50% was expected for unlinked genes, 
yet zero recombination was again seen between F6-R6 and F9-R9. This eliminated the 
possibility of a chromosomal rearrangement specific to the UV90 mutant, and suggested 
the possibility of generalized reduced recombination between these CAPS markers. 
UV90 and UV+ progeny were tested a second time on race tubes to also rule out 
the possibility that some progeny were misclassified. 10 progeny were disregarded after 
producing unclassifiable phenotypes (Fig. 15). This reduced the total number of progeny 
and the number ofrecombinants from 7/39 (17.9%) to 3/29 (10.3%) (Table 10). This 
resulted in a very small sample size and a drastic change in the recombination frequency. 
New primers were designed downstream of marker F9-R9 in an attempt to avoid 
the region between F6-R6 and F9-R9 which was producing zero recombination. 6 pairs 
of CAPS markers were tested with parental UV90 strains (Fig. 19). Markers LCFl-LCRl 
and FlO-RlO did not produce any results with either OR or MV strains and were not used 
further (Fig. 19). 
RCF3-RCR3 and RCF4-RCR4 produced identical bands for both OR and MV after 
restriction enzyme digestion (Fig. 19). This was due to a fault during primer designing, 
where I did not check for the presence of multiple restriction enzyme sites in the CAPS 
marker sequence. Multiple restriction enzyme sites were found in these CAPS markers, 
causing the cleaved products to appear to be roughly the same size for both strains. 
These markers were therefore disregarded for further use. LCF2-LCR2 and Fl 1-Rl 1 
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produced different bands for OR and MV after digestion and were chosen for use in 
mapping (Fig. 19). 
Six out of 39 (15.38%) identical UV+ and UV90 progeny were recombinant with 
both LCF2-LCR2 and Fl 1-Rl 1 markers (Table 12). These values were adjusted to 2 out 
of 29 (6.9%) after the previously disregarded race tubes were removed from the total 
values (Table 12). This again drastically reduced the recombination frequency. Zero 
recombination was also seen between LCF2-LCR2 and Fl 1-Rl 1. However, one 
recombinant was seen between F9-R9 and LCF2-LCR2 and Fl 1-Rl 1 markers (Fig. 36). 
The lower recombination frequencies to the right of F9-R9 again indicated that the UV90 
gene was further downstream, and likely to the right of the centromere. 
No recombination was seen between F6-R6 and F9-R9 markers, as well as 
between LCF2-LCR2 and Fl 1-Rl 1. One possible explanation is that the total number of 
progeny was simply too small to be able to detect more recombinants for each CAPS 
marker. The corrected pool size from 39 to 29 progeny greatly reduced the number of 
recombinants. However, Dr. Kamyar Motavaze had 49 total progeny and also did not 
detect any recombination between markers F6-R6 and F9-R9 (Fig. 18). The prd-1 and 
prd+ progeny also produced identical recombinants betweenprd-1 and F6 or F9, 
showing no recombination between F6 and F9. 
It was noted on the Broad Institute Neurospora crass a database in March 2013 
(http://www.broadinstitute.org/annotation/ genome/neurospora/N ews.html) that a change 
in the orientation was made to the region left of the Linkage Group VI centromere. The 
164 
primers on the left of the centromere therefore changed locations (Table 20). The 
previous order of the primers used in mapping, from left to right on the chromosome, 
was: F3, F6, F9, Fl 1, LCF2 (Table 20). The new order of the primers is now reversed: 
LCF2, Fl 1, F9, F6, F3 (Table 20). The distances between the primers remained the same 
as previously. In light of this new information, it appears that the LCF2 and Fl 1 primers 
are farther to the left than F9, F6, and F3, and therefore should have produced a larger 
number of recombinants as they moved away from UV90, not fewer. It is unknown why 
this was the case, except that there appears to be low recombination rates in that entire 
region. 
It is also unknown whether or not there is an inversion to the left of the Linkage 
Group VI centromere in Mauriceville relative to Oak Ridge. An inversion could explain 
the low recombination frequencies in that region in our mapping crosses. Chromosomal 
inversions often create inversion loops during crossover events, which cause breaks in the 
chromosome and the loss of genes (Griffiths et al., 1993). These chromosomal breaks 
and gene deletions can be lethal and thus reduce the number of recombinant progeny 
observed (Griffiths et al., 1993). Inversions may also prevent crossover events from 
occurring altogether by preventing homologous pairing in the chromosome, and thus 
reducing the total number ofrecombinants (Griffiths et al., 1993). 
Another explanation is that the chromosome is not inverted, however, there are 
little to no recombination or crossover events occurring in those regions of the 
chromosome. The distance between F6 and F9 primers is approximately 270,000 bp, and 
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between LCF2 and F 11 is 170,000 bp (Table 20), and so it seems unlikely that there 
would be no crossover events amongst such a large chromosome fragment. There is the 
possibility that neighbouring genes or genes on other chromosomes are preventing 
recombination events (Catcheside and Corcoran, 1973). Catcheside and Corcoran (1973) 
discovered that certain recombination genes (dubbed rec-2+ and rec-3+) were 
responsible for reducing recombination frequencies between the arg-3 and his-2 genes on 
Linkage Group I. rec-2+ was found to reduce recombination by approximately half 
between arg-3 and his-2, and rec-3+ nearly eliminated recombination in that region 
altogether (Catcheside and Corcoran, 1973). It is also interesting to note that rec-2+ is 
located in Linkage Group V, and also reduces recombination betweenpyr-3 and leu-2 in 
Linkage Group IV, indicating that genes on completely different chromosomes can have 
an effect on reducing recombination rates (Catcheside and Corcoran, 1973). Catcheside 
and Corcoran (1973) also noticed rec genes affecting non-allelic recombination. 
Repetitive sequences of DNA can be responsible for non-allelic crossovers, and 
also a reduction in recombination frequencies (Griffiths et al., 1993). Duplications of 
regions of DNA can cause misaligned chromosomes during crossover events and create 
gene duplications or deletions, which may be lethal and reduce recombination rates 
(Griffiths et al., 1993). Repetitive sequences occur in approximately 10% of the 
Neurospora genome (Galagan et al., 2003). The fact that the Broad Institute reversed the 
orientation of the previous contig on Linkage Group VI suggests that there may be 
similar sequences at the beginning and end of that region. Given the large region of 
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DNA in Linkage Group VI which appears to have little to no recombination, it seems 
likely that repetitive sequences or recombination-suppressing genes may be responsible 
for this anomaly. 
New spores from the cross between csp-1; bd; UV90 (sg #227) and MV wild type 
(sg #258) were picked in order to increase the number of progeny and obtain a better 
sample size for mapping. bd; UV+ progeny were distinguished from UV90 progeny by 
their faster growth rates and rhythmic conidiation on the race tubes (Fig. 24 ). UV90 
progeny, as previously, were identified by low amplitude rhythms of conidiation (Fig. 
25). bd+ progeny exhibited faster growth rates than bd, and UV90 strains were 
distinguished by their constant conidiation (Figs. 26 and 27). The phenotypes matched 
previously reported observations for UV90 progeny (Li et al., 2011 ). 
CAPS markers RCF5-RCR5, RCF6-RCR6 were designed to the right of the 
centromere to further narrow down the location of the UV90 gene (Tables 2 and 3). The 
sequence of 668F-668R was obtained from Jin et al. (2007). Only RCF5-RCR5 and 
668F-668R markers both produced distinct bands for each parental strain after digestion 
and were used for PCR (Fig. 28). 8 out of 85 progeny (9 .41 % ) were recombinant with 
RCF5-RCR5, and 3 out of 85 progeny (3.53%) were recombinant with 668F-668R (Table 
17). The decreasing recombination frequency indicated that the CAPS markers were 
moving closer to UV90. It was likely situated to the right of marker 668F-668R. The 3 
recombinants with 668F-668R (#143, 184 and 122) were also recombinant with RCF5-
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RCR5 (Table 17), indicating that the crossover event that produced recombination in both 
of those markers would have occurred to the right of 668F-668R (Fig. 41 ). 
CAPS markers F15-R15 and F16-R16 were designed and tested with UV90 
parental strains (Tables 2 and 3, Fig. 33). F16-R16 was chosen for PCR as the MV 
product produced an uncleaved DNA product, and thus would be easier to distinguish 
from the cleaved OR product (Fig. 33). 8 out of 85 progeny (9.41 %) were recombinant 
with F16-R16 (Table 18). This increase in recombination frequency indicated that the 
UV90 gene was somewhere to the left of F16-R16, and likely closer to 668F-668R (Fig. 
36). The UV90 mutation therefore must be between 668F-668R and F16-R16 (Figs. 36 
and 41). 
One minor discrepancy occurred with the recombinant values. It was expected 
with 3/85 recombinants for 668F~668R and 8/85 progeny for F16-R16 that there would 
be a total of 11 different recombinant progeny between those two markers. However, 
csp-1; bd+; UV+ progeny #143 was recombinant with both markers (Tables 17 & 18; 
Fig. 41). This left a total of 9 different recombinant progeny for 668F-668R and F16-
Rl 6 (Tables 17 & 18; Fig. 41 ). One possible explanation for this discrepancy is that 
progeny #143 was misclassified as UV+ when it is actually UV90 and therefore should 
not be included, leaving a total of 9 recombinants. Another possible explanation is that 
progeny #143 is a double recombinant, and experienced a crossover event both to the 
right of 668F-668R, and to the left ofF16-R16. This would cause #143 to appear 
recombinant with both CAPS markers. In this scenario, one recombinant would need to 
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be added to the total for 668F-668R and one for F16-R16, leaving a total of 11 progeny. 
In either case, the total number of recombinants indicates the UV90 gene is located 
somewhere in between those CAPS markers (Fig. 36). 
The distance between CAPS markers 668F-668R and F16-R16 is approximately 
190,000 bp (Table 2). It was therefore necessary to further narrow down the region in 
which the UV90 gene was located. 8 CAPS markers were designed and tested with UV90 
parental strains (Tables 2 and 3, Fig. 37). Only recombinants from 668F-668R and F16-
R16 (Tables 17 and 18) were chosen for PCR with these markers because they would 
have a recombination event in this interval (Fig. 41 ). The numbers of recombinants are 
shown in Table 19. 3 recombinants were seen with 668F-668R, 1with3317F-3317R, 
and 2 with 3368F-3368R (Table 19; Fig. 41). The recombinant frequency decreases 
towards 3317F-R and increases towards 3368F-R, suggesting that the UV90 gene is 
located in between 668F-668R and 3368F-3368R. 
FGSC Knockouts 
Table 21 shows a list of UV90 candidate genes in the region between 668F-668R 
and 3368F-3368R. Knockouts of these genes were ordered from the Fungal Genetics 
Stock Center (FGSC) (Table 1 ). Gene prediction software at the Broad Institute is used 
to predict genes based on genomic sequences and detects the presence of open reading 
frames (ORFs), start and stop codons. 
(www.broadinstitute.org/annotation/ genome/neurospora/GeneFinding.html). Expressed 
sequence tags (ESTs) from the cDNA sequences were aligned against the predicted 
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genome sequences and only those ES Ts with high alignments (95%+) to one location 
were used in gene predictions 
(http://www.broadinstitute.org/annotation/ genome/neurospora/GeneFinding.html). 
FGSC knockouts were created by knocking out individual genes using a cassette 
containing Hygromycin B resistance (Colot et al., 2006). Only FGSC knockout #18029 
produced arrhythmic, constant conidiation on the race tube which resembled UV90 (Figs. 
42-44). This corresponded with gene NCU05950 (Table 1) and was chosen as a potential 
UV90 candidate. A cross was then performed between FGSC # 18029 and csp-1; chol-1 
bd; UV90;frq10 (sg #80) to determine ifthe knockout resembled UV90 when placed 
through a cross. 
The race tube phenotypes for knockout # 18029 also looked very similar to the 
UV90 phenotype. bd+ progeny were separated from bd by their faster growth rates (Fig. 
45). On media containing choline, csp-1; bd; UV+ progeny exhibited clear, rhythmic 
conidiation, and csp-1; bd; UV+; frq 10 progeny exhibited the same fluffy, arrhythmic 
conidiation as the control (Figs. 46 and 4 7). The most interesting results were seen in the 
UV90 strains. csp-1; bd; UV90; frq10 was arrhythmic with constant conidiation, whereas 
csp-1; bd; UV90 strains appeared to have a low amplitude rhythm at the beginning of the 
race tubes that tapered off to an arrhythmic pattern (Figs. 46 and 4 7). On media with no 
choline, csp-1; bd; UV+ progeny exhibited a rhythmic pattern, yet bands were not as 
distinct and clear to observe (Fig. 48A). This is the result of the chol-1 mutation which 
exhibits a slower growth rate and longer period when choline levels are depleted (Lakin-
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Thomas, 1996). esp-I; bd; UV90 progeny appeared arrhythmic on low choline (Fig. 
48B). In the frq 10 strains, chol-1; UV+ progeny on low choline appear to have a long 
period, low amplitude rhythm, as expected (Fig. 49A). chol-1; UV90; frq 10 strains 
abolish the rhythm and appear completely arrhythmic (Fig. 49B). This is identical to 
what was seen in the UV90 mutants previously (Li et al., 2011). These results confirm 
that FGSC knockout # 18029 exhibits the same allelic segregation, phenotype and growth 
rate as UV90, giving strong evidence to conclude gene NCU05950 and UV90 are the 
same. It was also demonstrated in the lab via PCR analysis by Amanda Mohabeer that 
NCU05950 was the correct gene that was replaced with a Hygromycin B resistance 
cassette. 
In the presence ofthefrq10 mutation, the UV90 phenotype appears to be 
completely arrhythmic (Li et al., 2011 ). UV90 also abolishes the rhythm found in chol-1; 
frq 10 strains grown on media without choline (Fig. 49B), giving strong evidence that it is 
involved with, or part of, the FRQ-less oscillator (FLO) (Li et al., 2011). However, low 
amplitude rhythms have previously been seen in UV90 strains that contain the frq gene 
(Li et al., 2011 ). This is also noticed in the progeny used for mapping from the cross 
between esp-I; bd; UV90 and Mauriceville wild type. Some of the csp-1; bd; UV90 
progeny appear to have a very low amplitude rhythm, as well as UV90 progeny from the 
knockout cross (Figs. 9, 25, and 46). Since the knockout resembled UV90, it is possible 
that the original UV90 mutation is a null mutant or results in a loss of function protein. 
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The UV90 mutation has been seen to dampen the amplitude of the FRQ protein 
(Li et al., 2011). This suggests that the UV90 gene is likely interacting with, or possibly 
supporting the FRQ-WCC feedback loop. Furthermore, since UV90 is believed to be part 
of the FLO, this is an indicator that the FLO may be interacting in some manner with the 
FRQ-WCC feedback loop (Li et al., 2011 ). 
Transformation of Neurospora crassa 
In order to further confirm whether the NCU05950 gene was in fact UV90, a 
complementation test was performed where the wild type copy of the NCU05950 gene 
was inserted into the UV90 mutant strain in an attempt to restore the rhythm. Restoration 
of the rhythm would provide conclusive proof that the NCU05950 gene is in fact, UV90. 
Typically transformations in Neurospora are performed using the pDE 1 plasmid which 
contains a non-functional part of the his-3 (histidine) locus, as well as multiple restriction 
enzyme sites for insertion of desired genes (Ebbole, 1990). The plasmid would be 
transformed into a his-3 strain, where recombination at the his-3 locus would produce a 
functional histidine gene that can be selected by placing transformants on media without 
histidine. Unfortunately, this method was not used in this study due to the fact that the 
lab has been unable, for several years, to create a his-3; UV90 double mutant. Several 
different crosses between his-3 and UV90 strains appear to be viable with the production 
of spores, yet germination rates have repeatedly been exceptionally low. A his-3; UV90 
double mutant has been unattainable. 
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It was therefore decided to transform Neurospora with the naked wild type copy 
of the NCU05950 gene and a copy of the Hygromycin B resistance gene (hyg) which 
would be used to select for transformants, based on the methods by Staben et al. (1989). 
Strains which would receive the DNA were esp-I; ehol-I bd; UV90 (sg #224) and esp-I; 
ehol-I bd (sg #26). Strains esp-I; ehol-I bd; UV90; .frq10 (sg #213) and esp-I; ehol-I bd; 
.frq10 (sg #80) were not used in this transformation due to the presence ofthe.frq10 
mutation. This mutation is created by replacing the .frq gene with a cassette containing 
the Hygromycin resistance gene (Colot et al., 2006), making it impossible to detect ifthe 
transformed strains contained our inserted hyg gene. It was expected that the NCU05950 
gene would restore the rhythm in the UV90 strain. The esp-1; ehol-1 bd strain was 
transformed to determine if there would be any phenotypic effects of having multiple 
wild type copies of the UV+ gene. 
Thirteen transformants were seen with esp-I; ehol-I bd and 1 with esp-I; ehol-I 
bd; UV90. All transformants grew on plates and microtiter wells containing Hygromycin 
B, confirming the presence of the hyg gene. Race tube analysis of the transformants, 
however, did not show clear evidence of a successful transformation. The UV90 
transformant showed no rhythm and very little conidiation along the length of the race 
tube (Fig. 51 ). The UV+ transformants showed some rhythmic conidiation for several 
days before changing to an arrhythmic pattern, with the exception of transformants #26-1 
and #26-6 which showed a constant rhythm (Figs. 51-53). Growth rates for the UV90 
transformant were very slow at a mean of 0.32 (± 0.015) mm/hr (Table 27). UV+ 
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transformants had a slow mean growth rate of 0.675 (± 0.035) mm/hr and a longer period 
of 25.07 (± 0.943) hr (Table 27). PCR and restriction enzyme digestion analysis revealed 
that UV+ transformants #26-6, 26-7, 26-11, and 26-12 may have the inserted NCU05950 
gene (Figs. 50 and 55). However, race tube analysis for #26-7, 26-11and26-12 
transformants showed no clear rhythmic conidiation (Figs. 52-53). #26-6 showed the 
strongest evidence via PCR that it received the NCU05950 gene (Fig. 55), and race tube 
analysis showed a clear rhythmic pattern (Fig. 52). The UV90 transformant did not show 
any PCR product (Fig. 54). One PCR product was seen at one point (Fig. 55), but this 
was believed to be non-specific binding of the primers as this result was not repeatable. 
Therefore, it could not be concluded that the UV90 transformant obtained the wild type 
copy of the NCU05950 gene or whether or not NCU05950 is capable ofrestoring the 
UV90 phenotype. 
The results obtained from this transformation may be due to known difficulties in 
the experimental design. In Neurospora, sequences of DNA in transformations will 
usually insert themselves through non-homologous recombination at various locations in 
the genome (Asch et al., 1992; Case et al., 1992). It has also been discovered in 
Neurospora that during these insertion events, portions of the inserted plasmid DNA can 
be lost, as much as 450 bp (Asch et al., 1992). This is a plausible explanation for the 
results obtained. It is likely that both the hyg and NCU05950 genes were inserted into 
random locations in the genome. The loss of inserted DNA can also explain why no PCR 
product was seen in the UV90 transformant, if large sections of DNA necessary for 
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primer binding were lost. Furthermore, Asch et al. (1992) discovered that linearized 
plasmid was separated into 2 fragments and inserted into different locations in the 
genome. If this also occurred during the UV90 transformation, it is likely that fragments 
of both genes were inserted into several random DNA sequences, causing the 
abolishment of the rhythm seen on the race tubes. 
Case et al. (1979) have experienced successful transformations with inserted 
linear and plasmid DNA replacing the desired gene of interest. This suggests the 
possibility that the transformation may work if it was repeated several more times to get 
more recombinants. 
Sequencing of gene NCU05950 
Several attempts were made to sequence the UV90 gene candidate NCU05950. 
Sequencing of the gene was attempted in order to characterize the UV90 mutation and 
confirm the identity of the UV90 gene. Some PCR products were obtained for 
sequencing to the left of the gene for F6-R3 primers (Fig. 59; Appendix VIII). Sequences 
for approximately the first and last 20 basepairs were ignored for all products due to 
inaccuracies in the sequencing method. Some misaligned basepairs were observed in the 
sequences, however, these were not observed when the sequencing was repeated and 
were disregarded. No base pairs changes were seen in the sequence for this PCR product. 
The sequence produced by F6-R3 primers also falls just to the left of NCU05950 (Fig. 
57), and therefore did not provide any information as to the type of gene mutation. 
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Some PCR products were seen along the NCU05950 gene that were larger than 
expected (Fig. 60). The 500 bp fragment from UV90BFor-Rl primers (Fig. 60) matched 
a sequence on Linkage Group II, around 2.046 Mbp (Appendix VIII). This corresponded 
to a region inside gene NCU06756, listed as a ubiquitin protein ligase 
(www.broadinstitute.org/annotation/genome/ neurospora/FeatureSearch.html). The 1 kb 
fragment from UV90AFor-R2 primers (Fig. 60) matched a sequence on Linkage Group 
VI, around 2.655 Mbp (Appendix VIII). This corresponded to a region inside gene 
NCU04073, currently listed as a hypothetical protein 
(www.broadinstitute.org/annotation/ genome/neurospora/F eatureSearch.html). As with 
previous sequencing, the first and last 20 basepairs were ignored. Triplicates of each 
DNA sample were submitted for sequencing, and any mismatches were not observed 
more than once and were also disregarded. 
It is unclear whether or not the matches to other Linkage Groups observed in 
sequencing are an indication of the gene function. There is the possibility that during 
mutagenesis, random fragments of coiled DNA were broken and reattached at various 
locations, causing extraneous fragments of DNA in the NCU05950 gene. The 
NCU05950 gene could not be sequenced, yet problems with obtaining PCR products 
were observed in multiple UV90 strains. This indicates that the NCU05950 gene is 
disrupted in the UV90 mutant, and helps add evidence to the hypothesis that NCU05950 
is possibly the UV90 gene. 
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Characterization of gene NCU05950 protein product 
The hypothetical protein product ofNCU05950 was compared against other 
proteins in an attempt to determine the function. PHYRE2 protein program produced a 
ferritin-like model structure for one domain of NCU05950 (Fig. 61; Appendix IX). 
However, the confidence in this prediction was only 33.3%, and thus it is not a definitive 
conclusion that the gene has a ferritin-like structure. The entire predicted structure gave 
no clues as to the protein function. 
Other proteins were compared to NCU05950 using Jpred3 protein program (Table 
28; Appendix IX). All of the similar proteins were found exclusively in fungi, 
specifically other fungi that live in soil and manure (Table 28). This indicates that this 
protein is possibly unique to fungi, yet not exclusive to Neurospora crassa. The match to 
other fungi with a highly conserved amino acid sequence (Appendix IX) suggests this 
gene is important and has gone through little evolutionary genetic variation even amongst 
different species. 
It was interesting to note that one protein match discovered had a sequence 
similarity to PDZ domain protein MUPPl in the brown rat (Table 28). MUPPl protein, 
which contains multiple PDZ (PSD-95/Drosophila Disc large/Z0-1 homology) domains, 
has been found to bind to and regulate the signal transduction of a melatonin receptor in 
humans (Guillaume et al., 2008). Melatonin is known as an important feature in the 
mammalian circadian clock and has also recently been discovered in plants (Paredes et 
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al., 2009). There is a possibility that the NCU05950 protein product may have an 
important role in signal transduction. 
FUTURE DIRECTIONS 
Transformation of Neurospora with gene NCU05950 
One of the most important experiments that needs to be repeated is the 
complementation test by transforming Neurospora with NCU05950. If performed 
correctly, this can provide definitive proof that this gene is responsible for the UV90 
phenotype. However, with the inability to create a his-3; UV90 double mutant strain, one 
possibility would be to use another gene that can be easily targeted using a plasmid. Case 
et al. (1992) have successfully restored quinic acid mutants, qa-2 and qa-JF, in 
Neurospora by using plasmids that contain part of a functional copy of these genes. This 
allowed for targeted transformations since only a homologous recombination event could 
produce functional copies of these genes, which can be tested for on media without 
aromatic amino acid supplements (Case et al., 1992). 
Successful transformations have also been performed by creating a recipient 
Neurospora strain that contained the 3' end of the Hygromycin resistance gene (hyg) 
downstream from the glutamate dehydrogenase mutant (am) gene (Cambareri and 
Kinsey, 1994). The inserted plasmid contained the 5' of the hyg gene and also a copy of 
am (Cambareri and Kinsey, 1994). Hygromycin resistance can therefore only be 
observed if homologous recombination between the recipient and donor strains occurs. 
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Both recipient strains (FGSC #8071 and #8072) and plasmids used for transformations 
are available at the FGSC (Cambareri and Kinsey, 1994). Successful targeting of specific 
regions in Neurospora was achieved with both methods. UV90 can be crossed with 
either the quinic acid mutants (qa-2, qa-JF) or the glutamate dehydrogenase mutant (am) 
to create a double mutant that can be used for plasmid targeting. 
It is also possible that the transformation experiment can be repeated as 
performed, with the exception of introducing a piece of the NCU05950 gene with a large 
amount of flanking sequences on either direction to attempt to target the gene to the 
correct location. It has been noticed previously in Neurospora that homologous 
recombination in transformation events is dependent upon the length of the inserted 
fragment (Asch et al., 1992). 
Another possibility is to repeat the experiment performed, but with placing the 
wild type NCU05950 gene directly into the Hygromycin resistance plasmid (pCSN44), 
and then transform the entire plasmid into Neurospora. This may prevent issues with 
non-homologous recombination since an entire plasmid will be inserted as opposed to 
two lone fragments of DNA that will almost certainly recombine at various locations. 
The recipient strain that uptakes the entire plasmid (including the wild type gene) will be 
also resistant to Hygromycin. 
Sequence and gene function of UV90 
Another experiment which failed after repeated attempts was the sequencing of 
NCU05950. PCR and sequencing should be repeated with new primers to confirm if the 
179 
previous sequencing results matching fragments of NCU05950 to Linkage Groups II and 
VI can be repeated. PCR will also need to be repeated on the regions of NCU05950 that 
showed a normal sized PCR product yet were unable to be sequenced. Sequencing may 
provide clues as to the nature of the mutation and possibly the gene function of UV90. If 
there is a mutation in the promoter region of the gene, this may prevent transcription and 
translation of a protein product. A mutation in the amino acid sequence of the protein 
may provide clues as to the affect this has on the final protein sequence and structure. 
Knowing the sequence of the UV90 mutation will also provide information as to the 
nature of the protein product: specifically, does the UV90 mutant protein have any 
function or is it completely abolished? 
Characterize protein product of UV90 
The protein product and the function of gene NCU05950 are currently unknown. 
One method of determining the function is to identify which other proteins the desired 
protein is interacting with. Typically, target proteins are tagged with an epitope tag 
which can then be detected using an antibody specific for that epitope (Honda and Selker, 
2009). Epitope tags may interfere with protein folding, processing, modification, or 
function unless a polypeptide linker (made up of 10-glycines) is placed between the 
epitope tag and the protein (Honda and Selker, 2009). Interacting tagged proteins can 
then be co-immunoprecipitated from cell extracts and identified using mass spectrometry 
(Honda and Selker, 2009). 
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Other protein tags that have previously been used are Myc-6xHis tandem affinity 
purification (TAP) tag and FLAG-6xHis TAP tag (Honda and Selker, 2009). A green 
fluorescent protein (GFP) tag may also be added to the UV90 gene and inserted using an 
appropriate vector. GFP tag is particularly useful due to the fact that it produces green 
fluorescence under UV light (Honda and Selker, 2009). This can be used in detecting the 
movement and localization of the UV90 protein product in the cell using live-cell 
confocal microscopy. 
It will also be useful to determine if the gene transcription of UV90 is rhythmic. 
Northern blotting and quantitative reverse transcription PCR (qRT-PCR) can be used to 
detect mRNA levels at regular intervals to determine the nature of the gene transcription. 
UV90 protein rhythms can similarly be observed using Western blotting of the tagged 
protein. If either UV90 mRNA or protein levels are rhythmically expressed, it can be 
determined if the rhythms are necessary for their function by expressing the genes using a 
promoter that is constantly induced and non-rhythmic. In addition, continuing to 
compare the predicted protein product with those in other fungi may reveal information if 
the function of a similar protein is discovered. 
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4% agar: 
2 g Difeo Bacto-Agar 
50mLddH20 
APPENDIX 
Appendix I 
Mix together agar and water, sterilize and pour contents into two sterile small (8.5 cm) 
Petri plates. 
Minimal agar medium: 
2 mL 50x/Vogel's stock 
2 g D-glucose 
2 g Difeo Bacto-agar 
100 mL dd H20 
Several drops green food colouring 
1 mL choline (10 mM), final concentration 100 µM* 
Mix all ingredients together. For baby tubes, use 1 mL of media per tube, cover with 
cotton plugs, sterilize and lean tubes on their sides to produce slants. For stock tubes, use 
3 mL per large test tube, cover with plastic caps, sterilize and slant. 
*Added if Neurospora strain contains choline (chol-1) mutation. 
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50x/Vogel's Stock: 
Add the following in succession to a 250 mL flask: 
188 mL dd H20, stir with heat 
32.8 g Na3-citrate · 2H20, let dissolve 
62.5 g KH2P04 anhydrous, let dissolve 
25.0 g NH4N03 anhydrous, let dissolve 
Turn off heat and add water to 250 mL. Add the following while stirring: 
2.5 g MgS04 · 7H20, let dissolve 
1.25 g CaCh · 2H20 dissolved in 5 mL water, let dissolve (Add calcium mixture slowly 
with a pasteur pipette submerged below the solution surface to avoid precipitation) 
1.25 mL trace elements solution 
0.625 mL biotin solution (make fresh) 
Allow solution to cool completely, add 2 mL chloroform and cap tightly. Store at room 
temperature. 
Biotin solution: 
1 mg biotin per 10 mL of 50150 ethanol/water 
Weigh a small amount (close to 1 mg) of biotin and add 50/50 ethanol/water for a final 
concentration of 0.1 mg/mL. 
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Trace elements solution: 
Add in succession to 9.5 mL water (dd H20), while stirring: 
0.5 g citric acid· H20 
0.5 g ZnS04 · 7H20 
0.1gFe(N~)2(S04)2·6H20 
0.025 g CuS04 · 5H20 
0.066 g MnS04 · 4H20 (or 0.05 g MnS04 · H20) 
0.005 g H3B03 anhydrous 
0.0037 g (N~)6Mo1024 · 4H20 (ammonium molybdate hydrate) 
Keep refrigerated and wrapped in foil to keep dark. 
Maltose-arginine (MA) medium: 
2 mL 50xNogel's stock 
0.5 mL L-arginine (2% or 20 mg/mL), final concentration 0.01 % 
0.5 g maltose 
2 g Difeo Bacto-agar 
100 mL dd H20 
Several drops green or blue food colouring** 
1 mL choline (10 mM), final concentration 100 µM, optional* 
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Mix all ingredients together. Sterilize media separately from race tubes sealed with 
cotton plugs at both ends. For short (30 cm) race tubes, use 6 mL per tube. For long (40 
cm) race tubes, use 8 mL per tube .. 
*May be added if Neurospora strain contains choline (cho/-1) mutation. 
**Blue food colouring is typically added to media containing choline; green without 
choline 
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Liquid minimal medium: 
2 mL 50xNogel's stock 
2 g D-glucose 
100 mL water 
Appendix II 
Several drops blue or green food colouring, optional 
Mix all ingredients together and sterilize. 
DNA Extraction Buffer: 
1.21 g Tris (final concentration 100 mM) 
1.86 g EDTA (final concentration 50 mM) 
1mL10% SDS 
Dissolve Tris and EDTA with stirring in 80 mL dd H20. Adjust pH to 8.0. Add water 
for a total volume of 100 mL. Store at room temperature. 
To make DNA extraction buffer with 1 % SDS, measure 1 mL 10% SDS with 9 mL DNA 
extraction buffer. 
RNase A: 
0.121 g Tris (final concentration 10 mM) 
500 µL glycerol 
10 mg RNase powder 
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Dissolve Tris in 80 mL dd H20. Adjust pH to 8.0. Add water for a total volume of 100 
mL. Place 500 µL glycerol into 1.5 mL screw-cap conical tube. (If glycerol is too dense 
to pipette, measure 500 µL in grams, 1 mL = 1.26 g). Add 500 µL of Tris-HCI solution 
and RNase powder. Vortex to mix and store in fridge. 
TE Buffer: 
0.121 g Tris (final concentration 10 mM) 
0.0372 g EDTA (final concentration 1 mM) 
Dissolve Tris and EDTA with stirring in 80 mL dd H10. Adjust pH to 8.0. Add water 
for a final volume of 100 mL. Can be sterilized in 1.5 mL screw-cap conical tubes and 
frozen. 
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CAPS marker: Right Side of Centromere - RCF5 & RCR5 
(Linkage Group VI; Supercontig 6) 
>N. crassa OR74A (NCIO) supercontl0.6 ofNeurospora crassa (OR74A) [DNA] 
3,102,391 - 3,102,921 + 
CACCAAGAGCATGACTTCATTGCACACCA 
GACTGAAGTCAGCAGAGAATCCGTTCACAAAGCCGACTGTCACTGGGCCTGG 
GATTGGAGCCCATCCCACTGACTTACGAACCTTGGCCAC~GTGTAGCG 
AGCCAAGGTTGAAAACTTTCAATATAAAGGATGAGTTGAATTGGGGAACTGA 
GGGAATGGCGACATCGGGTCATGTCGTGGTCTCGGCAGATACAfiihGAGCC 
ACCGAATGTATTCAGGAGTCTGTTTAATGATGTTACTACACCCAATACCTTCC 
TGATGCCAACATGAGTAAGGCAGTCAGGGTTGGAAGGCAAACTAAGTGTGTC 
CGTGGATAGCCTTGGGCTTATACATCTCCTCCAAATACTTCTCCTCCTCCACC 
GTTAAAACCTTGCCTCTAGCGGTGATTGCTTCTTCCAAACGCTCAACGCTGCT 
AAAACCAATGATTGGACTGATGACGCGCTTAGCAATC 
(http://www.broadinstitute.org/annotation/genome/neurospora/Regions.html) 
Forward Primer (RCF5): GCGAATTGGAAATCTCCAAGGG 
Reverse Primer (RCR5): ATCTCCCACGTAGCCTTGGCTT (reverse & complement of 
green) 
FORWARD: 22nt, GC: 50%, Tm: 69.62 
REVERSE: 22nt, GC: 54.55%, Tm: 69.08 
SNP location: 3,102,537 
Taqal enzyme cuts at TCGA: cut in OR (TCGA); uncut in MV (TCAA) 
Size of OR sequences: 146, 107, 278 bp; Size ofMV sequences: 253, 278 bp 
Total CAPS marker size: 531 bp 
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Polymerase Chain Reaction (PCR): 
Primer Preparation: 
Centrifuge primer tubes several times to collect primers (about 10 sec. x 2 times). Use 
"nmoles" amount on Invitrogen or IDT invoice that arrives with primers, add this amount 
(in µL) of sterile TE Buffer (nmole concentration). Mix well and centrifuge to collect 
primers. Dilute primers to 10 pmol concentration for PCR (99 µL dd H20 + 1 µL of 
primer = 10 pmol). 
PCR recipes: 
Table Al. 
PCR recipe using Taq DNA polymerase. 
PCRRecipe More than -12 samples Less than -12 samples 
Taq IOX Thermopol Buffer 2 µL 2 µL 
Water (sterile, dd H20) 14.52 µL 13.8 µL 
dNTP Mix (from NEB) 0.4 µL 0.4 µL 
Taq Polymerase 0.08 µL 0.8 µL (diluted*) 
Forward primer (10 pmol) 1 µL 1 µL 
Reverse primer (10 pmol) 1 µL 1 µL 
DNA template (50 ng/µL 1 µL 1 µL 
concentration) 
20 µL total 20 µL total 
*diluted Taq Polymerase: If using a small number of samples, it is difficult to measure 
out 0.08 µL per tube. Dilute 1 µL of IOX Buffer+ 9 µL water= 10 µL of IX Buffer. 
Take 1 µL Taq Polymerase+ 9 µL of IX Buffer= 10 µL of Diluted Taq Polymerase. 
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Mix first 4 ingredients in this order: water, Taq Buffer, dNTP, and Taq Polymerase. Add 
1 µLeach of Forward primer, Reverse primer and DNA template to each sample, mix 
gently. 
Table A2. 
PCR recipe using Takara LA Taq polymerase. 
PCRRecipe 
LA Taq lOX Buffer 5 µL 
Water (sterile, dd H20) 15 µL 
LA dNTP 8 µL 
Takara LA Taq Polymerase 1 µL 
Forward primer (10 pmol) 10 µL 
Reverse primer (10 pmol) 10 µL 
DNA template (stock concentration; should 1 µL 
be at least 50 ng/µL) 
50 µL total 
Mix first 4 ingredients in this order: water, LA Taq Buffer, LA dNTP, and LA Taq 
Polymerase. Add Forward primer, Reverse primer and DNA template to each sample, 
mix gently. 
PCR conditions: 
Table A3. 
PCR conditions using Taq DNA Polymerase. Conditions are based on NEB "Taq 
Polymerase" PCR Manual. 
Step Temperature Time 
Initial DNA Step 1 94 °C 3 min 
denaturing 
DNA denature Step 2: i) 94 °C 15 sec 
(26-35 cycles) (for a DNA fragment less than 1000 
196 
bp; for 1 kb or more use 30 sec - 1 
min) 
Primer annealing Varies* 15 sec 
ii) (for fragment less than 1000 bp; for 1 
kb or more use 30-45 sec) 
Strand extension 72 °C 1 min 
iii) (typically 1 min per 1 kb; use 
minimum 1 min for smaller fragments) 
Final extension Step 3 72 °C 5 min 
(for less than 1000 bp, for more use 10 
min) 
Storage Step 4 4°C infinitely 
*Step 2 annealing temperature: Use the actual "Tm, 50 mM Na+/NaCl" value in the 
Invitrogen or IDT invoice from both primers (not the calculated Tm). Optimal annealing 
temperature is 3-5 °C less than the primer with the lowest Tm. 
Table A4. 
PCR conditions using Takara LA Taq polymerase. Conditions are based on Takara "LA 
Taq Polymerase" PCR Manual 
Step Temperature Time 
Initial DNA Step 1 94°C 3 min 
denaturing 
DNA denature Step 2: i) 94 °C 15 sec 
(26-35 cycles) (for a DNA fragment less than 1000 
bp; for 1 kb or more use 30 sec - 1 
min) 
Primer annealing Varies** 1 min 
and extension* ii) (for "2-step" PCR, use 1 min per kb) 
Final extension Step 3 72 °C 5 min 
(for less than 1000 bp, for more use 10 
min) 
Storage Step4 4°C infinitely 
197 
Appendix IV 
*Primer annealing and extension are combined in one step, as recommended by Takara 
LA Taq PCR manual. "3-step" PCR using a 72 °C extension (see Table A3) will also 
work. 
**Step 2 annealing temperature: Use the actual "Tm, 50 mM Na+/NaCl" value in the 
Invitrogen or IDT invoice from both primers (not the calculated Tm). Optimal annealing 
temperature is 3-5 °C less than the primer with the lowest Tm. 
Restriction Enzymes: 
Table AS. 
Restriction enzymes used in digestion of UV90 progeny 
Restriction Enzymes 
Restriction Eco RI Taqa.1 Hae III Mspl Msel 
Enzyme 
Recipe 
Water 14.5 µL 14.3 µL 14 µL 14.5 µL 13.8 µL 
(sterile, dd 
H20) 
Restriction 2 µL 2 µL 2 µL 2 µL 2 µL 
Enzyme 
Buffer* 
Restriction 0.5 µL 0.5 µL 1 µL 0.5 µL 1 µL 
Enzyme** 
DNA-PCR 3 µL 3 µL 3 µL 3 µL 3 µL 
product 
BSA -- 0.2 µL -- -- 0.2 µL 
(optional) 
Incubation 37 65 37 37 37 
temperature 
(oC) 
20 µL 20 µL 20µL 20 µL 20µL 
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*All enzymes used Buffer #4 with the exception of Eco RI, which uses Eco RI Buffer. 
**Restriction Enzyme amount depends on enzyme concentration. For a concentration of 
10,000 units/mL (U/mL), use 1 µL per sample, for 20,000 U/mL, use 0.5 µL per sample. 
Mix first 4 ingredients in this order: Water, Restriction Enzyme Buffer, Restriction 
Enzyme, and BSA (optional). Add 3 µL of PCR product to each sample, mix gently. 
Incubate samples in a water bath at incubation temperature for 1.5 hours. 
Gel Electrophoresis: 
lOX TAE Buffer: 
48.4 g Tris 
3. 72 g EDT A, disodium salt, dihydrate 
11.4 mL acetic acid 
Measure out,..., 600 mL dd H20 into a beaker. Add, with stirring: Tris, EDTA, and acetic 
acid one at a time. Make sure each is dissolved fully before adding the next. Adjust pH 
to 8.0. Pour into a graduated cylinder and add water for a final volume of 1 L. 
Gel Preparation: 
Table A6. 
Recipes for preparation of agarose gels 
Small Gel (30 mL) Laree Gel (150 mL) 
IX TAE Buffer 3 mL lOXTAE 1 X T AE Buffer 15 mL IOXTAE 
buffer + 27 mL buffer+ 135 mL 
water water 
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Agarose (l.5%) 0.45 g Agarose (1.5%) 2.25 g 
Ethidium Bromide EB: 0.9 µL Ethidium Bromide EB: 4.5 µL 
(3%) OR Gel Red* Gel Red: 3 µL (3%) OR Gel Red* Gel Red: 15 µL 
*Gel Red is strongly preferred as it is not a carcinogen 
Mix appropriate amount of 1 OX TAE buffer and water to get IX T AE buffer and add 
agarose. 
Heat in microwave, swirling often, until agarose is well dissolved. Let cool until warm 
and add Gel Red. Swirl gently until thoroughly combined and pour into gel mold with 
combs. Let stand for 20-30 min until set. 
Running Buffer: 
Prepare IX T AE Running Buff er and pour into electrophoresis box with prepared gel. 
Ensure entire gel is submerged and covered approximately 0.5 cm. Small gel boxes (30 
mL gels) use approximately 250 mL IX TAE buffer (25 mL lOX TAE + 225 mL water). 
Large gel boxes (150 mL gels) use approximately 1000 mL IX TAE buffer (100 mL lOX 
TAE + 900 mL water). 
Preparing & Loading Samples: 
Table A7. 
Recipes for gel electrophoresis loading with PCR and restriction enzyme products 
Small Gel- Small Gel- Small Gel-
undi2ested samples digested samples Ladder 
6X 2µL 6X Loading 3 µL 6X Loading I µL 
Loading Dye Dye 
Dye 
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(NEB) 
PCR 10 µL PCR 15 µL Ladder* 1 µL 
product product 
- - - -
Water (sterile, 4µL 
dd H20) 
Total 12 µL 18 µL 6µL 
Large Gel- Large Gel- Large Gel-
undh~ested samples di2ested samples Ladder 
6X 2 µL 6X Loading 4µL 6X Loading 1 µL 
Loading Dye Dye 
Dye 
(NEB) 
PCR 10 µL PCR 20 µL Ladder* 1 µL 
product product 
- - - -
Water (sterile, 4µL 
dd H20) 
12 µL 24µL 6µL 
*Use either 100 hp ladder or 1 kb ladder (NEB), depending on size of DNA fragment 
For each sample, mix 6X Blue Loading Dye (NEB), PCR product, and water (optional) 
together in a PCR eppendorf tube. PCR product amounts can be altered from the above 
values as long as 6X loading dye is diluted to a final concentration of 1 X. 
Load samples and dye into agarose gel wells (covered with 1 X T AE running buff er) 
closest to the negative (black) anode. Attach electrodes and run until loading dye has 
moved about halfway down the agarose gel. Small gels (30 mL) use 70 Volts for ,.., 30 
minutes. Large gels (150 mL) use 80-100 Volts for 45-60 minutes. 
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Sequence ofNCU05950 and primers for creation of"AD" CAPS marker for 
Neurospora transformation 
CCGGATGACTTCATCTTCCCTGTTGAACTCGTGGTCCGTTCCTGATGATTCAA 
TCCTTGTAGTGTACATATACCTAGGTACATAGGTAGTTGAAGGTGTTTTTGGT 
TGGGTGATCAACCACTGATCGATGTGAGTGACAGACTCGTGCGACTGACAGA 
TCACTGTACATAGCGCACATTAGCGACCAAACAAGGTTAAAATGGCGTATAA 
GTGCGCATTGACCAACTGTTTCTACCACCCACCAGGACAGCAGCGCCTTGGT 
AGGCTGATGAGGCTAGAGGCTAGAGGTAGTCTGGATAGCCGCACGTGCACTC 
GCGCCTGCTGTTCAGCCCCAGGGCCACACAGCACACACAGGGTTCGCTAGAG 
TTCGTTGGGCTCTGGCGCCTGTACACTAGCAAAAGTTTTGCCGGAGGCGGCTG 
AATAAGGCACGAGCAAGGATGAACCAACCAGATGACCGCTCCAAATCTTGC 
GTCGGTGGATTTTTAGCCGCACATGGCAGGCGCATTGAA 
CCGTGACACATTTGTTGCTGCAATCACCAATTCAATTCAATACGCGACCGAGA 
AGACCTTGTGCTGGGCTCCAGTTGCGGGAAGGAACGCCTGGAAATGAGTCGG 
GGCGCGTTGAAATTTGGAAACAGCGACGACGACGATCGATATCGATAAGGAC 
AACTTTCCCTAGGTTCCTTGGGTTCCCTTATCCCGTCATTCATCCCTACCTAGG 
TCCTGCCTCACCTCGCGCAATCATCGCCCGATTCCAAGCCGACGGCCGACCA 
CATTTCGGGACACTGCAGCAAGTCCATCGCGACACATTCCTTCCTTTGCCTGA 
TGAACCGACCTCGCTAGCAGTCCCCTCCCCCGCGGGCACCCGACAGAAGCCG 
AAGCAACTCGACTAAACCAGCACCACAAGCCATTTTCACGACGGGACCCAAC 
TTTTTTTTTTTTTTTTTTTTGGTTTTTTTTTTGTCGGTCTGATCTCATTTCGTCAT 
CGATCGAGTTTCATCTCTTCGCGACGGTCTTTTCTCCCAACTTTACTTCGA 
CGACGTCTGGCTTCAAGACGAGACTTTTTCTTGTCGCTTCGCGCIJ ift 
CAATTGACAAACGTCATCCGACGACTTGATACCGACCGACCGACCGACC 
ACCATCCGACTGGCGACACGGCACATAAAGAAGGGAGGACAAGATAACA 
AGATGGGCAACTTTTGCTCAACCTGCTTCGGCGGTAGGAGGAGCGATGA 
CTACGATGAGGTAGGTTTCGGCATAGCGGCCACAGTCCGATGACATGGC 
CATCAAAAGAGGCATTCGACGGAACAAGAGAACTGACGTGGACTGTTGC 
GTGACACAGGAGGACGAGGCCCAGCATCTCTTCGACGAGAACAACATGC 
ACTACGGGAGCTTTGATCAGCAACACATGATGAACCAGGAAGATCCCCA 
AGAGACAGAAAGGGAAATTGCGGCTCTGCAGGGCGTGGTGGAACGCAC 
ATCAAAGTATGCCCTCCCACCTGAAATGTCTCCCATCCAAGATCTAGTCC 
TGCAGGACGCTCCTGCTCCCTACGGCTTTGCCAACCAGCGCTACAATGC 
CCTGCTTTCCAAGCTCTCAACCCACGATGACATGGCCGCCGTTGCACGG 
GTTGACTGGGGCACCCCTGAGGACGACAGCATGGAGATGCTGCGCAAA 
GCTTCCTTGCCAACCATCCCCATCAAGGCTGAAGGAGGCGAGGCCCTCG 
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TCGGTAACTTTACCGATGCCGCTGCCGCCATGCGCTGAAACCATACCAC 
GACACCAAAACCATGACTTGCTGTCTATACCCTATCCACCTGATGCCGACA 
GCAACATGACAGAACATCCACAGTATCCTCCGACCCAGAATATACCACACCA 
TACGTTCATCAAACCAGAACCATCTGACACAACAATAACTCCGGGACTCCTT 
GGCCATGCCGATACGAGGTGGCATGCCCAAGTTCGCTTGGCCGGTTTCCCCC 
ATCATATTTTCCTTTTGTAATTTCTCGTCTTTCCTGATGCTGTTCCGGAAACAG 
CGGGCGTTCAGC---GATAGGTCTGCGGCCAGAGACAACGTGGCATGGC 
AGGATGTTATGTTGATGAGTTGTCGATACCCGTCGAGGTGGGATACAGCATC 
CATTCGTCTCATACATCACCGCTTCGTATGCCCAAGTTGTTGGATAAGGCCAA 
GGATAGGCTTAAAAACGGCGTGTCTGGGGGTATGTATGCGTTGTACAGCAAC 
AATCCAATTTAATGCTTTCCTTTGTTCAATGACTGGATCAGTGCTGTTTGGAC 
CAACCCATGGTGGTGTAGTCCTCCGGCCCCCAACAAACAAAATGTTGACAAG 
GCGCGCGCCCACTAAATGTCAGCCACGTTCATCAAGTTCCGTTTTCTTGCCCA 
TTGTCAAAGATATAA CCCTTTGCACAAA 
ACTGACCCTTGTTTAATGCTTGTATAGAAACACCGCGTTTCCATCGGTGGTGG 
ACATGATCCGAGATGCGACCACAGCCATTT 
(http://www.broadinstitute.org/annotation/genome/neurospora/Regions.html) 
Bold, underlined area= location ofNCU05950 (putative UV90 gene): 3,347,867-
3,348,756 
Extra adenine (A) will be inserted at #--into the primer sequence to create a second 
EcoRI restriction enzyme size 
1) Two pieces: "AB" and "CD" created using overlapping primers with an extra 
adenine 
F4-> "AB" 
<- Rev2B-NCU05950 
For2C-NCU05950 -> 
"CD" <-R4 
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2) Final "AD" piece created with the extra adenine using "AB" and "CD" as 
templates 
F4-> 
GAATTC 
Overlapping primers with extra adenine (A): 
Forward (For2C-NCU5950): 
TCAGCGAATTCGATAGGTCTGCGGCCAG 
27nt; GC = 59.26%; Tm= 79.48 
Reverse (Rev2B-NCU5950): 
CTGGCCGCAGACCTATCGAATTCGCTGA 
27nt; GC = 59 .26%; Tm = 79 .48 
Wild type csp-1; chol-1 bd; frq1° (#80): 1081 hp, 1550 hp (with EcoRI digestion) 
With mutagenic primers: 1081hp, 1062hp, 488hp (with EcoRI digestion) 
Additional overlapping primers designed which were unsuccessful and not used in 
the transformation: 
Forward (ForC-NCU5950): 
GCGTTCAGCGAATTCGATAGGT 
21nt; GC = 52.38%; Tm= 67.6 
Reverse (RevB-NCU5950): 
ACCTATCGAATTCGCTGAACGC 
21nt; GC = 52.38%; Tm= 67.6 
Forward (For3C-NCU5950) 
CTTTCCTGATGCTGAATTCCGGA 
21nt; GC = 52.38%; Tm= 68.76 
Reverse (Rev3B-NCU5950): 
TCCGGAATTCAGCATCAGGAAAG 
21nt; GC = 52.38%; Tm= 68.76 
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Extra primers to test for presence of" AD" CAPS marker after transformation: 
F3: 
21 nt; GC = 52.38%; Tm= 68.38 
AD-Rp: 
21 nt; GC = 52.38%; Tm= 67.91 
Entire piece: 968bp; After EcoRI digestion: 577, 391 hp 
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Neurospora transformation: 
Minimal medium for transformation: 
2 mL 50XNogel's stock 
1.5 mL choline (2 mg/mL) 
1.5 g sucrose 
1.5 g agar 
lOOmLddH20 
Green or blue food colouring, optional 
Mix all ingredients together and sterilize. Use 100 mL per flask. Swirl flask after 
sterilizing to encourage growth on the sides of the flask. 
Sorbitol (lM): 
182.17 g sorbitol 
Dissolve sorbitol in ~ 700 mL of dd H20. Add water to make 1 L and sterilize. 
Bottom agar: 
91 g sorbitol 
10 mL 50XNogel's stock 
7.5 mL choline (2 mg/mL) 
14 g agar 
206 
Appendix VI 
50mLFIGS 
2 mL Hygromycin B (50 mg/mL), final concentration 0.2 mg/mL (Invitrogen) 
Dissolve sorbitol, 50X and choline in ---350 mL dd H20 and top up to 450 mL. Add agar 
and autoclave. Add FIGS and hygromycin B. Use 20 mL per small (8.5 cm) Petri plate. 
Top agar: 
50mLddH20 
2 mL 50X/Vogel's stock 
1.5 mL choline (2 mg/mL) 
1.8 g sorbitol 
0.5 g agar 
lOmLFIGS 
Mix water, 50X, choline and sorbitol. Top up to 90 mL. Add agar and autoclave. Add 
FIGS. Use 5 mL per small (8.5 cm) Petri plate. 
FIGS: 
10 g sorbose 
0.25 g fructose 
0.25 g glucose 
50 mL water 
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Mix all ingredients together, autoclave and cool. 
Recovery medium: 
0.2 mL 50XNogel's stock 
1.82 g sorbitol 
9mLddH20 
150 µL choline (2 mg/mL) 
1 mL FIGS 
Mix together SOX, sorbitol, water and choline. Autoclave, cool and add FIGS. 
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SOU SOC 51U SIC S7U 57C 67U 67C 68U 68C 71U 71C 74U 74C 100 bp 
ladder 
78U 78C 81U 81C 83U 83C 87U 87C UV90 MV 100 bp 
I kb 
500 bp 
1 kb 
500 bp 
Figure Al. PCR results from csp-1; bd; UV90 progeny #50-87 using F9-R9 primers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with Taqal restriction enzyme. 
"Cut" OR DNA exhibits two overlapping bands, each -250 bp in size. "UV90" (csp-1; 
bd; UV90) and "MV" (Mauriceville, esp+; bd+; UV+) served as controls. 
#83 and #87 resembled MV, and were determined to be recombinants. 
209 
A 
B 
Appendix VII 
3U 3C 5U 5C 6U 6C SU 8C 15U 15C 23U 23C 28U 28C 29U 29C 1 kb 
31U 31C 32U 32C 35U 35C 36U 36C 41U 41C 48U 48C UV90 MV 1 kb 
6U 6C 28U 28C UV90 MV 1 kb 
2 kb 
1.5 kb 
1 kb 
500 hp 
Figure Al. PCR results from csp-1; bd; UV90 progeny #3-48 using F6-R6 primers. 
U ="uncut", undigested DNA; C ="cut", DNA digested with EcoRI restriction enzyme. 
"UV90" (csp-1; bd; UV90) and "MV" (Mauriceville, esp+; bd+; UV+) served as 
controls. Most progeny resembled UV90 control after digestion with the exception of #5, 
#6 and #31 which resembled MV, and thus were determined to be recombinants. #6 and 
#28 were repeated in (B). 
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LALIGN Outputs for Neurospora crassa NCU05950 sequencing 
(http://embnet.vital-it.ch/software/ LALIGN_form.html) 
lalign output for Oak Ridge wt vs. UV90 F6 primer 
LALIGN finds the best local alignments between two sequences version 2.1 u09 
December 2006 Please cite: X. Huang and W. Miller (1991) Adv. Appl. Math. 12:373-
381 resetting to DNA matrix alignments< E( 0.05):score: 65 (50 max) 
Comparison of: 
(A) ./wwwtmp/.3903.1.seq Oak Ridge wt 506 bp 
506 nt 
(B) ./wwwtmp/.3903.2.seq UV90 F6 primer 206 bp 
206 nt 
using matrix file: DNA (5/-4), gap-open/ext: -14/-4 E(limit) 0.05 
100.0% identity in 204 nt overlap (54-257:3-206); score: 1020 E(lOOOO): 
1. 3e-77 
60 70 80 90 100 110 
Oak AGGGCCACGGTGTATTATCCGAGGCATACGGTCGATCAGTCGGTCGATCATAATGGTGTG 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 AGGGCCACGGTGTATTATCCGAGGCATACGGTCGATCAGTCGGTCGATCATAATGGTGTG 
10 20 30 40 50 60 
120 130 140 150 160 170 
Oak CGCCCGGGGACAGCGCTGTAGTGAGTTGGTGCACGATTTTGAGAAGGAACAGGAACACCT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 CGCCCGGGGACAGCGCTGTAGTGAGTTGGTGCACGATTTTGAGAAGGAACAGGAACACCT 
70 80 90 100 110 120 
180 190 200 210 220 230 
Oak CTCGTATAACAAACAAGAGGATTGGGGACTAAGGATTTACGGTCGACGAGCTACACAGAG 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 CTCGTATAACAAACAAGAGGATTGGGGACTAAGGATTTACGGTCGACGAGCTACACAGAG 
130 140 150 160 170 180 
240 250 
Oak GCTCTTTTTTCTTTATACGTTTTC 
........................ 
. . . . . . . . . . . . . . . . . . . . . . . . 
UV90 GCTCTTTTTTCTTTATACGTTTTC 
190 200 
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lalign output for Oak Ridge wt vs. UV90 F5 primer 
LALIGN finds the best local alignments between two sequences version 2.lu09 
December 2006 Please cite: X. Huang and W. Miller (1991) Adv. Appl. Math. 12:373-
381 resetting to DNA matrix alignments< E( 0.05):score: 76 (50 max) 
Comparison of: 
(A) ./wwwtmp/.31701.1.seq Oak Ridge wt 966 b 
966 nt 
(B) ./wwwtmp/.31701.2.seq UV90 F5 primer 709 bp 
709 nt 
using matrix file: DNA (5/-4), gap-open/ext: -14/-4 E(limit) 0.05 
99.6% identity in 710 nt overlap (33-742:1-709); score: 3509 E(lOOOO): 
2.7e-284 
40 50 60 70 80 90 
Oak GTTCCCCGCAAAAAAGATGCCAATCTCGGCTGTGACACTCGTCGACTTGAACGAGTTCCA 
.......................................................... 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 GTTCGCCGCAAAAA-GATGCCAATCTCGGCTGTGACACTCGTCGACTTGAACGAGTTCCA 
10 20 30 40 50 
100 110 120 130 140 150 
Oak GCCCTGATGTTGATGGTAAAGCTCCATTTTCGCAGTCTCCGATAGCAGCACGTATCATTT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 GCCCTGATGTTGATGGTAAAGCTCCATTTTCGCAGTCTCCGATAGCAGCACGTATCATTT 
60 70 80 90 100 110 
160 170 180 190 200 210 
Oak ATCGCAACATGTTTCCATGTTTTCGCCATGTGCAGACGTTGCAACGTGAAAATATAACCC 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 ATCGCAACATGTTTCCATGTTTTCGCCATGTGCAGACGTTGCAACGTGAAAATATAACCC 
120 130 140 150 160 170 
220 230 240 250 260 270 
Oak GAGTCGACGGGAACCCGACGAGATGGAACTCCATGATGGGCATCGGCATGGACCCAAGTC 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 GAGTCGACGGGAACCCGACGAGATGGAACTCCATGATGGGCATCGGCATGGACCCAAGTC 
180 190 200 210 220 230 
280 290 300 310 320 330 
Oak ACAGTGGGACTTCCAGGGCAATAGTGTACCGCAAAGTCGGGTCGCTTCCACTATCAGGGC 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 ACAGTGGGACTTCCAGGGCAATAGTGTACCGCAAAGTCGGGTCGCTTCCACTATCAGGGC 
240 250 260 270 280 290 
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340 350 360 370 380 390 
Oak AGTAAGTCCGAAGTCCGGTGAGCTCCGCACCGGGGCTTCCTTGTCTAGAACACTCATCAA 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 AGTAAGTCCGAAGTCCGGTGAGCTCCGCACCGGGGCTTCCTTGTCTAGAACACTCATCAA 
300 310 320 330 340 350 
400 410 420 430 440 450 
Oak TCAGCAAGTTGAGACGTTTCAGCAGAAATGATGACGGGACATTTCCGGATGACTTCATCT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 TCAGCAAGTTGAGACGTTTCAGCAGAAATGATGACGGGACATTTCCGGATGACTTCATCT 
360 370 380 390 400 410 
460 470 480 490 500 510 
Oak TCCCTGTTGAACTCGTGGTCCGTTCCTGATGATTCAATCCTTGTAGTGTACATATACCTA 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 TCCCTGTTGAACTCGTGGTCCGTTCCTGATGATTCAATCCTTGTAGTGTACATATACCTA 
420 430 440 450 460 470 
520 530 540 550 560 570 
Oak GGTACATAGGTAGTTGAAGGTGTTTTTGGTTGGGTGATCAACCACTGATCGATGTGAGTG 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 GGTACATAGGTAGTTGAAGGTGTTTTTGGTTGGGTGATCAACCACTGATCGATGTGAGTG 
480 490 500 510 520 530 
580 590 600 610 620 630 
Oak ACAGACTCGTGCGACTGACAGATCACTGTACATAGCGCACATTAGCGACCAAACAAGGTT 
........................................................... 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 ACAGACTCGTGCGACTGACAGATCACTGTACATAGCGCACATTAGCGACCAAGCAAGGTT 
540 550 560 570 580 590 
640 650 660 670 680 690 
Oak AAAATGGCGTATAAGTGCGCATTGACCAACTGTTTCTACCACCCACCAGGACAGCAGCGC 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 AAAATGGCGTATAAGTGCGCATTGACCAACTGTTTCTACCACCCACCAGGACAGCAGCGC 
600 610 620 630 640 650 
700 710 720 730 740 
Oak CTTGGTAGGCTGATGAGGCTAGAGGCTAGAGGTAGTCTGGATAGCCGCAC 
.................................................. 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
UV90 CTTGGTAGGCTGATGAGGCTAGAGGCTAGAGGTAGTCTGGATAGCCGCAC 
660 670 680 690 700 
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lalign output for Oak Ridge wt vs. 213 F6 primer 
LALIGN finds the best local alignments between two sequences version 2.1 u09 
December 2006 Please cite: X. Huang and W. Miller (1991) Adv. Appl. Math. 12:373-
381 resetting to DNA matrix alignments< E( 0.05):score: 76 (50 max) 
Comparison of: 
(A) ./wwwtmp/.25499.1.seq Oak Ridge wt 964 bp 
964 nt 
(B) ./wwwtmp/.25499.2.seq 213 F6 primer 703 b 
703 nt 
using matrix file: DNA (5/-4), gap-open/ext: -14/-4 E(limit) 0.05 
99.7% identity in 704 nt overlap (46-749:1-703); score: 3488 
E(lOOOO): 1.5e-282 
50 60 70 80 90 100 
Oak ATCCGTCAAGGGCCACGGTGTATTATCCGAGGCATACGGTCGATCAGTCGGTCGATCATA 
........................................................... 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 ATCCGTCA-GGGCCACGGTGTATTATCCGAGGCATACGGTCGATCAGTCGGTCGATCATA 
10 20 30 40 50 
110 120 130 140 150 160 
Oak ATGGTGTGCGCCCGGGGACAGCGCTGTAGTGAGTTGGTGCACGATTTTGAGAAGGAACAG 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 ATGGTGTGCGCCCGGGGACAGCGCTGTAGTGAGTTGGTGCACGATTTTGAGAAGGAACAG 
60 70 80 90 100 110 
170 180 190 200 210 220 
Oak GAACACCTCTCGTATAACAAACAAGAGGATTGGGGACTAAGGATTTACGGTCGACGAGCT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GAACACCTCTCGTATAACAAACAAGAGGATTGGGGACTAAGGATTTACGGTCGACGAGCT 
120 130 140 150 160 170 
230 240 250 260 270 280 
Oak ACACAGAGGCTCTTTTTTCTTTATACGTTTTCAAGCTTCATGTATCAAAGATTTGCATGT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 ACACAGAGGCTCTTTTTTCTTTATACGTTTTCAAGCTTCATGTATCAAAGATTTGCATGT 
180 190 200 210 220 230 
290 300 310 320 330 340 
Oak CTTATGGTGTTGGCGTGGGTGTTGAAAGGAAGGAATGGGATGAGATTGGAGCATTTATGT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 CTTATGGTGTTGGCGTGGGTGTTGAAAGGAAGGAATGGGATGAGATTGGAGCATTTATGT 
240 250 260 270 280 290 
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350 360 370 380 390 400 
Oak AAAGTTAGGATATACCCTTAATGTTTTATCTCGTCATTCTTCTCAGTCGTAAATGTCAAA 
.............................................................. 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 AAAGTTAGGATATACCCTTAATGTTTTATCTCGTCATTCTTCTCAGTCGTAAATGTCAAA 
300 310 320 330 340 350 
410 420 430 440 450 460 
Oak AATCGAAGTGGCCTCATCACTCTGATATGCTTGCGACAAGAGCCGAGTGCAGTGTGTAGT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 AATCGAAGTGGCCTCATCACTCTGATATGCTTGCGACAAGAGCCGAGTGCAGTGTGTAGT 
360 370 380 390 400 410 
470 480 490 500 510 520 
Oak AGAGGGCCGTGAAGCCCGAGGAACCTCCGAAGAAAGGAAGGAAAGCCCAGACCGTCACCT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 AGAGGGCCGTGAAGCCCGAGGAACCTCCGAAGAAAGGAAGGAAAGCCCAGACCGTCACCT 
420 430 440 450 460 470 
530 540 550 560 570 580 
Oak GTGGAGTTTAAAGGTTCCCCGCAAAAAAGATGCCAATCTCGGCTGTGACACTCGTCGACT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GTGGAGTTTAAAGGTTCCCCGCAAAAAAGATGCCAATCTCGGCTGTGACACTCGTCGACT 
480 490 500 510 520 530 
590 600 610 620 630 640 
Oak TGAACGAGTTCCAGCCCTGATGTTGATGGTAAAGCTCCATTTTCGCAGTCTCCGATAGCA 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 TGAACGAGTTCCAGCCCTGATGTTGATGGTAAAGCTCCATTTTCGCAGTCTCCGATAGCA 
540 550 560 570 580 590 
650 660 670 680 690 700 
Oak GCACGTATCATTTATCGCAACATGTTTCCATGTTTTCGCCATGTGCAGACGTTGCAACGT 
........................................................... 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GCACGTATCATTTATCGCAACATGTTTCCATGTTTTCGCCATGTGCAGACGTTGCAGCGT 
600 610 620 630 640 650 
710 720 730 740 
Oak GAAAATATAACCCGAGTCGACGGGAACCCGACGAGATGGAACTC 
............................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GAAAATATAACCCGAGTCGACGGGAACCCGACGAGATGGAACTC 
660 670 680 690 700 
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lalign output for Oak Ridge wt vs. 213 F5 primer 
LALIGN finds the best local alignments between two sequences version 2.1 u09 
December 2006 Please cite: X. Huang and W. Miller (1991) Adv. Appl. Math. 12:373-
381 resetting to DNA matrix alignments< E( 0.05):score: 75 (50 max) 
Comparison of: 
(A) ./wwwtmp/.9973.1.seq Oak Ridge wt 966 bp 
966 nt 
(B) ./wwwtmp/.9973.2.seq 213 F5 primer 626 bp 
626 nt 
using matrix file: DNA (5/-4), gap-open/ext: -14/-4 E(limit) 0.05 
99.8% identity in 627 nt overlap (19-645:1-626); score: 3112 
E(lOOOO): 3e-251 
20 30 40 50 60 70 
Oak TGTGGAGTTTAAAGGTTCCCCGCAAAAAAGATGCCAATCTCGGCTGTGACACTCGTCGAC 
........................................................... 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 TGTGGAGTTTAA-GGTTCCCCGCAAAAAAGATGCCAATCTCGGCTGTGACACTCGTCGAC 
10 20 30 40 50 
80 90 100 110 120 130 
Oak TTGAACGAGTTCCAGCCCTGATGTTGATGGTAAAGCTCCATTTTCGCAGTCTCCGATAGC 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 TTGAACGAGTTCCAGCCCTGATGTTGATGGTAAAGCTCCATTTTCGCAGTCTCCGATAGC 
60 70 80 90 100 110 
140 150 160 170 180 190 
Oak AGCACGTATCATTTATCGCAACATGTTTCCATGTTTTCGCCATGTGCAGACGTTGCAACG 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 AGCACGTATCATTTATCGCAACATGTTTCCATGTTTTCGCCATGTGCAGACGTTGCAACG 
120 130 140 150 160 170 
200 210 220 230 240 250 
Oak TGAAAATATAACCCGAGTCGACGGGAACCCGACGAGATGGAACTCCATGATGGGCATCGG 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 TGAAAATATAACCCGAGTCGACGGGAACCCGACGAGATGGAACTCCATGATGGGCATCGG 
180 190 200 210 220 230 
260 270 280 290 300 310 
Oak CATGGACCCAAGTCACAGTGGGACTTCCAGGGCAATAGTGTACCGCAAAGTCGGGTCGCT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 CATGGACCCAAGTCACAGTGGGACTTCCAGGGCAATAGTGTACCGCAAAGTCGGGTCGCT 
240 250 260 270 280 290 
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320 330 340 350 360 370 
Oak TCCACTATCAGGGCAGTAAGTCCGAAGTCCGGTGAGCTCCGCACCGGGGCTTCCTTGTCT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 TCCACTATCAGGGCAGTAAGTCCGAAGTCCGGTGAGCTCCGCACCGGGGCTTCCTTGTCT 
300 310 320 330 340 350 
380 390 400 410 420 430 
Oak AGAACACTCATCAATCAGCAAGTTGAGACGTTTCAGCAGAAATGATGACGGGACATTTCC 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 AGAACACTCATCAATCAGCAAGTTGAGACGTTTCAGCAGAAATGATGACGGGACATTTCC 
360 370 380 390 400 410 
440 450 460 470 480 490 
Oak GGATGACTTCATCTTCCCTGTTGAACTCGTGGTCCGTTCCTGATGATTCAATCCTTGTAG 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GGATGACTTCATCTTCCCTGTTGAACTCGTGGTCCGTTCCTGATGATTCAATCCTTGTAG 
420 430 440 450 460 470 
500 510 520 530 540 550 
Oak TGTACATATACCTAGGTACATAGGTAGTTGAAGGTGTTTTTGGTTGGGTGATCAACCACT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 TGTACATATACCTAGGTACATAGGTAGTTGAAGGTGTTTTTGGTTGGGTGATCAACCACT 
480 490 500 510 520 530 
560 570 580 590 600 610 
Oak GATCGATGTGAGTGACAGACTCGTGCGACTGACAGATCACTGTACATAGCGCACATTAGC 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GATCGATGTGAGTGACAGACTCGTGCGACTGACAGATCACTGTACATAGCGCACATTAGC 
540 550 560 570 580 590 
620 630 640 
Oak GACCAAACAAGGTTAAAATGGCGTATA 
........................... 
. . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GACCAAACAAGGTTAAAATGGCGTATA 
600 610 620 
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lalign output for Oak Ridge wt vs. 213 Fl primer 
resetting to DNA matrix alignments < E( 0.05):score: 70 (50 max) 
Comparison of: 
(A) ./wwwtmp/.31701.1.seq Oak Ridge wt 609 bp 
609 nt 
(B) ./wwwtmp/.31701.2.seq 213 Fl primer 398 bp 
398 nt 
using matrix file: DNA (5/-4), gap-open/ext: -14/-4 E(limit) 0.05 
99.2% identity in 398 nt overlap (31-428:1-398); score: 1963 E(lOOOO): 
7.5e-156 
40 50 60 70 80 90 
Oak GAAGACCTTGTGCTGGGCTCCAGTTGCGGGAAGGAACGCCTGGAAATGAGTCGGGGCGCG 
........................................................... 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GAAGACCTTGTGCTGGGCTCCAGTTGCGGGAAGGAACGCCTGGAAATGAGCCGGGGCGCG 
10 20 30 40 50 60 
100 110 120 130 140 150 
Oak TTGAAATTTGGAAACAGCGACGACGACGATCGATATCGATAAGGACAACTTTCCCTAGGT 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 TTGAAATTTGGAAACAGCGACGACGACGATCGATATCGATAAGGACAACTTTCCCTAGGT 
70 80 90 100 110 120 
160 170 180 190 200 210 
Oak TCCTTGGGTTCCCTTATCCCGTCATTCATCCCTACCTAGGTCCTGCCTCACCTCGCGCAA 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 TCCTTGGGTTCCCTTATCCCGTCATTCATCCCTACCTAGGTCCTGCCTCACCTCGCGCAA 
130 140 150 160 170 180 
220 230 240 250 260 270 
Oak TCATCGCCCGATTCCAAGCCGACGGCCGACCACATTTCGGGACACTGCAGCAAGTCCATC 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 TCATCGCCCGATTCCAAGCCGACGGCCGACCACATTTCGGGACACTGCAGCAAGTCCATC 
190 200 210 220 230 240 
280 290 300 310 320 330 
Oak GCGACACATTCCTTCCTTTGCCTGATGAACCGACCTCGCTAGCAGTCCCCTCCCCCGCGG 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GCGACACATTCCTTCCTTTGCCTGATGAACCGACCTCGCTAGCAGTCCCCTCCCCCGCGG 
250 260 270 280 290 300 
340 350 360 370 380 390 
Oak GCACCCGACAGAAGCCGAAGCAACTCGACTAAACCAGCACCACAAGCCATTTTCACGACG 
............................................................ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
213 GCACCCGACAGAAGCCGAAGCAACTCGACTAAACCAGCACCACAAGCCATTTTCACGACG 
310 320 330 340 350 360 
218 
Appendix VIII 
400 410 420 
Oak GGACCCAACTTTTTTTTTTTTTTTTTTTTGGTTTTTTT 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..... . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..... . 
213 GGACCCAACTTTTTTTTTTTTTTTTTTTTTTTTTTTTT 
370 380 390 
BLAST searches at Broad Institute Neurospora crassa database 
(http://www.broadinstitute.org/annotation/ genome/neurospora/Blast.html) 
500 hp piece - #213 with Rl primer 
Tt:ur~et Score (Bits) r:x~ert Alignment Lengtlu Identities IPosiltives 
• N. crassa OR74'A (NC12}: Supercontig 2: 2046700-2046934 -
Score = 451.752 (227), Expect=O.O 
Identities=234/235 (99%), Positives=234/235 {99%) 
Query GGCAAACTTTCCTTTTTTCGACTCCCATGTTTCAAAATCCGCCACGAGGTCGGAGTCGTC 
I I 11111 11111 11 1111111111111 II 11 11 l 11 1111 11 11 11 11111 111111 111 
Sbjct GGCAAACTTTCCTTTTTTCGACTCCCATGTTTCAAAATCCGCCACGAGGTCGGAGTCGTC 
1 Query AAGAAGAGTGGTGTAGAAATCGCTTGTGGCAAGAATTTGCCCGCGCATTTGGACCCGATC 
111111111111111111111111111111111I11111111111111111111111111 
Sbjct AAGAAGAGTGGTGTAGAAATCGCTTGTGGCAAGAATTTGCCCGCGCATTTGGACCCGATC 
1
1 Query CCTTGTGCTCGCCACGGGTCCATCCGTAAGATTGGCGAGGCTGCGCCGTGAATGTCCCGT 
111111111111111111111111111111111 l I I I I I I I I I I I I I I I I I I I I I I I I I I 
lsbjct CCTTGTGCTCGCCACGGGTCCATCCGTAAGATTGGCGAGGCTGCGCCGTGAATGTCCCGT 
I 
!ouery GTTGTTGGCGGCGAAAATCAGCGCAAGAACCTGCGCCGAGGC-TTGATCTGCCAG 
I 111111111111111111111111111111111111111111 111111111111 
lsbjct GTTGTTGGCGGCGAAAATCAGCGCAAGAACCTGCGCCGAGGCTTTGATCTGCCAG 
I 
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500 hp piece - #213 with UV90BFor primer 
Target Sccre (BEtts) Expect Alignment Length Identities :Posittih;es 
..,. N. crassa OR74A (NC12): Supercontig 2: 2046531-2046681 + 
Score = 295.723 (147), Expect=O.O 
Identities=149/151 (98%), Positives=149/151 (98%) 
Query CCAGGCAATCCCGACGAACATCTAACACCAGGTGCTGCTGGATAACACGATGAGTCAAGA 
11111111J11111111111lIIJ1111J11111111111111J1111111111111111 
Sbjct CCAGGCAATCCCGACGAACATCTAACACCAGGTGCTGCTGGATAACACGATGAGTCAAGA 
Query TGCTGTTGAAAAAGGCGTCTCTTGCCTTGTCCTCCATCTGCCGCTTCGCGTCATATTCAA 
1111111111111!IIII111111111111111111111111111111J11111111111 
Sbjct TGCTGTTGAAAAAGGCGTCTCTTGCCTTGTCCTCCATCTGCCGCTTCGCGTCATATTCAA 
Query GGATTTGGATCTTGGCGCCTATGCTRASAAG 
1111111111111111,lllllllll I Ill 
Sbjct GGATTTGGATCTTGGCGCCTATGCTGAGAAG 
500 hp piece - UV90 with Rl primer 
Target S<t:ore ~Bats) IE:xpect Alignment length Identities Positives 
..,. N. crassa OR74A (NIC12): Supercontig 2: 2046766-2046899 -
Score = 239.874 (116), Expect=O.O 
Identities=l26/134 (94%), Positives=126/134 {94%) 
Query AGKGGTGTAGAAATKSCTTGTGGCAAGAATTTGCCCGCGCATTTGGACCCGATCCCTTGT 
II 11111111111 111111111111111111111111111,11111111111111111 
Sbjct AGTGGTGTAGAAATCGCTTGTGGCAAGAATTTGCCCGCGCATTTGGACCCGATCCCTTGT 
Query GCTCGCCACGGGTCCATCCGTAAGATTGGCGAGSCTGCGCCGYGAATGTCCCGTSYTGTT 
1111111111111111111111111111111'11 11111111 11111111111 1111 
Sbjct GCTCGCCACGGGTCCATCCGTAAGATTGGCGAGGCTGCGCCGTGAATGTCCCGTGTTGTT 
Query GGCGGCGAAMATCA 
I 11 I I 11 II I 111 
1sbjct GGCGGCGAAAATCA 
I 
I 
I 
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500 hp piece - UV90 with UV90BFor primer 
• N. crassa OR74A. (NC12): Sapercontig 2: 2046535-2046750 + 
Score= 412.154 {202), Expect=O.O 
Identities=209/216 (96%), Posi.tives=209/216 (96%) 
Query GCAATCCCGACGARCATCTAACACCAGGTGCTGCTGGATAACACGATRAGTCAAGATGCT 
1111111111111 11111111 1111111111111111111111111 111111111111 
Sbjct GCAATCCCGACGAACATCTAACACCAGGTGCTGCTGGATAACACGATGAGTCAAGATGCT 
Query GTTGAAAAAGGCGTCTCTTGCCTTGTCCTCCATCTGCCGCTTCGCGTCATATTCAAGGAT 
111111111111111111111111111111111111111111111111111111111II1 
Sbjct GTTGAAAAAGGCGT'CTCTTGCCTTGTCCTCCATCTGCCGCTTCGCGTCATATTCAAGGAT 
Query 'l'TGGATCTTGGCGCCTATGCTGASAAGGAAGGSAAACTGACAAAAGGCAAACTT"TCCTTT 
11111111111111111111111 11111111 111111111111111111111111111 
Sbj ct TTGGATCTTGGCGCCTA'I'GC'l'GAGAAGGAAGGGAAACTGACAAAAGGCAAACTT'TCCTTT 
Query TTTCGACTCCCMTGTTWCAAAATCCRCCACGAGGTC 
11111111111 1111 11111111 1111111111 
Sbjct TTTCGACTCCCATGTTTCAAAA.TCCGCCACGAGGTC 
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1 kb piece - #213 with R2 primer 
,.. N. crassa OR74A (NC12): Supercontig 6: 2654898-2655137 + 
Score = 463.295 {232), E~pect=O.O 
Identities=237/240 (98%), Positives=237/240 {98%) 
Query CAGGTATTCGACCACGTACCTGGTATCCGCAGGGGCATGGTCTAAAGTTACGATCAGAGA 
111111. 1111111111111111111111111111111111111111111.11111:J11. 1111 
Sbjct CAGGTATTCGACCACGTACCTGGTATCCGCAGGGGCATGGTCTAAAGTTACGATCAGAGA 
Query GATCAAACTCCTCGATACAGAGGGGGCTATAGTATACTAGTTAGTCTGATGTGT'TCTTGT 
I I I I I I. I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I ~ I I I I I I I I I I I 
Sbjct GATCAAACTCCTCGATACAGAGGGGGCTATAGTATACTAGTTAGTCTGATGTGTTCTTGT 
Query GGACGGCCGAGGGCGTTGTGACAGGGGGTCGGCTCGAGGCTGAGGAAGGCGGAGAGAGCA 
I I I I I Ii I I I I 1· I I I I 11 I I I I I I I I I I I I I I I I I I I I I ii I I I I I I I I I i I l I 111 I I I I I I 
Sbjct GGACGGCCGAGGGCGTTGTGACAGGGGGTCGGCTCGAGGCTGAGGAAGGCGGAGAGAGCA 
Query GGCATGACRAGGCCATGGAGGGGCAGGGGCAGTCGTCATGGATTCGGCTGGAGRWAGGTC 
I I I I I 11 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I ~ I I< I I I I I I I I I I I I 
Sbjct GGCATGACGAGGCCATGGAGGGGCAGGGGCAGTCGTCATGGATTCGGCTGGAGAGAGGTC 
I 
,,. N. crassa OR74A (NC12): SUipercontig 6: 2. 654808-2654871 + 
Score = 128.16 {64), Expect=3.5233E-29 
1 ldentities=64/64 (100%), Positives=64/64 (100%) 
i 
:Query AACAGAACTGGCATATCTGGGGTGGGGCGGCGGCGTTAGCGCTCAGGTTGAGCCAAAAGA 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I :1111111111111111111111 
Sbjct AACAGAACTGGCATATCTGGGGTGGGGCGGCGGCGTTAGCGCTCAGGTTGAGCCAAAAGA 
Query AMA 
I II 11 
lsbjct AMA 
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1 kb piece - #213 with UV90AFor primer 
Target S~ore (Bfui.] ~xpect A~ignment len!jth Identitmes Positives 
! ... N. crassa OR74A (NC12): Supercontig 6: 2655229-2655646 -
I Score = 783.319 {393), Expect=O.O 
I Identjties=409/418 (97%), Positives=409/418 {97%) 
I 
!ouery GCGTTGGGAGTGACGGCAAGCTGGAGGCTGCTCCCAGGTAAACGGGGACGACTGTGAGGT 
'1 I I I ~ I I I I I I I I I J I I I I I I I J I I I I I I J I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
, Sbj ct GCGT'TGGGAGTGACGGCAAGCTGGAGGCTGCTCCCAGGTAAACGGGGACGACTGTGAGGT 
1,· Query GTCGGGTCGAATACGGATKGATGGAATCCTTTTCCMCTTGTCGGTAAGGTAGGTATTAAA 
111111111111111111 111111111!111111 111111111t11111111111111 
Sbjct GTCGGGTCGAATACGGATGGATGGAATCCTTTTCCACTTGTCGGTAAGGTAGGTATTAAA 
Query AGGGCCGTAAACTAGCGGCGCGAAAATTGGTCTATGGTAGAAAGAAGCAAAGGAGGACCT 
I I I I I r I I I I I I I I I r I I I I I I I I I I I 11 I r I I I I I I I I I I I I I I I I I I I I I I I I I t I I I 
Sbjct AGGGCCGTAAACTAGCGGCGCGAAAATTGGTCTATGGTAGAAAGAAGCAAAGGAGGACC'T 
Query GATAATAACGCCCGTGGTAATGTAAGATACAGAGAATAGAGGGTCGGTGCCTCT'TCNNNN 
I I I I I I I I I I I I I J I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I l'I I I I I 
Sbj ct GATAATAACGCCCGTGGTAATGTAAGATACAGAGAATAGAGGGTCGGTGCCTCT'TCTTTT 
Query NNNGAGGGGTTGTGCTCGTGTCAACAAATGGGGGATTATTAGAGAGAACAAAGT'TGGCCG 
i I I I I I I I l I I I I I I I I I I I I I I I I I I I I I I I I I I I I' 1111111111: 111111111 
Sbj ct TTTGAGGGGTTGTGCTCGTGTCAACAAATGGGGGATTATTAGAGAGAACAAAGT'TGGCCG 
Query GATGTGGGTGGAAAGGAAC'TGCGTGGA:CGGGATGCGGGTGCAGGCAAGT'TTGAGCACAGG 
I I I I I I I I I I I I I I I I I I l I I I I I I I I I I I I I I I I I I I I I I I I I I I' 11111111111111 
Sbjct GATGTGGGTGGAAAGGAAC'TGCGTGGACGGGATGCGGGTGCAGGCAAGTTTGAGCACAGG 
Query TGGAAGCGAGCGAAACGCAGAGCCTTCCAGCAAAACGTCCTCGGCTGAGCGCTAGTCC 
111 f I I I I I I I I l I I I I l I I I I I I I I I I l I I I I I I I I I l I I I I J 11111111111111 
Sbjct TGGAAGCGAGCGAAACGCAGAGCC'TTCCAGCAAAACGTCCTCGGCTGAGCGCTAGTCC 
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1 kb piece - UV90 with R2 primer 
.... N. crassa, OR74A (NC12): Su1percontig 6: 2654898-2655047 + 
Score = 284512 (142), Expect=O.O 
Identities=147/150 (98%), Positives=147/150 (98%) 
Query CAGGTATTCGACCACGTACCTGGTATCCGCAGGGGCATGGTCTAAAGTTACGATCAGAGA 
1111111111111111111111111111 l I I I I I I I I I I I I I I l I I I I I I I I I I I I I I I I 
Sbjct CAGGTATTCGACCACGTACCTGGTATCCGCAGGGGCATGGTCTAAAGTTACGATCAGAGA 
Query GATCAAACTCCTCGATACAGAGGGGGCTATAGTATACTAGTTAGTCTGATGTGTTCTTGT 
111t111111111111111111111111111111111111111t1111111111111111 
Sbjct GATCAAACTCCTCGATACAGAGGGGGCTATAGTATACTAGTTAGTCTGATGTGTTCTTGT 
Query GGACGGCCGAKGGCRTTWTGACAGGGGGTC 
1111111111 Ill II 111111111111 
Sbjct GGACGGCCGAGGGCGTTGTGACAGGGGGTC 
.... N. crassa OR74A {NC12): Su1percontig 6: 2654808-2654871 + 
Score= 128.499 (64), Expect=l.98258E-29 
Identities=64/64 (100%}1 Positives=64/64 (100%) 
Query AACAGAACTGGCATATCTGGGGTGGGGCGGCGGCGTTAGCGCTCAGGTTGAGCCAAAAGA 
111J111111111111111111111111111111111111111 :11111111111111111 
Sbjct AACAGAACTGGCATATCTGGGGTGGGGCGGCGGCGTTAGCGCTCAGGTTGAGCCAAAAGA 
Query A.AAA 
1111 
Sbjct A.AAA 
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1 kb piece - UV90 with UV90AFor primer 
Target Sco:re ~1121its) !Expect Aiignment !Length Identities Pos~ftB\res 
• N. crassa OR74A (NCl2): Supercontig 6: 2655323-2655646 -
Score= 587.444 (293), Expect=O.O 
Identities=3l2/324 (96%), Positives=312/324 (96%) 
Query CACTTGTYGG'l'AAGGTAGGTATTAAAAGGGCCGTAAAMTAGSGGCGCGAAAAWTGGTCTA 
1111111 11111111111111111111111111111 Ill 1~11111111 111·1111 
Sbjct CACTTGTCGGTAAGGTAGGTATTAAAAGGGCCGTAAACTAGCGGCGCGAAAATTGGTCTA 
Query TGGTAGAAAGAAGCAAAGGAGGACCTGATAATAACGCCCGTGGTAATGTAAGATACAGAG 
I I I I I I I I I I I I I l I I I I I I I I I I I I I I t I I I I I I I I I I I I I I ~ I I I I I I I I I I I I I I I I 
Sbjct TGGTAGAAAGAAGCAAAGGAGGACC'l'GATAATAACGCCCGTGGTAATGTAAGATACAGAG 
Query AATAGAGGGTCGGTGCCTCTTCNNNNNNNGAGGGGTTGTGCTYGTGTCAACAAATGGGGG 
1111111111111111111111 1111111111111 ~1111111111111111 
Sbjct AATAGAGGGTCGGTGCCTCTTCTTTTTTTGAGGGGTTGTGCTCGTGTCAACAAATGGGGG 
Query ATTATTAGAGAGAACAAAGTTGGCCGGATGTGGGTGGAAAGGAACTGCGTGGACGGGATG 
I I I I I I I I I I I I I 111111111111111111111111111111;11111111'111111111 
Sbjct ATTATTAGAGAGAACAAAGTTGGCCGGATG'l'GGGTGGAAAGGAACTGCGTGGACGGGATG 
Query CGGGTGCAGGCAAGTTTGAGCACAGGTGGAAGCGAGCGAAACGCAGAGCCTTCCAGCAAA 
I I I I I I I I I I I I I J I I I I I I I I I I I I I I J I I I I I I I I I l I I I I ~ I I I I I I I I I l I I I I I I 
Sbjct CGGGTGCAGGCAAGTTTGAGCACAGGTGGAAGCGAGCGAAACGCAGAGCCTTCCAGCAAA 
Query ACGTCCTCGGCTGAGCGCTAGTCC 
111111111111111111111111 
Sbjct ACGTCCTCGGCTGAGCGCTAGTCC 
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Secondary structure and 
disorder prediction 
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Figure A3. PHYRE2 secondary structure and disorder prediction for protein product of 
Neurospora crassa gene NCU05950. 
Confidence Key= represents the probability ofNCU05950 protein product being 
homologous to the template. 
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PokWerrltln·llke 
! 1 d2gt;a1 Alignment 20 S11P9rt.ntly1HP0062·111ce 
P11Mly:HP006Z.Hke 
POI ,_..r:toxln 
2 '2.lzDI.. Alignment 21 Chelit: Ii Pot Molecule;c>utatlve membr•ne ·~ PDffltle~ blpd • an Invasion prteln auoclated' wftt:I the type.1112 
secretion system of burtholderia pseudomallel. 
3 ~ Alignment 24 
PD9 hHdltr:prowln binding 
ce..IRl It PO. MolecWt:sfll9M iweteln: 
....nti.: st:ro®r• of the tluoresc:ence recovery protein from 
synecl:locy$tll sp2 pee 6808 
-~lyf .. 
~= -·:Al POI ~:photolyase; 
4 ~ Alignment =·- ~, ·_: o~I *'1tture of a pr.okaryotlc (S-4:) ~ phrb i atf'~rlQm t\!lm-.C:lenl wttt;i an fe•s cltlmr and a 6,7· 
-•3 rtbltVlum•llne antlenn• chl'Omophore •t 1.45a 
lotion 
, .... Th~fold 
5 
.dlmll.. Alignment 2-9 ......... :Thloredoxln·•· 
Putlly:Yuz&.Nke 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) 
Figure A4. PHYRE2 top 5 protein templates matching Neurospora crassa gene 
NCU05950 protein product. 
Confidence(%)= represents the probability ofNCU05950 protein product being 
homologous to the template. 
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Jpred3 protein sequence alignments with Neurospora crassa NCU05950 protein 
product 
(http://www.compbio.dundee.ac.uk/www-jpred/index.html) 
QUERY 
UniRef90 02GRJ7 
UniRef90-UPI000023E1 E1 
UniRef90-B2A067 
UniRef90-A7EA02 
UniRef90-A4RIX4 
UniRef90-B6GXY1 
UniRef90-A2QWY 4 
UniRef90-05BCG8 
UniRef90-A 1 DMW4 
UniRef90-QOCl11 
UniRef90-B8NPB4 
UniRef90-B60423 
UniRef90-COS031 
UniRef90-A6RA59 
UniRef90-B2W9B9 
UniRemo::::aou774 
lupas_21 
lupas_14 
lupas_28 
jnet ~ .. 
conf 
sol25 
sol5 
9 8 6 2 4 7 0 0 0 1 5 7 8 8 8 7 7 6 4 3 0 0 0 0 0 0 1 
BBBBBBBBB B BB 
4 6 7 7 7 7 7 7 7 7 6 6 6 
BBBB 
solO 
jhmm 
jpssm 
QUERY 
UniRef90 Q2GRJ7 
UniRef90-UPI000023E 1E1 
UniRef90-B2AQ67 
UniRef90-A7EA02 
UniRef90-A4RIX4 
UniRef90-B6GXY1 
UniRef90-A2QWY4 
UniRef90-Q5BCG8 
UniRef90-A 1 DMW4 
UniRef90-QOCl11 
UniRef90-B8NPB4 
UniRef90-B60423 
UniRef90-COS031 
UniRef90-A6RA59 
UniRef90-B2W9B9 
UniRemo::::QoU774 
lupas_21 
lupas_ 14 
lupas_28 
jnet 
conf 
sol25 
sol5 
solO 
jhmm 
jpssm 
BB BB 
.... 
~ 00 ro M 
HMMNQEDPQETERE[JAALQGVVERTSNNMVO YDMVPHDK 
HMMGQEDPAE~QRE EALQRVVARTSDAMVD YEI PQDK 
A llJN G E N D T lLJE ~Q R E .N..E A L Q R v I A K T s D N M v D F D I A p Q E N 
QM~ p ED P~E v QR ElLJE AL QR v v ART s D N v D y DI A p s NH 
S QADPLE ORELEALQKVVAQTSNH VD FALVPPNA 
Q T G Q E D p E Q R E lLJE A L Q R v v A R T s D N v D F E I T p Q D 
HQASQPDSEYVRREREALESI CQRTSDSVI D WSI QPQPH 
T 0 G NH p D p s y L KR ERE AL EA I c QR Ts D s v I D ws L Q p Q pH 
0 O~N Q p D p G y v RR ERE AL EA I c QR Ts D s v I D ws L Q p Q pH 
NOi NNPDPENI KREREALEAI CQRTSESVI D WSLQPQPH 
SO NQPDSGYVRREREALEAI CQRTSESVI D WSLQPQPH 
TQGNHPDTGYLKREREALEAI CORTSDSVI D WSLQPQPH 
.N...NAJi.QODPEDLKREREALEAI CORASDTVI D WALQSOPN 
~G s ~Q R D p E y L K R E R E L E A I c Q R T s D s v v D w A L Q p H Q .£. 
H RAG p D p E y L K Q ERE L EA I c QR Ts D s v I D WA s s Q[LJ 
H NIY.JP Q p D p EEL RR QR EN L ER I c A ET NE Q L I p s Q£_S 
HNAPQPDPEE RRQRET ER CAETSEO P~AT PPE~S 
6 7 7 7 7 6 5 0 7 9 9 9 9 9 9 9 9 9 9 9 9 9 8 6 0 5 8 7 1 0 0 8 8 6 1 5 7 7 7 7 
B B BB BB B BB BB B B 
B B B 
B 
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QUERY 
UniRef90 Q2GRJ7 
UniRef90-UPI000023E 1E1 
UniRef90-B2AQ67 
UniRef90-A7EA02 
UniRef90-A4RIX4 
UniRef90-B6GXY1 
UniRef90-A2QWY4 
UniRef90-Q5BCG8 
UniRef90-A 1 OMW4 
UniRef90-QOCl11 
UniRef90-B8NPB4 
UniRef90-B60423 
UniRef90-COS031 
UniRef90-A6RA59 
UniRef90-B2W9B9 
UniRef9o=::QoU774 
lupas_21 
lupas_14 
lupas_28 
jnet 
conf 
sol25 
so IS 
so to 
jhmm 
jpssm 
QUERY 
UniRef90 Q2GRJ7 
UniRef90-UPI000023E 1E1 
UniRef90-B2AQ67 
UniRef90-A7EA02 
UniRef90-A4RIX4 
UniRef90-B6GXY1 
UniRef90-A2QWY 4 
UniRef90-Q5BCG8 
UniRef90-A1DMW4 
UniRef90-QOCl11 
UniRef90-B8NPB4 
UniRef90-B60423 
UniRef90-COS031 
UniRef90-A6RA59 
UniRef90-B2W9B9 
UniRef9o=::QoU774 
lupas_21 
lupas_14 
lupas_28 
jnet 
conf 
sot25 
sols 
so to 
jhmm 
jpssm 
Appendix IX 
90 0 110 120 
PMQDAPAPY~FANQRYNALLSK~STHDDMAA~AR~OWGTP AAQTAPGPY~Y~GQRYQTLLSKLSSHDDLIPSVARVOWGLP 
GNRGTTTPFAYAGQRYQHLVAKLSNQGO~APVSKVDW LIP 
AAPDSPEM~YAYPARYHNLLSK SSHDDLIAAVAR O~~J-,P 
D~~AAPKb~b~~~~~~g~~t~~~~~82~~~~~~k~8~~ 
~pg~~~~~:PTSVPSQRTDTTTPAVSTHRTSPPSRPTSG QPRATL QPRATLRGS[SZ]SPS TSRPESHOGAP QPRATGPIY]SPASSR FQPRAT[(IP 
G 
p 
A[(IPE[SZ]SEQ PKNOEYAH~ 
EQPTNOAEYA[(IFNERFAT~ 
7 7 7 7 7 7 7 7 7 7 7 7 6 0 1 6 7 7 7 6 3 2 6 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 
B B B B BB B B B B B 
BB B 
130 140 150 
E D E T I E M Q K N G p A s T I E ..S...D D G p L v G T F A D A A A A M Q 
EOOSMEM[(IRKAS[(IP~I P~KAEGGEALVGNFTOAAAAMR 
0 D D T ~E M Q Q G v M p I K [SZ]E G G D s L v G N F A D A A A A M 
DD D T I E M Q Q NT A p I K LIE GAE p L v G NF AD A A A A MR 
DDEDVEEMKKY.lL_ PVK.£.ED~GP LGGFADAESAME 
DEON EMHNGAILYJP P KLiEAAEPF GTF 
-tma- -flm9-
7 6 5 2 4 4 4 4 0 5 7 8 8 6 0 2 6 7 6 1 4 6 7 7 6 4 4 5 6 5 0 0 0 0 0 0 0 9 
B B BBBB B B BBBBBB B 
B B B 
B 
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Chi-square tests: 
12 =(observed- expected)2/expected 
Degrees of freedom (df) =(#of classes -1) 
p values obtained from Microsoft Excel, 2010 
First group of progeny: csp-1; bd; UV90 (sg #227) x Mauriceville wild type (Table 
8): 
Observed: 44 total 
Expected: 
x2 
UV90 
25 
22 
0.409 
Total: 12 = 3.318; df= 1; p = 0.0685 
UV+ 
14 
22 
2.9 
Second group of progeny: csp-1; bd; UV90 (sg #227) x Mauriceville wild type (Table 
14): 
Observed: 100 total 
Expected: 
x2 
bd; UV90 
21 
25 
0.64 
Total: x2 = 2.72; df = 3; p = 0.4368 
bd; UV+ 
19 
25 
1.44 
bd+; UV90 
25 
25 
0 
bd+; UV+ 
21 
25 
0.64 
Progeny from cross: FGSC Knockout #18029 x csp-1; chol-1 bd; UV90;frq1° (Table 
24): 
frqlO 
Observed: 55 total 
Expected: 
x2 
bd; UV+ 
18 
13.75 
1.31 
Total: x2 = 7.39; df = 3; p = 0.0601 
bd; UV90 
8 
13.75 
2.40 
bd;frqlO 
16 
13.75 
0.368 
bd; UV90; 
7 
13.75 
3.31 
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